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ABSTRACT
Total energy intake, physical activity, body size and body composition determine total energy 
expenditure. An imbalance between total energy intake and total energy expenditure causes
obesity. Overweight and obesity remains the most prevalent, modifiable cardiovascular risk factor
for children and adolescents. In adolescence, obesity is associated with adverse non-invasive,
subclinical cardiovascular phenotypes. In adulthood, these subclinical cardiovascular phenotypes
and specific, obesity-related serum metabolomic profiles are predictive of future cardiovascular
disease (including stroke and myocardial infarction) and cardiovascular disease mortality.
To investigate the association between determinants for total energy expenditure with
the severity of obesity, with obesity-related cardiometabolic risk factors and with subclinical 
cardiovascular phenotypes in children and adolescents with obesity.
The present study was based on data from participants of the Childhood Overweight
Biorepository of Australia (COBRA) and a derivative, longitudinal study-arm entitled
COBRA-CVR (COBRA-Cardiovascular Risk). COBRA is comprised of 438 children and
adolescents aged 6–18 years with overweight and obesity. COBRA-CVR includes a subset
of 101 former COBRA-participants with obesity, aged up to 25 years, who were followed-
up an average of 5.5 years later for the COBRA-CVR sub-study.
Among youth with obesity, low grip strength (a global measure of muscular strength) was
associated with poorer cardiometabolic health indicated by higher systolic blood pressure,
higher low-density lipoprotein-cholesterol, higher carotid intima-media thickness (cIMT) and
higher continuous metabolic syndrome score. Compositional analysis of macronutrients
revealed that the dietary proportion of proteins is negatively associated with total energy intake,
irrespective of whether carbohydrates or fats were the diluents. Several adiposity measures
(including body mass index, waist circumference, bioimpedance related percentage body fat)
showed associations consistent in direction and strength with metabolites that are associated 
with cardiovascular disease risk. Particularly, adiposity-related metabolomic profiles in post-
pubertal males resembled profiles from adults that are predictive for cardiovascular disease and
mortality. Increasing the severity of obesity from early to late adolescence was associated with
increased pulse wave velocity (PWV) in males and with reduced carotid elasticity in females.
Moreover, blood pressure was positively associated with PWV and glycoprotein acetyls
(GlycA, a measure of chronic inflammation) was negatively associated with carotid elasticity.
Male sex was the only factor associated with increased cIMT.
Obesity in youth is a multifactorial disease of pandemic scale that is in need of methods for
prevention and risk stratification to alleviate the associated negative public health impacts. This
study provides evidence for approaches that are clinically translatable to youth with overweight
or obesity: to reduce total energy intake by ensuring sufficient protein intake; and factors that
could help identify those at higher risk for adverse cardiometabolic outcomes.
KEYWORDS: Childhood, adolescence, obesity, hand grip strength, protein leverage
hypothesis, metabolomics, subclinical cardiovascular phenotypes
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TIIVISTELMÄ
Lihavuus johtuu energian saannin ja kulutuksen epätasapainosta. Se on lapsilla
keskeinen sydän- ja verisuonitautien riskitekijä. Teini-ikäisillä lihavuus lisää
varhaisten, oireettomien valtimomuutosten esiintyvyyttä. Aikuisilla nämä valtimo-
muutokset sekä lihavuuteen liittyvät metaboliset muutokset ennustavat sydän- ja 
verisuonitapahtumia ja niihin liittyvää kuolleisuutta.  
Väitöskirjatutkimuksen tavoitteena oli selvittää ravitsemuksen vaikutuksia
lapsuusiän lihavuuden vaikeusasteeseen ja tutkia kehon koostumuksen yhteyttä
veren metabolomiikkamuuttujiin sekä varhaisiin valtimomuutoksiin. Lisäksi
tutkimuksessa arvioitiin käden puristusvoiman yhteyttä varhaisten valtimomuu-
tosten ilmenemiseen.
Väitöskirjatutkimus on osa australialaista Childhood Overweight Biorepository 
of Australia (COBRA)-tutkimusta ja sen jatko-osaa COBRA-CVR. COBRA-
tutkimukseen osallistui 438 iältään 6–18-vuotiasta ylipainoista tai lihavaa lasta,
joista 101 osallistui COBRA-CVR-jatkotutkimukseen.
Ravintoainesanalyysin perusteella ravinnon proteiiniosuus oli sokeri- ja 
rasvakulutuksesta riippumatta tutkimusryhmässä käänteisesti yhteydessä kokonais-
energiansaantiin. Metabolomiikka-analyyseissä eri kehonkoostumusmittarit korre-
loivat useisiin metaboliitteihin, joiden on todettu ennustavan valtimotautiriskiä.
Yhteydet olivat vahvimpia teini-ikäisillä pojilla. Lihavuuden vaikeutuminen teini-
iässä oli yhteydessä varhaisiin valtimomuutoksiin, pojilla lisääntyneeseen valti-
moiden jäykkyyteen ja tytöillä alentuneeseen kaulavaltimon joustavuuteen. Lisäksi
verenpaine korreloi suoraan valtimoiden jäykkyyteen ja inflammaatiotekijä
glykoproteiini-A käänteisesti kaulavaltimon joustavuuteen. Alentunut käden puris-
tusvoima oli yhteydessä korkeampiin systolisen verenpaineen, LDL-kolesterolin,
kaulavaltimon seinämäpaksuuden ja metabolisen oireyhtymän riskipisteytyksen
arvoihin.  
Ravintoainesanalyysi voi antaa lisätietoa painonhallintaan. Etenkin teini-ikäi-
sillä pojilla vaikea lihavuus on yhteydessä metabolisiin muutoksiin. Lihavuuden
vaikeutumisen estäminen teini-iässä saattaisi vähentää varhaisten valtimomuutosten
esiintymistä. Käden puristusvoimamittauksilla voi olla mahdollista arvioida lihavien
lasten alttiutta valtimotaudin riskitekijöille.
AVAINSANAT: Lapsuus, teini-ikä, lihavuus, metabolomiikka, varhaiset valtimo-
muutokset, puristusvoima
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1 Introduction
Globally, the prevalence of obesity in youth aged 5-19 years has increased nearly eight-fold over the
last four decades (Di Cesare et al.,2019), affecting close to one in five children or adolescents in the
United States (US) in 2015-2016 (Skinner et al.,2018) and approximately one in twelve children aged 
2-17 years in Australia in 2017-2018 (Australian Bureau of Statistics, 2018). In Europe, the
corresponding prevalence of obesity amongst children aged 2-13 years was 5.7% between 2011-2016 
with highest rates in Mediterranean countries and lowest rates in countries in central Europe (Garrido-
Miguel et al.,2019). Obesity is caused by a genetic susceptibility for weight gain, an obesogenic 
environment and genome-environment interactions inducing epigenetic changes (Swinburn et al.,2002;
Thaker,2017). Weight gain as a consequence of genes appear rather low based on genome-wide
association studies. In contrast, factors related to the obesogenic environment people live in contribute 
to a greater extent. Ultimately, all these factors, hereinafter termed determinants of obesity, adversely 
influence the ratio of total energy intake (TEI) to total energy expenditure (TEE) (Lobstein et al.,2015). 
TEE is determined by physical activity, TEI, body size and body composition, and interactions between
those factors (Westerterp,2017). Efficient treatment options for obesity in childhood and adulthood are 
limited and the likelihood for a child with obesity to have a weight in the obese category in adulthood
is ~80% (Freedman et al.,2001; Ward et al.,2017). Preventive factors related to the TEI/TEE ratio are 
therefore paramount. Also, there is evidence to suggest that prevention of obesity in early childhood is
cost-effective, particularly due to obesity related cardiovascular and metabolic disease and mortality
later in the life-course (Gortmaker et al.,2015; Trasande et al.,2009). Therefore, the overall aim of this
study was to investigate factors that contribute to an imbalanced TEI/TEE ratio and measures or 
methods that allow risk stratification for obesity-related cardiometabolic outcomes in children and
adolescents.
The specific aims I and II of this study focus on factors that are novel in their application to children 
and adolescents with obesity and are related to TEI and TEE, respectively. The main determinants for
TEE are body size, body composition, TEI and physical activity (Westerterp,2017). Combined, these
determinants impact on the three main components of TEE that are resting energy expenditure (REE, ~
55-65% of TEE), diet-induced energy expenditure (DEE, ~10%) and activity-induced energy
expenditure (AEE, ~25-35%) (Westerterp,2017). REE is fairly constant at a given body composition 
and size, and the contribution of DEE on TEE is rather small. In contrast, AEE is the most variable
component of TEE, and overall, reflects the sum of physical activity (Washburn et al.,2014). The gold 
standard to assess TEE is the doubly labelled water method (Schoeller et al.,1982). For physical activity, 
many methods are proposed, each providing information on different facets of physical activity (Sylvia
et al.,2014). Recently, a number of studies have examined the utility of hand grip strength in large
population studies. Hand grip strength is a global measure of muscular strength and increases with
physical activity training. Studies in adolescence and senescence have shown associations between
lower grip strength and higher cardiovascular disease (CVD) and all-cause mortality (Kim et al.,2017; 
Lopez-Jaramillo et al.,2014; Ortega et al.,2012). Hand grip strength is simple to assess and appears to 
have predictive value for various health outcomes in adulthood. However, data on grip strength in
children and adolescents with obesity, particularly for obesity-related adverse cardiometabolic 
outcomes, are lacking. 
Besides TEE, TEI is the most obvious determinant of human weight. TEI results from the proportional 
energy intake from carbohydrates, fats and proteins, each contributing roughly 50%, 30% and 20% to 
the total energy intake in a standard diet (National Health and Medical Research Council,2006, updated 
September 2017). Differences in the macronutrient composition, particularly changes in the energy
derived from proteins, has been the background for the protein leverage hypothesis. Using nutritional
geometry in animals and adult humans, the founders of the protein leverage mechanism suggested that 
the proportion of energy from proteins may have a disproportionately high impact on TEI (Simpson et 
al.,2005). This mechanism, while increasing TEI may also contribute to increasing weight in people 
living in westernised countries with an abundancy of food supply - a concept termed protein leverage 
12
  
       
        
 
           
          
        
      
          
          
      
    
       
      
    
     
          
            
            
       
         
          
     
       
        
     
           
        
      
         
         
         
  
 
            
      
    
          
         
     
         
        
    
           
     
     
       
      
          
        
              
        
          
       
      
hypothesis. Whether protein leverage exists in childhood and adolescence, and whether protein leverage
contributes to weight change in children with obesity has not been investigated.
Once an imbalanced TEI/TEE ratio has caused weight gain and subsequent obesity, the human body
will physiologically defend the new weight status, which may lead to adverse health-related
consequences (Schwartz et al.,2004). In fact, obesity in youth is associated with a plethora of adverse 
health-related consequences, of which adult cardiometabolic diseases are the most important for public 
health and healthcare systems (Olshansky et al.,2005). Therefore, specific aim III of this study focusses
on a systems biology approach, i.e. metabolomics, as a method for CVD risk-stratification and risk
prediction in children and adolescents with obesity. Obesity-related cardiometabolic risk factors in
youth include elevated systolic blood pressure (SBP) and diastolic blood pressure (DBP), elevated total 
cholesterol and triglycerides (Skinner et al.,2015), insulin resistance (IR) (Friedemann et al.,2012) and 
elevated markers for a low-grade, chronic inflammation (Schipper et al.,2012). Similar to excessive 
weight, these cardiometabolic risk factors share a strong tendency to track, or persist, from childhood
into adulthood (Juhola et al.,2011; Ward et al.,2017). Furthermore, in adulthood they are associated 
with CVD and type 2 diabetes (T2DM), and ultimately with increased mortality rates (Caprio et 
al.,2020; Lindberg et al.,2020a; Reilly et al.,2011). Over the past two decades there has been a rapid
increase in volume, variety and velocity of medical data - summarized under the term “Big data”
(Hulsen et al.,2019). Novel methods derived from Big data analysis ideally are accurate and cost-
effective in improving risk-stratification and risk prediction for cardiovascular disease beyond the level
from traditional cardiometabolic risk factors (Hlatky et al.,2009). Metabolomics may be such a method, 
providing information on large amounts of metabolites that are a consequence of the individual`s
genetic background and environment. Results from metabolomic analysis reflect an individual`s
phenotype more closely than analysis based on other omics-platforms such as genomics, 
transcriptomics or proteomics (Rattray et al.,2018). In adulthood, metabolomic studies have revealed
specific profiles comprised of metabolites that are caused by increasing body mass index (BMI) levels
(Holmes et al.,2014; Wurtz et al.,2014). Such metabolomic profiles have been associated with 
cardiometabolic risk factors (Tulipani et al.,2016; Zhao et al.,2016), type 2 diabetes (Wang et al.,2011),
and future CVD (Holmes et al.,2018). However, limited analogous data are available in children and
adolescents with obesity. This is unfortunate, as this is a population with high risk for the development
of cardiometabolic diseases, where early detection would seem most beneficial for the long-term
outcome.
Aim IV of this study will cover the relation between changes in adiposity measures and changes in 
traditional cardiovascular risk factors over time on changes in large artery properties. Changes in large
artery properties in this study will be reflected by a comprehensive assessment of subclinical 
cardiovascular phenotypes in children and adolescents. Subclinical cardiovascular phenotypes illustrate
intermediate outcomes of the process of arteriosclerosis before the manifestation of CVD. They can be
assessed non-invasively, their method of assessment is well-tolerated and overall, these phenotypes are 
increasingly used in youth for research purposes. Such phenotypes comprise the carotid intima-media
thickness (cIMT), pulse-wave velocity (PWV) and the carotid artery elasticity. In youth, they are
associated with various, pro-atherogenic conditions such as type 1 diabetes, chronic kidney disease and 
various other health issues (Urbina et al.,2009a). There is cumulative evidence for an association
between excessive weight and adverse subclinical cardiovascular phenotypes starting in early life. In 
childhood, the number and severity of traditional cardiovascular risk factors are associated with 
subclinical cardiovascular phenotypes in early adulthood (Juonala et al.,2010; Koivistoinen et al.,2011).
In adulthood, these phenotypes are predictive for future CVD and mortality (Boesen et al.,2015; Lorenz 
et al.,2007; Mitchell et al.,2010). Longitudinal cohort studies have also shown that former adolescents
with overweight or obesity, who regain normal body mass index (BMI) by adulthood can equalize their 
most cardiovascular risk factors to those who had a BMI always in the healthy range, but results for 
cIMT are inconsistent (Buscot et al.,2018; Juonala et al.,2011). However, studies in children and
adolescents with obesity that investigate the association between longitudinal adiposity measures or key
cardiovascular risk factors (such as blood pressure, blood lipids, fasting glucose levels or inflammatory
markers) with subsequent subclinical cardiovascular phenotypes are sparse. Such studies could inform
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the clinician as to which participants and which exposure measurements could be prioritized as
intervention targets. 
In conclusion, children and adolescents with obesity are a vulnerable group, especially for adverse
cardiometabolic health outcomes and CVD-related mortality in adulthood. Effective treatment options 
in youth are limited, and the persistence of obesity and obesity related cardiometabolic risk factors into
adulthood highlights the importance of primary and secondary prevention. Better understanding of
factors that contribute to obesity, markers or methods that identify the most vulnerable of children or 
adolescents with obesity and markers or methods that allow risk prediction are needed to tackle the
obesity pandemic and its adverse health effects. In a cohort of children and adolescents with obesity, 
this study aimed to investigate the association between determinants for an adverse TEI/TEE ratio with 
the severity of obesity, with obesity-related cardiometabolic risk factors and with subclinical 
cardiovascular phenotypes. The specific aims tested were: i) the association between grip strength, a
determinant for TEE, with obesity-related cardiometabolic outcomes; ii) the protein leverage hypothesis 
as a contributor to increased TEI and weight gain; iii) associations between adiposity measures and 
CVD-specific metabolomic profiles; and iv) associations between changes in adiposity measures and 
changes in traditional cardiovascular risk factors over time on subclinical cardiovascular phenotypes.
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2 Review of the Literature
2.1 Adiposity and adiposity-related mortality in adulthood
The World Health Organization (WHO) defines overweight or obesity as an accumulation of excess
body fat to the extent that it may have adverse health-effects (WHO). In adults, overweight and obesity
are determined by a body mass index (BMI) greater or equal to 25 kg/m2 and 30 kg/m2, respectively. In
the United States (US), the most recent analysis of trends for the prevalence of obesity amongst adults
showed a continuous rise, from 33.7% in 2007/2008 reaching 39.6% in 2015/2016 (Hales et al.,2018). 
Obesity in adulthood is associated with increased morbidity and mortality, with CVD as the major 
contributor (Afshin et al.,2017; McGee et al.,2005). Further details of evidence for obesity-related
mortality arose from a meta-analysis in four continents including 239 prospective studies and more than
10 million participants: the results showed a J-shaped curve for the association between BMI and all-
cause mortality with the vertex situated at a normal-weight BMI between 20-25kg/m2 (Di Angelantonio
et al.,2016). Detailed results showed that hazard ratios per 5-units increase in BMI for all-cause 
mortality were higher for younger adults (35-49 years versus 70-89 years), higher for males versus
females and the major underlying causes for mortality were (ranked by priority) coronary heart disease,
stroke, respiratory disease and cancer (Global et al.,2016). A corresponding meta-analysis from the
United Kingdom showed a relative risk (RR) for overall mortality of 1.20 [95%CI 1.12-1.29] for men
and 1.28 [95%CI 1.18-1.37] for women and specifically for death from CVD of 1.45 [95%CI 1.33-
1.59] for men and 1.53 [95%CI 1.38-1.69] for women with obesity, compared to normal weight
counterparts (McGee et al.,2005).
An estimated 70% of adults with obesity included in studies investigating measures of adult BMI and
overall and disease-specific mortality rates were not obese in childhood or adolescence (Simmonds et 
al.,2016). However, based on increasing prevalence rates for obesity in childhood and the persistence
of excessive weight from childhood into adulthood, the fraction of adults with obesity that were already
obese in childhood or adolescence is likely to increase over the next decades. The next section will 
discuss the prevalence of overweight and obesity and demographic characteristics of overweight and 
obesity in the paediatric age range over the last 5 decades.
2.2 Prevalence of overweight and obesity in children and adolescents
In countries such as the US, Brazil, Mexico, Saudi Arabia and China, the prevalence of overweight and
obesity (determined by the 85th and 95th centile of BMI reference charts, see section 2.4) in childhood
was below 15% in 1972 (Lobstein et al.,2015). However, within just 3 decades, the average weight in 
US children has increased by 5 kg (Lobstein et al.,2015). And this trend is ongoing: the most recent
evaluation of US data revealed that the prevalence of obesity in US youth aged 2-19 years has increased
from 13.9% in 1999/2000 to 18.5% in 2015/2016 (Craig M. Hales,2017). Globally, 370 million children 
and adolescents were estimated to be affected by obesity in 2016 ("Global Nutrition Report: Shining a
Light to Spur Action on Nutrition,"2018). 
Detailed demographic analysis, including the effects from sex, ethnicity/race, household income and
education level on obesity rates in childhood were published based on data from the US National Health
and Nutrition Examination Survey (NHANES). Overall, sex did not show any differences, but variation 
was seen according to ethnicity/race with higher rates for Hispanic (25.8%), followed by non-Hispanic
black (22%), non-Hispanic white (14.1%) and non-Hispanic Asian youth (11%) (Craig M. Hales,2017). 
Analysing a similar NHANES dataset, the severity of obesity across the paediatric lifespan was shown
to increase with age, regardless of sex and ethnicity/race (Hall et al.,2018). Individuals with highest 
household income showed a lower prevalence (10.9%), compared to those with lowest income (18.9%) 
and those with higher level of education (college graduate) had a lower prevalence (9.6%) compared to
those with lower level of education (high school graduate or less) with a prevalence of 21.6% (Ogden
CL,2018).
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2.3 Overview of obesity-related health effects in childhood and adulthood 
Increasing weight during childhood is associated with a plethora of short-term and long-term
consequences affecting mental and somatic health. Whereas adverse health consequences from obesity 
separately for childhood and adulthood age are well known, there is limited evidence for BMI in
childhood to represent an independent predictor for adult morbidity.
Short-term, mental health outcomes for children with obesity include higher risks for depression and 
anxiety (>30% increase) (Lindberg et al.,2020b; Sutaria et al.,2019) and for low self-esteem and 
behavioural disorders (Rankin et al.,2016) when compared to normal-weight counterparts. Short-term
somatic consequences compared to normal weight children include a higher risks for asthma (relative
risk 1.29) (Lang et al.,2018), non-alcoholic fatty liver disease (34.2% for obese versus 7.6% for children 
with normal weight) (Anderson et al.,2015) and musculoskeletal problems (Krul et al.,2009). Children 
with obesity have a high risk for an adverse cardiometabolic profile including low-grade systemic 
inflammation (Singer et al.,2017), high blood pressure (Du et al.,2019; Wuhl,2019), dyslipidaemia
(Skinner et al.,2015), type 2 diabetes (Galuska et al.,2018) and adverse subclinical cardiovascular
phenotypes (Urbina et al.,2009a) which is discussed in detail in sections 2.6 and 2.8.
Obesity in adulthood is strongly associated with increased morbidity from many diseases such as
diabetes (20% increase of the risk to develop T2DM for each 1kg/m2 increase in BMI (Hartemink et 
al.,2006)), CVD (Khan et al.,2018), obesity-related hypoventilation syndrome (Mokhlesi,2010), non-
alcoholic fatty liver disease (NAFLD)(Loomba et al.,2013), cancer (Nomura et al.,2010) and chronic 
kidney disease (Coresh et al.,2007). Obesity in adulthood is also associated with increased all-cause 
mortality, predominantly due to CVD (Prospective Studies et al.,2009), respiratory disease and cancer
(Berrington de Gonzalez et al.,2010; Global et al.,2016). 
Systematic reviews and cohort-studies have investigated the relation between childhood and adult BMI,
and between childhood BMI and adult morbidity with conflicting findings. There is convincing 
evidence from systematic reviews (Simmonds et al.,2015) and growth trajectory simulations (Ward et 
al.,2017) that a child with obesity will remain in the obese weight category in adulthood. Also, there
are associations between higher BMI in children aged 12 years and older with adult manifestation of
type 2 diabetes mellitus (OR 1.70, 95%CI 1.30-2.22) and coronary heart disease (OR 1.30, 95%CI 1.16-
1.47) from a systematic review and meta-analysis (Llewellyn et al.,2016). However, the predictive
ability for BMI in childhood for type 2 diabetes and cardiovascular disease in adulthood is overall low. 
In studies where the association between childhood BMI and adult comorbidities were adjusted for 
adult BMI levels, the associations for childhood BMI as predictor regressed to the null (Lloyd et 
al.,2010, 2012; Park et al.,2012; Umer et al.,2017). This is largely explained by the fact that most adults
(~70%) with obesity and CVD had a normal weight during their childhood 4-7 decades ago (Llewellyn
et al.,2016; Simmonds et al.,2016). No other measure than BMI has shown any benefits for the
determination of obesity in childhood or to predict adult obesity and morbidity. A collection of the most
commonly used measures is discussed in the following section (Simmonds et al.,2015). 
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2.4 Adiposity measures in children and adolescents
Body mass index (BMI) is the accepted standard measure to determine overweight and obesity for
children 2 years of age and older and adults (Freedman et al.,2009b; Styne et al.,2017). BMI is
calculated by body weight in kg divided by height in meters squared. BMI thresholds in adulthood are
static, sex-independent (i.e. 25kg/m2 for overweight, and BMI >30kg/m2 for obesity) (WHO,1995), and
well related to morbidity and mortality (WHO,1998). In childhood and adolescence, measures such as
BMI or the percentage body fat need to take into account the changes in anthropometry related to normal
growth, sex, and puberty. Hence, BMI-values need to be compared to age and sex-adjusted reference-
data from large populations and transformed into centiles or standard deviations (SD) or z-scores for 
comparability.
The two most widely used classification system for BMI are the Centers for Disease Control (CDC)
growth charts (based on data from NHANES) (Ogden et al.,2014) and the International Obesity 
Taskforce (IOTF) cut points (Cole et al.,2000). For completeness, the World Health Organisation
(WHO) is the third most common classification system (de Onis et al.,2007) (see Table 1). According
to the NHANES reference, overweight and obesity is determined by a BMI exceeding the 85th or 95th 
centile, corresponding to ~ 1.44 or 1.96 BMI z-scores (CDC,2020; Ogden et al.,2014), whereas the
IOTF curves were fitted to align with adult BMI thresholds at the age of 18 years (Cole et al.,2000).
Whereas for overweight, the IOTF and the 85th CDC centile are comparable, the IOTF cut-off for 
obesity is higher than the 95th CDC centile, rather corresponding to the 97th CDC centile among school-
aged children. Such differences between classification systems may complicate comparisons across
studies (Flegal et al.,2006).
Table 1. Cut-offs for overweight and obesity in childhood
Overweight and Background Age Year of
obesity cut-off coverage publication
CDC BMI ≥ 85th centile Five national surveys in US children 2-18 2000 
BMI ≥ 95th centile and adolescents from 1963 to 1994 years (Kuczmarski 
et al.,2002)
IOTF BMI ≥ 85th centile Nationally representative growth data 2-18 2000 (Cole
BMI ≥ 95th centile from 6 countries including Brazil, years et al.,2000)
Great Britain, Hong Kong,
Netherlands, Singapore and United
States
WHO BMI ≥ 1 SD National Center for Health Statistics / 0-18 2007 (de
BMI ≥ 2 SD WHO growth reference data from years Onis et
1977 al.,2007)
CDC: Centers for Disease Control; IOTF: International Obesity Taskforce; WHO: World Health
Organization; SD: standard deviation; BMI: body mass index
Children and adolescents with severe obesity (>97th centile, i.e. > 3 BMI-SD) are at high risk for future
cardiovascular and metabolic disease (Friedemann et al.,2012). In this subgroup, substantial weight 
increments are reflected in small increments in tenths or hundredths of percentiles, standard deviations
or z-scores (Flegal et al.,2009; Woo,2009). Therefore, the American Heart Association and the
Endocrine Society recommend to use the percentage above the 95th BMI centile (%>95th BMI-centile)
rather than centiles, standard deviations or z-scores (Flegal et al.,2009). The %>95th BMI-centile is the
ratio of the individual`s BMI divided by the relevant 95th BMI-centile for an age- and sex-matched
individual multiplied by 100%: e.g. the 95th BMI-centile for a male adolescent 14 years is 26 kg/m2. If 
17
  
           
              
       
     
         
      
 
 
       
        
       
         
      
       
      
           
        
    
 
                
           
             
          
    
 
             
        
        
        
          
          
           
      
       
            
 
          
              
            
        
         
           
            
            
          
        
       
        
     
        
             
               
      
  
the adolescents` BMI is 32kg/m2, the %>95th BMI-centile is (32/26) x 100% = 123%). The %>95th BMI-
centile is a continuous variable, starting from the 95th BMI centile (i.e. the cut-off for obesity). The
%>95th BMI-centile measure revealed advantages in monitoring children and adolescents with severe 
obesity (Cole et al.,2005; Flegal et al.,2009) due to an improved visual tracking on the growth chart for
clinical purposes (Gulati et al.,2012) and a solid correlation with the number and the severity of 
cardiometabolic risk factors (such as abnormal cholesterol, SBP and haemoglobin A1c-values (HbA1c))
(Skinner et al.,2015). 
BMI, BMI centiles, BMI z-scores and the %>95th BMI are reflecting sheer mass rather than adiposity, 
i.e. these measures cannot quantify body fatness and lean mass (Prentice et al.,2001). However, the
level of agreement for BMI predicting body fatness improves with higher BMI-levels, reaching a
moderately high sensitivity of 70-80%, with a specificity of 95% when compared with the dual X-ray
absorptiometry (DXA) as the reference method (Freedman et al.,2009a). Similar, the strength of the
association between BMI and CVD risk increases with increasing levels of BMI according to a
systematic review and meta-analysis investigating 63 studies with nearly 50`000 children (Friedemann
et al.,2012). Measures other than BMI aim to quantify and characterise body fatness, as excessive fat is
the main compartment associated with obesity-related cardiometabolic disease (Barker,2005; Fortuno
et al.,2003; Prentice et al.,2001).
The most accurate, yet cumbersome method to assess body fat is the deuterium dilution method. It
calculates total body water and fat-free mass according to an algorithm that uses the difference in
secreted markers between baseline and post ingestion. As this method is not feasible for general practise,
I will subsequently review the most common clinically assessed measures that were also used as
exposures for this study.
In children with overweight (i.e. between the 85th and 95th centile), waist circumference (WC) was
suggested superior to predict excess body fatness and adverse risk factor levels (Freedman et al.,2009a). 
In adults, a waist to height-ratio (WtH), a derivative of waist circumference, has been suggested superior 
to WC and BMI to predict CVD, T2DM (Ashwell et al.,2012) and central obesity (Ashwell et al.,2014). 
Studies in children and adolescents advised a WtH-ratio cut-off of 0.5 to assess cardiovascular risks
(McCarthy et al.,2006a) with other studies proposing higher or lower cut-offs (Graves et al.,2014; 
Nambiar et al.,2010; Ribeiro et al.,2010). However, WC and WtH-ratio require age- and sex-specific
cut-offs, both are subject to larger measurement errors when compared to BMI (Ulijaszek et al.,1999),
both require physical contact which may be impractical in some settings, and the amount of additional
information for risk prediction when BMI is already known may be little (Freedman et al.,2007).
Bioimpedance analysis (BIA) is another commonly used method to differentiate body weight into fat
mass and fat-free mass. A single frequency alternating electrical current of 50 kHz estimates the amount
of total body water. As fat contains little water, impedance is a surrogate for fat-free body mass and
body fat can be calculated from the total weight subtracting the fat-free body mass. Limitations to BIA
include that the resistance of arms and legs (due to lower diameters) represent almost 90% of the 
impedance while only representing ~ 50% of the body weight. Hence, changes in muscle mass
disproportionally impact on BIA results. The second limitation is based on the assumption that fat-free
mass consists of 73% water. Factors such as hydration status, a full bladder or exercise will therefore
affect the results. These limitations in mind, the validity of BIA results is based on reference data 
comparing results with dual-energy X-ray absorptiometry (DXA) or – more cumbersome - stable
isotope dilution methods. Such reference data, adjusted for sex in children aged 6-18 years have been 
published, illustrating a comparable development of body fatness until puberty in both sexes with males
proportionately decreasing and females gaining body fat during puberty (McCarthy et al.,2006b). A 
study comparing BIA and DXA results for body fatness in obese adolescents before and after a weight 
management intervention have shown acceptable mean differences (0.4 to 2.1%) of body composition
measures with large limits of agreements (~15% for fat free mass). The study group concluded that
bioimpedance may be a valuable tool to assess body composition at a group level but inaccurate for an 
individual assessment (Wan et al.,2014).
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2.5 Determinants of obesity in childhood and adolescence
Obesity is a multifactorial disease involving genetic and obesogenic, environmental factors as drivers
for excessive weight gain (Agostoni et al.,2011; Sabin et al.,2010). In brief, from a genetic point of 
view, obesity is seen as a multiallelic condition with high heritability but overall small individual allelic
effects (Lee,2013). The use of genome-wide association studies have revealed more than 100 risk alleles
that contribute to a predisposition for weight gain. However, their individual effect seems rather low at
~0.17 kg/m2 per additional risk allele (Speliotes et al.,2010). Also, obesity phenotypes have shown
large variations even amongst groups with almost identical genotypes (McGarvey,1991) and obesity-
associated genes fail to explain the rapid onset of the obesity-epidemic over the last 4 decades (Herrera
et al.,2011). In contrast to those risk alleles, the presence of specific monogenic or syndromic forms of
obesity are exceedingly rare. Phenotypes caused by syndromic forms of obesity may include specific
features such as short stature, developmental disabilities and functional and structural disorders of
sensory organs (Sabin et al.,2011). Most of the monogenic forms are involved in the regulation of satiety
and hunger such as those forms affecting the leptin/leptin receptor system (Mantzoros et al.,2011). 
Other than genetics, various environmental and behavioural factors have been identified to adversely 
impact on the TEI/TEE ratio (Swinburn et al.,1999) and to promote childhood obesity. They include 
factors related to antenatal and maternal conditions, socioeconomic status, lifestyle or behaviour, sleep
characteristics and the food environment people live in. The effect of each of those factors may be 
small, but the cumulative effect of a series of such factors that make up the daily routine of entire
populations is substantial. As a consequence, understanding the environmental and behavioural
determinants of obesity during childhood and adolescence is key for preventive strategies (Woo Baidal 
et al.,2012). Many determinants discussed below are integrated in international clinical guidelines for
prevention of childhood obesity (Barlow et al.,2007; Cuda et al.,2018; Styne et al.,2017). 
More recently, associations between environmental chemical exposures, particularly between endocrine 
disrupting chemicals (EDCs) and adverse effects on weight status have gained recent attention
(Braun,2017). EDC`s are chemical compounds that may alter hormonal actioning and signalling
(Zoeller et al.,2012) and there are concerns that such alterations may have higher impact during the
period of infancy and childhood, when hormonal homeostasis is detrimental for normal growth and 
development. EDC classes that have been investigated for possible associations with weight status
include phthalates, bisphenol A, triclosan and perfluoroalkyl substances. The body of evidence for an
association between antenatal or postnatal exposure and subsequent weight status increases, however
the overall findings are inconsistent (Andersen et al.,2013; Braun et al.,2014; Buckley et al.,2016a;
Buckley et al.,2016b; Buser et al.,2014; Hoepner et al.,2016; Johnson et al.,2014; Li et al.,2015;
Maresca et al.,2016; Mora et al.,2017). Various mechanisms of action of these EDC have been
proposed: i) perfluoroalkyl substances are associated with impaired birth weight. Decelerated 
intrauterine growth followed by accelerated infant growth is associated with higher adiposity and 
cardiometabolic risk markers later in life (Perng et al.,2016); ii) phthalates might interfere with the
metabolism of thyroid hormones, glucocorticoids and androgens; iii) bisphenol A may act in oestrogen
signalling and iv) triclosan can disrupt gonadal and thyroid hormone circuits (more details are reviewed
in (Braun,2017). Further research in large population studies will be required including a large set of 
known behavioural and environmental factors to adjust for confounding to estimate the contribution of
ECD on weight gain. The next sections will discuss those known factors, divided in two periods: the
first covering the first 1000 days of life starting from conception, the second covering the later period 
of childhood and young adolescence.
2.5.1 Determinants of obesity during the first 1000 days of life from conception
The origins for the development of childhood overweight or obesity can be identified very early in life
with some studies declaring the period from 0-5 years as critical for the attainment of an excessive 
weight status in (Cunningham et al.,2017; Cunningham et al.,2014). In addition, a recent systematic
review showed that origins of obesity in childhood can be identified as early as the first 1000 days of 
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life, starting from day 1 of conception until the second birthday of the child (Woo Baidal et al.,2016). 
A summary of the aforementioned study is provided as follows divided into two periods: i) an antenatal
till birth, followed by ii) a postnatal from birth till the second anniversary.
i. For the first period, the study reported evidence for gestational diabetes mellitus, higher
maternal pre-pregnancy BMI, excessive gestational weight gain and maternal tobacco smoking
to be associated with childhood overweight. Limited evidence was found for the mode of 
delivery (Caesarean section versus vaginal delivery) as a risk factor for the development of 
overweight or obesity. Maternal age was not, and increasing maternal parity was inversely 
associated with childhood overweight (Woo Baidal et al.,2016).
ii. During the second period from birth until the second birthday, factors consistently associated
with later child overweight were: higher birthweight, rapid weight gain, and changes in the 
faecal microbiome composition (with higher concentrations of Staphylococcus aureus being 
associated with childhood overweight). In addition, based on three large US prospective 
studies, low socioeconomic status (SES) was consistently identified as a risk factor for later
childhood obesity. Inconsistent evidence was found for behavioural factors including sleep
quantity or screen time, and no studies investigated the effect of physical activity / active play 
time in infancy on later obesity development. For breastfeeding, the evidence for an association 
with childhood overweight was inconsistent, however, the authors concluded that breastfeeding
may provide a protective effect. Nutritional factors such as the early introduction of solid foods
before 4 months, maternal intake of coffee or tea during infancy and high protein intake were
found to increase the risk for childhood obesity (Woo Baidal et al.,2016). 
2.5.2 Determinants of obesity in older children and adolescents
Table 2 illustrates an overview of risk factors for the development of obesity in older children and young 
adolescents, including factors related to the following categories: screen time, sleep characteristics, food
environment, socioeconomic status and neighbourhood factors. Included were cohort studies, 
populational data, systematic reviews and meta-analysis where available. Factors specifically related to 
energy intake and energy expenditure are discussed in the subsequent sections 2.5.3 and 2.5.4.
There is substantial multi-collinearity between the factors investigated amongst studies. E.g. screen time
is associated with higher BMI but also with reduced sleep duration, which is a risk factor per se (Zhao
et al.,2018). Similar, the consumption of sugar-sweetened beverages (SSB) is associated with increased
BMI levels, however this relation is partly mediated by lower socio-economic status (SES) (Chung et 
al.,2018). Specific methodological problems arise for studies that investigate the effect from SSB. First, 
there is considerable heterogeneity in the definition of an SSB (Bucher Della Torre et al.,2016). Second, 
SSB are a marker of a poor-quality diet (Ambrosini et al.,2013), therefore, it is difficult to isolate the
independent effect from SSB. Second, higher levels of physical activity may confound the results as
physical activity is related to higher sports drink intake in some studies (Tomlin et al.,2013).
When investigating the effects from SES, a couple of specific characteristics are important. First, 
various definitions and metrics are commonly used in studies investigating SES. Some authors use 
country-specific indices, whereas others combine measures of parental income and occupation as 
exposure measure. Irrespective of the exact measure used, SES is believed to be one of the strongest
risk factors for developing obesity in childhood, particularly in countries with “Western lifestyles”
(Magnusson et al.,2014; Stamatakis et al.,2010). Also, there is evidence for an aggravation of
associations between SES and rates of obesity in childhood: In many populations with higher SES, the
incidence of obesity in childhood has generally slowed down or even reversed in recent years (Chung
et al.,2016; Cunningham et al.,2014). In contrast, there is limited evidence for a similar development in
countries with people exposed to lower SES (Cunningham et al.,2014; Morgen et al.,2014). Factors
related to total energy intake, particularly the macronutrients composition and total energy expenditure
are discussed in the following sections 2.5.3 and 2.5.4. 
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21 
Table 2. Studies investigating environmental, socio-economic, behavioural, food-related and early-life risk factors for obesity in childhood and
adolescence
Measures Study Metrics on study Outcome Reference
site design 
Screen time TV watching assessed by 2015 US High school >5 hours TV watching is associated with (Chaput,2017)
Youth Risk Behaviour Surveys students mean age - consumption of SSB, OR = 2.72 [95%CI
in one US cohort of high 16y / n = 24`800 / 2.23 to 3.32]
school students Nationally - risk for obesity, OR = 1.78 [95%CI 1.40
representative to 2.27]
sample / cross-
sectional
Associations between screen UK The Child Heart Compared to 1 or less hours of screen time (Nightingale et 
time and ponderal index and Health Study in per day, reported screen time of 3 or more al.,2017)
(weight/height3), skinfold England (CHASE) hours was associated with higher
thickness and bioimpedance- cohort / cross- - ponderal index 1.9% [95%CI 0.5% to 
related fat mass (kg/m5) sectional survey / 3.4%]
aged 9–10 years / n - skinfold thickness 4.5% [96%CI 0.2%
= 5887 to 8.8%]
- fat mass index 3.3% [95%CI 0.0% to 
6.7%]
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Overall screen time and World Systematic review Medium-quality reviews by (Stiglic et 
adiposity of published - Costigan et al. (Costigan et al.,2013) al.,2019)
systematic reviews showed in 32/33 studies a strong 
relationship between overall screen time
and weight status including 7/8 studies 
with low risk for bias. 
- Ekris et al. (van Ekris et al.,2016)
reported strong evidence for an
association between screen time and 
BMI and BMI z-score
- Carson et al. (Carson et al.,2016)
reported a strong association between
screen time and unfavourable body
composition in 11/13 longitudinal 
studies, 4/4 case-control studies and 
26/36 cross-sectional studies
Sleep Sleep time and obesity World 2-102 years / n Pooled OR for short sleep duration (<10 (Cappuccio et 
(children) = 30`002 hours) and obesity:
al.,2008)/ Meta-analysis of - 1.89 [95%CI 1.46 to 2.43]
cross-sectional
studies
Association between Greece Population data, Adjusted OR between insufficient sleep time: (Tambalis et 
Insufficient sleep time (9 hours school-based health - 1.26 [95%CI 1.21 to 1.31] with al.,2018)
for children, 8 hours for survey in youth increased screen time
adolescents, according to a aged 8-17 years / n - 1.21 [95%CI 1.17 to 1.25] with
Consensus Statement of the = 177`091 (40% of overweight/obese 
American Academy of Sleep population)
Medicine (Paruthi et al.,2016)) 
and overweight/obesity 
Sleep duration and subsequent US, NZL, 0-18 years / n = (Magee et 
weight gain Canada 10`959 / systematic al.,2012)
  
 
   
   
 
 
  
 
   
    
 
 
 
    
   
 
 
  
    
 
 
 
 
  
    
 
 
      
 
 
    
 
 
 
     
 
     
 
  
     
 
 
 
 
    
 
  
 
      
   
 
 
   
   
    
 
  
  
    
  
  
  
   
  
 
 
 
 
  
 
 
 
       
      
    
    
  
   
   
 
 
  
 
review including 7
longitudinal studies
with children
Increasing versus decreasing US 8-11 years / n = 37 
sleep time by 1.5 hours per / randomized cross-
night for 7 days over trial
Food
environment
Effect of exposure to 30-
second commercials embedded
in cartoon-video
US 2-6 years / n = 46 /
randomized
controlled trial
Effect of consuming SSB and 
household income
Canada 4-5 years / n = 2103 
/ longitudinal 
follow-up study
Association between SSB and
obesity
World Review of
systematic
literature reviews / 
children aged 6 
months to 19 years
Systematic analysis of the 
methodology of cohort and
experimental studies
investigating the influence of 
SSB on the risk of obesity in 
childhood and review of
conclusions in light of the
methodological quality
World Review including
29 cohort studies
and 3 randomized 
controlled trials
Shorter sleep duration significantly predicts
subsequent weight gain in 7/7 longitudinal 
studies
Less sleep is associated with increased 
energy intake (-134 kcal/d, P < 0.05) and 
increased weight (0.22 kg, p <0.001)
Children exposed to video-commercials were 
significantly more likely to choose the
advertised item
RR for overweight >3x higher for children
with regular SSB consumption living in low-
income households compared to non-
consuming children in sufficient income 
households
9 reviews concluded there was a direct
association between the SSB consumption 
and obesity in children and adolescents, 4 did 
not find an association. Two meta-analysis
with highest quality scores showed 
discrepant results
More than half the studies presented with
methodological issues that may affect the
conclusions drawn. Studies that passed 
methodological assessment indicated positive
associations between SSB and the 
development of obesity, particularly in 
overweight individuals
(Hart et 
al.,2013)
(Borzekowski et 
al.,2001)
(Dubois et 
al.,2007)
(Keller et 
al.,2015)
(Bucher Della
Torre et
al.,2016)
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Systematic review and meta-
analysis on the quantitative 
effect of screen advertising of
food on children's dietary
intake
World Children and
adolescents aged 2-
18 years, mean 8.8
years
Various Effect of early life risk factors UK Children until age 7
factors >3 years of life and obesity years / n = 8234 /
rate at age 7 longitudinal follow-
up study
Exposure to 4.4 minutes of food advertising
on average would increase a child's food 
consumption by 60.0 kcal [95%CI 3.1 to
116.9]
Playing an advergame with food cues for 5 
minutes would increase consumption on 
average by 53.2 kcal [95%CI 31.5 to 74.9]
Relative risk associated with obesity at age 7
years: 
- parental obesity (both parents): 
adjusted OR 10.44 [95%CI 5.11 to 
21.32];
- very early adiposity rebound: OR 15.00 
[95%CI 5.32 to 42.30];
- > 8h TV time/week at 3 years: OR 1.55 
[95%CI 1.13 to 2.12];
- catch-up growth: 2.60 [95%CI 1.09 to 
6.16];
- birth weight, per 100g: 1.05 [95%CI
1.03 to 1.07];
- Less than 10.5 hours sleep at age 3
years: OR 1.45 [95%CI 1.10 to 1.89]
(Russell et 
al.,2019)
(Reilly et
al.,2005)
24 
Socioeconomic 
Status (SES)
Associations between income- US Grades 1,4,7,10 / n
status and ethnicity on weight = 111`799
status
For every 1%-increase in the proportion of
low-income status, the prevalence of 
overweight/obesity increased by 1.17%
Race/ethnicity was no longer associated with
overweight/obesity prevalence, when 
adjusted for income-status
(Rogers et 
al.,2015)
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25 
Associations between SES: Early Childhood Association between SES, race, birthweight, (Williams et 
weighted measure of parental Longitudinal Birth smoking status and family-dinner with al.,2018a)
income, both parent`s Cohort (ECLS-B) / overweight or obesity at Kindergarten entry:
educational attainment and n = 14`000 - OR for children in lowest SES quintile
prestige of occupation, Children / born compared to highest SES quintile for
with child`s BMI at 2001 in the US overweight/obesity 1.7 [95%CI 1.3 to 
Kindergarten 2.2];
- OR for Black versus White children
1.57 [95%CI 1.21 to 2.05] and for
Hispanic versus White 1.65 [95%CI
1.31–2.08];
- OR per 100gr increase in birthweight
1.07 [95%CI 1.06-1.08];
- OR for parental smoking 1.40 [95%CI
1.17–1.67];
- OR for family-dinner 0.96 [95%CI
0.93–0.99]
Systematic review of
associations between 
SES and childhood-adolescent
weight status in asset-rich
countries (SES = parental
education, income and 
occupation)
Data from
the 27
richest 
OECD 
countries
Systematic review
between 1990-
2013, youth 
between 0-21 years,
158 papers
included
Bivariable: Associations between SEP and (Barriuso et 
childhood-adolescent weight status were: al.,2015)
- inverse for 60.4% of the studies, null for
18.7% and 20.9% of studies identified
another dependant variable (e.g. age,
sex or ethnicity)
Multivariable: Associations between SEP and
childhood-adolescent weight status were:
- inverse for 51.1%, null for 20% and 
27.8% identified another dependant
variable
               
       
        
    
  
   
 
   
 
  
  
 
  
  
  
  
 
     
 
  
    
     
   
     
    
   
       
   
 
    
 
 
 
 
 
  
  
 
   
 
 
    
  
      
 
  
 
    
 
  
 
 
 
 
   
 
 
 
 
  
 
 
 
 
 
    
  
  
 
   
        
 
 
Combined Index of
Community Socio-Educational
Advantage (ICSEA) including
parents’ occupation and 
education, school geographical
location and the proportion of 
Indigenous students.
Outcome: BMI
26 
Neighbourhood
factors
Physical activity environment,
Nutrition environment
characteristics
SEIFA-scores
(SEIFA = areas in ranked
according to relative socio-
economic advantage and 
disadvantage, based on 5-
yearly Census data)
Proximity to unhealthy food 
outlets and weight outcomes
AUS
US
AUS
New 
York
City, US
Longitudinal follow 
up study of the 
Australian Capital
Territory Physical
Activity and
Nutrition Survey
(ACTPANS) 
between 2006 to 
2018
age 6-11 years /
n=730 / cross-
sectional
Age 2-18 years / n= 
444 / cross-
sectional
3`507`542 student-
year observations
2009-2013 
Compared to the highest ICSEA quintile,
individuals with lowest ICSSEA had an
adjusted prevalence ratio of 1.52 [95%CI
1.25 to 1.84] for overweight and obesity
Corresponding adjusted prevalence ratios for
overweight or obesity were:
- 1.56 [95%CI 1.37 to 1.78] for 0-2 days
per week of physical activity (60m/d)
compared to 6-7 days per week
- 1.44 [95%CI 1.23 to 1.68] for >/=5h TV
and computer time versus 0-1h per
weekday
- 1.44 [95%CI 1.19 to 1.76] for
Indigenous status versus non-
Indigenous status
For favourable physical activity environment
& nutrition environment: 
- Likelihood for obesity 7.7% vs 15.9%
Neighbourhood education/occupation score 
negatively associated with BMI. Higher
family education positively associated with 
lower BMI
Living > 0.025 miles away was associated 
with lower risk for obesity and BMI z scores 
(decreased ratio of obesity between 2.5-4-
4%).
(Yang et 
al.,2019)
(Saelens et 
al.,2012)
(Juonala et 
al.,2019)
(Elbel et 
al.,2020)
Abbreviations: TV: television; SSB: sugar-sweetened beverage; BIA: bioimpedance analysis; OR: Odds ratio; RR: relative risk; 95%CI : 95% confidence
interval; US: United States; UK: United Kingdom; NZL: New Zealand, AUS: Australia ; OECD: Organisation for Economic Cooperation and Development;
SES: Socio-economic status; n: number of individuals; SEIFA-scores : Australian Socio-Economic Indexes for Areas -score 
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2.5.3 Total energy intake
Obesity is caused by a mismatch between TEI and TEE (Han et al.,2010; Jequier et al.,1999; Swinburn
et al.,2002). The total energy surplus of energy intake for normal growth among US children and
adolescents between 1988–1994 to 1999–2002 was estimated to be 110–165 kilocalories per day. For
a child to become an overweight adolescent, the same figure over a 10-year period was estimated at
678-1017 kcal/d (Wang et al.,2006). In accordance, data from the 1977-1978 Nationwide Food 
Consumption Survey and the 1989-1991 and the 1994-1997 Continuing Surveys of Food Intake by 
Individuals showed that children overall increased their TEI by almost 200 calories per day between 
the assessment of the surveys, along with increasing rates of overweight and obesity (Nielsen et 
al.,2002). 
So far, many studies focussed on identifying solitary food products that may be responsible for 
excessive energy intake and elevated BMI levels. Consequently, foods with high carbohydrate-content
such as pizza or SSB were often targeted. In fact, SSB contribute up to ~40% of the added sugars in the 
US (McGuire,2016). They increase the TEI in youth (Malik et al.,2013) and are linked to adult
cardiometabolic disease outcomes (Malik et al.,2010). However, as discussed in the previous section 
2.5.2, there are methodological issues with addressing the particular effect from SSB on childhood BMI
levels and many other food sources are subject to confounding by other determinants of obesity in 
childhood. 
A different approach was to look at the amount and composition of macronutrients in daily nutrition. 
Macronutrients include carbohydrates, fats and proteins and their amount consumed determines the
total energy intake (see Figure 1). Proteins contain less energy than the equivalent mass amount of fats,
and their percentage contribution to the daily TEI is just about 20% compared with 50% from
carbohydrates and 30% from fats in a standard diet (National Health and Medical Research
Council,2006, updated September 2017). Nonetheless, subtle changes in the percentage energy intake 
from proteins may have a disproportionately high impact on TEI, a mechanism termed protein leverage
(PL). Based on this mechanism, the protein leverage hypothesis (PLH) was formulated (Simpson et 
al.,2005), which posits that in humans, PL contributes to weight gain and obesity. 
Figure 1. Food and its nutritional and energy-providing components
Energy is provided by the intake of the three macronutrients: carbohydrates, fats and proteins (dashed
boxes). With permission from Stephen Simpson and David Raubenheimer, authors of “Eat Like
Animals”, March 2020.
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2.5.3.1 Protein leverage hypothesis
The protein leverage hypothesis predicts that diets low in the proportion of energy from proteins
stimulate a compensatory increase in food intake and hence TEI to attempt to achieve a certain absolute 
protein intake (Simpson et al.,2005). This hypothesis is based on studies in various insects, birds, fish
and mammals, using an approach termed nutritional geometry. The foundation of this hypothesis is that
first, separate appetite systems control the intake of different macronutrients to guide the animal towards 
an optimally balanced diet to achieve best possible outcomes for growth, survival and reproduction; 
and second, in situations of unbalanced food supply, an adequate intake of proteins takes precedence 
over carbohydrates and fats (Berthoud et al.,2012; Raubenheimer et al.,1997; Simpson et al.,2014).
Before the development of the protein leverage hypothesis, the novel concept of nutritional geometry
was used in a study with locusts in 1991 (Raubenheimer D.,1993). The authors investigated the effect 
from foods with various proportions of carbohydrates and proteins (ranging from high protein/low carb
to high carb/low protein) on the time span until the locusts successfully molted to become winged adults 
or died beforehand. Foods with one specific composition of proteins and carbohydrates were provided
to the animals ad libitum. As plotted in figure 2, the relation between carbohydrates and proteins
followed a specific distribution. From this plot, the authors identified the intake point that best
represented the healthiest nutrition where the animals` growth and survival was balanced. The resulting 
plot also showed that locusts who ate too much carbohydrates lined up vertically close to a protein 
intake of about 150 mg, which is close to their protein-target at approximately 210 mg. However, to do 
so, they needed more time to become winged adults, which is associated with higher risk of being victim
to predators and they became obese, a very unusual outcome in insects. In contrast, those locusts fed on
a low carb diet increased their protein intake, at costs of a much lower intake of carbohydrates. Effects 
from a low carbohydrate/high protein diet were that these animals became lean and less likely to survive
to adulthood. This experiment illustrated the existence of different appetite systems for carbohydrates 
and proteins with different outcomes for growth and survival based on the diet that was eaten. Also, the
experiment showed that locusts had a preference for proteins over carbohydrates when the nutrition
provided does not allow to reach the target intake.
Figure 2. Plot of intakes of locusts fed ad libitum on diets with various proportions 
of carbohydrates and proteins
The bull`s eye illustrating the target diet, the diet that supported best growth and survival. With
permission from Stephen Simpson and David Raubenheimer, authors of “Eat Like Animals”, March 
2020.
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Subsequent works identified multiple appetite-systems in many animal species that aim for a balanced
diet that is specific for the animal and allows the best for survival, growth and reproduction. The first
locust-similar experiment involving humans was performed in an isolated chalet in the Swiss Alps, the
results of which were published in 2003 (Simpson et al.,2003). The experiment lasted one week, with
10 individuals involved. The first two days, participants were allowed to eat at their discretion from a
buffet including a large variety of foods and the macronutrients composition, proportional energy intake
per macronutrient and total energy intake was meticulously reported. Then, on days three and four, half 
the individuals where allocated to a high protein buffet and the other half of the participants to a high
carbohydrate and high fat diet, still allowed to eat as much as they liked. Subsequently, they returned 
to the original buffet for the last two days of the experiment. Results from the analysis of the first two
days showed that participants consumed food with a proportion of energy from proteins at 17% that is
well fitting with the suggested 15-20% for people all over the world. In the second phase of the
experiment, all participants aimed to maintain their protein intake at a similar level as during the first
two days. But to do so, those allocated to the high-fat high-carbohydrate diet had to increase their total 
energy intake by 35% to reach their target intake of proteins. In contrast, those allocated to the high-
protein diet decreased their energy intake by 38% compared to the free-choice period. The main 
conclusion was that similar to the experiment in locusts, the human appetite for proteins seemed to 
determine the total energy intake. This experiment was the background of the protein leverage
hypothesis that predicts that diets low in the proportion of energy from proteins stimulate a 
compensatory increase in food intake and hence TEI to attempt to achieve a certain absolute protein 
intake.
Further data supporting protein leverage in adult humans were based on experimental studies,
systematic compilations of data from numerous trials, and analyses of cohort and population data. 
Figure 3 illustrates how to test for protein leverage involving data from a compilation of clinical trials 
and experimental datasets (Gosby et al.,2014; Raubenheimer et al.,2015a; Raubenheimer et al.,2015b). 
A few premises to understand need to be mentioned:
1. The mechanism of protein leverage causes an increase in total energy intake when the
proportion of energy from protein in a diet is diluted by either fats and/or carbohydrates.
2. The strength of the protein leverage mechanism is diluted by the content of fibre. Fibre is –
similar to proteins – associated with satiety, however does not add on to the total caloric energy 
intake (Roberts et al.,2014).
3. The strength of protein leverage depends on the extent to which protein intake is prioritized 
over the regulation of other nutrients and on the actual percentage level of energy from protein 
sources.
Figure 3 A illustrates the total energy intake on the y-axis and the protein range from 5% to 54% on the 
x-axis, and figure 3 B illustrates a subset of the range of percentage protein values that is commonly
found in diets of free-living human populations ranging from 10-30%. The resulting relation is typical 
for a fitted line following a power calculation. The power calculation describes the relation between
food intake (in grams) and percent dietary protein (p) to maintain a constant, targeted intake of proteins 
(P, in grams). In other words, to maintain a targeted intake of proteins (P in grams) on a diet containing
a given proportion of proteins (p), P x pL grams of food must be eaten. The coefficient L describes the
strength of protein leverage. Assuming full protein leverage, i.e. L = -1, small changes in p will 
cause substantial changes in total intake (e.g. if the target intake of protein is 100g, a diet
containing 20% protein will cause an intake of 500 gr of food. If the dietary percent protein is
reduced to 16%, 625gr of this particular diet needs to be consumed to meet the protein target). 
Assuming no protein leverage, i.e. L=0, changes in p will not cause changes in total energy 
intake
A detailed discussion is in section 4.2.9. The grey and green dashed line in Figure 3 B illustrate the
extreme outcomes. For the grey dashed line represents complete protein leverage (L = -1), i.e. 
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individuals will maintain their protein intake at a fixed value (chosen here the mean value of the dataset 
at 386 kcal/d). The green dashed line indicates the outcome if total energy intake was maintained at a 
fixed level (L = 0) (chosen here is the mean value of the total energy intake from the dataset at 2086
kcal/d). However, the true results (blue and red dots) are following a power function with a strength of
leverage L of -0.525 that approached but did not achieve total protein prioritization. 
Figure 3. Data on protein leverage in adult humans
Figure 3 shows how to test for protein leverage. The plot includes data on TEI on the y-axis and the 
proportion energy (in %) from protein on the x-axis. The effect of protein leverage is best represented 
using a power calculation according to the following baseline formula: Required food intake = P x pL. 
Figure 2 B illustrates two hypothetical extreme outcomes: the grey dashed line for complete protein
leverage (L= -1), where the targeted protein intake would remain at a fixed value and one where total
energy intake would remain stable (i.e. no protein leverage, green dashed line). Plotted data suggest a 
partial protein leverage with a strength of leverage L at ~ -0.5.
The protein leverage as a contributor to the US obesity pandemic was formulated by the founders of
the protein leverage hypothesis in 2005 (Simpson et al.,2005). They observed data from the Food and
Agriculture Organization of the United Nations database of nutrient availability. The data showed that
the average diet composition between 1961 to 2000 in the US changed significantly, with a decrease of 
the proportion of proteins from 14% to 12.5%. The relevant study, revealing that a decline of 1.5% of
energy from protein sources between 1961 and 2013 was accompanied by an increase in TEI of 950 
kcal per capita was published in 2019 (Hall,2019). 
Studies in infants have shown positive associations between a higher percentage of energy intake from
protein sources with later development of obesity (Weber et al.,2014a). No data on protein leverage in
children or adolescents are available.
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2.5.4 Total energy expenditure
TEE is the total amount of energy needed to maintain homeostasis in biological systems. TEE is 
comprised of mainly three parts including resting energy expenditure (REE, ~55-65% of TEE), diet-
induced energy expenditure (DEE, ~10%) and activity-induced energy expenditure (AEE, ~25-35%)
(Westerterp,2017). The latter is the most variable portion for TEE, mostly related to the sum of physical 
activity (Washburn et al.,2014). The main determinants for TEE are body size, body composition, TEI
and physical activity (Westerterp,2017). The gold standard to evaluate TEE in humans is the doubly
labelled water (DLW) technique.
2.5.4.1 Assessment of resting energy expenditure and basal metabolic rate
REE is the amount of energy needed to maintain physiologic functions including respiration, cardiac
and body temperature regulation (Rachel K. Johnson,2001). A surrogate measure for REE is the basal
metabolic rate (BMR). BMR is measured under strict criteria: the individual needs to be completely
rested, fasted for at least 12 hours, free from any stress and the environment should be thermoneutral 
(Henry,2005). Primarily, the measurement of BMR in the early 20th century was used to diagnose hypo-
and hyperthyroidism. However, the interest for BMR raised in the late 20th century when BMR was
used to investigate the development of human obesity and to estimate people`s energy requirement
(previously, food intake surveys were used for similar questions). Based on this novel application for 
BMR, accurate measures using easily accessible anthropometric data were warranted (Henry,2005). 
After equations utilizing body surface areas as a proxy, the Food and Agriculture Organization, World
Health Organization (WHO) and United Nations University (UNU) Joint Expert Consultation on 
Energy and Protein Requirements which met in Rome 1981, requested Schofield to produce novel
formulas to predict BMR for both sexes in various age groups (Schofield,1985a). The equations by
Schofield rely on the parameters age, sex and weight and were based on a sample size of 7173 BMR
measurements. Other equations including different age groups and body compositions were
subsequently performed including one from the WHO (WHO,1985). 
The generalizability of the Schofield BMR results was found to be limited. Most of the studies reported
overestimation of BMR results (Henry,2005), with a few exceptions in children that reported
underestimation of BMR results (Bandini et al.,1990; Livingstone et al.,1992). Likely, this was related
to ethnicity (Europeans and North Americans formed the majority), and the overrepresentation of 
Italians (47%), who were subsequently found to have a higher BMR per kilogram bodyweight. Due to
the effect of body composition on REE (higher body weight resulting in higher REE and TEE), specific
equations for children and adolescents with overweight or obesity, including various parameters such 
as fat-free mass, fat mass and pubertal stage were generated (Lazzer et al.,2014; McDuffie et al.,2004; 
Tverskaya et al.,1998). Amongst those, the two formulas provided by Lazzer in 2014, including pubertal
stage (Tanner I-V) and gender and either weight and height or fat-free mass and fat mass are probably
the most accurate based on comparisons with indirect calorimetry using the Bland and Altmann Method
and cross-validation (Lazzer et al.,2014).
Irrespective of the method used to assess BMR, Goldberg suggested using BMR levels to identify
invalid food intake reports when TEE measures are not available (Goldberg et al.,1991). This approach
evaluates the reported energy intake by multiplying BMR with an estimated physical activity level 
(PAL, see later). The resulting measure reflects a minimum required energy intake for maintenance of 
basal metabolism, i.e. for homeostasis. Depending on the PAL used in the equation, this approach 
allows exclusion of under-reporters with high specificity.
2.5.4.2 Assessment of activity induced-energy expenditure (AEE)
There is no standard way to assess AEE, i.e. physical activity energy expenditure (Dencker et al.,2011). 
However, DEE is rather constant at 10% of TEE in an average mixed diet (Westerterp,2004). Utilizing
BMR as a surrogate for REE and provided TEE is known, AEE can be calculated as follows:
31
  
    
              
 
  
 
   
       
      
                  
    
     
       
            
      
 
      
   
     
      
      
           
        
         
           
       
        
       
  
         
         
          
 
              
     
  
  
            
     
   
 
         
        
     
        
   
AEE = 0.9 x TEE – REE
AEE is determined by body movement (i.e. physical activity) and body composition, and both are
related to each other as physical activity requires energy from stored sources in fat or muscle
(Westerterp,2013). It requires more energy to move a large body, as a consequence, AEE results need
to be adjusted for body size.
2.5.5 Physical activity, physical exercise and physical fitness
Physical activity is defined as any bodily movement produced by skeletal muscle that results in energy 
expenditure (Caspersen et al.,1985). Physical fitness is defined by the American College of Sports and 
Medicine as a set of attributes that people have or achieve that relates to the ability to perform physical
activity (Wilder et al.,2006). Components of physical activity include the measurement of body
composition, cardiorespiratory endurance, muscular fitness, and musculoskeletal flexibility (Wilder et 
al.,2006). Maximal oxygen uptake (VO2max) is the measure to define cardiorespiratory endurance, 
whereas muscular fitness is composed of muscular strength and muscular endurance. Musculoskeletal
flexibility rather focuses on joints and associated structures such as ligaments and muscles that cross 
the joints (Wilder et al.,2006). 
In the next sections, study-specific methods for the assessment of physical activity and physical fitness 
are reviewed and related to adverse cardiometabolic health-outcomes due to obesity.
2.5.5.1 Assessment of physical activity
Physical activity is vital for achieving and maintaining a healthy weight (Poorolajal et al.,2020) and an 
important factor to prevent or improve obesity-related health problems (Janssen et al.,2010; Tremblay
et al.,2011) such as high blood pressure (Aguilar-Cordero et al.,2020; Vale et al.,2015). 
Recommendations from various health care departments, professional and scientific organisations
require children and adolescents to perform 60 minutes of moderate-to-vigorous physical activity for
six or more days a week (Services,Last reviewed May 29, 2019; WHO,2011). However, data from the
2016 National Survey of Children`s Health revealed that only 24% of children and youth meet the 
recommended guidelines (US Department of Health and Human Services). For the assessment of
physical activity, many methods are proposed, each providing information on different facets. (Sylvia
et al.,2014)
If TEE and BMR are known, the total PAL of a person can be expressed in one measure, resulting from
the ratio of TEE/BMR. A PAL of 1.2 is considered for chair-bound or bedridden individuals, a PAL
level of 1.55 is for those with low activity levels and a PAL of 2.4 is for professional athletes (Black et 
al.,1996). 
However, the DLW technique to assess TEE is cumbersome and expensive, hence other methods are
commonly used. They may be based on subjective (self-report questionnaires), or objective methods 
(e.g. direct observation, indirect calorimetry, accelerometers) (Strath et al.,2013; Sylvia et al.,2014).
2.5.5.2 Accelerometery
Accelerometers assess the quantity and quality of physical activity including the amount of sedentary
time (e.g. sleep) (Rowlands,2007). They have proven practicability in children already at preschool age 
(Pate et al.,2006), are unobtrusive and easy to use (Rowlands,2007).
Guidelines regarding the validity of accelerometer data and cut-offs used to categorize intensity have 
been published (Colley et al.,2010; Colley et al.,2011). The CHASE study (Child Heart And Health
Study in England) in primary school children across ethnic groups showed inverse associations between 
the amount of time spent physically active and adiposity measures, insulin resistance, C-reactive protein
levels, low-density lipoprotein cholesterol (LDL-C) and positive associations with systolic blood 
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pressure and high-density lipoprotein cholesterol (HDL-C) (Owen et al.,2010). In an even larger cohort, 
including nearly 30`000 individuals aged 4-18, the intensity rather than the amount of physical activity 
was found to be the main determinant for variation of cardiometabolic risk factors (Tarp et al.,2018). A
meta-analysis including 6009 children and adolescents from eight studies of the ICAD (International
Children's Accelerometery Database) consistently concluded that increases in the amount of moderate
intensity are associated with beneficial cardiometabolic health (Renninger et al.,2020). 
2.5.5.3 Grip strength, a global measure of muscular strength
Muscular strength and muscular endurance indicate overall muscular fitness. Hand grip strength is a
global measure of muscular strength and increases with physical activity training. Hand grip strength 
can be easily measured by participants gripping a dynamometer with maximum force and the maximum
measured result, normalized for body weight after two attempts on each hand is used for further analysis
according to standardised protocols (CDC,2011). Recently, a number of studies investigated effects
from hand grip strength in large population studies. 
The variability of handgrip strength (further termed grip strength) is influenced by behavioural and
lifestyle factors and up to 56% by heritability according to a systematic review and meta-analysis
(Zempo et al.,2017). In a nationally representative sample of 8469 Australian children aged 7-15 years,
adiposity, fat-free mass and cardiorespiratory fitness were identified as correlates for grip strength 
(Fraser et al.,2020). Higher levels of grip strength in childhood are associated with lower continuous 
metabolic syndrome scores (a composite measure including the percentage body fat, SBP, triglycerides, 
HDL-C and glucose) in both boys and girls (Peterson et al.,2014). Besides inverse associations with
adverse cardiovascular risk factors, a systematic review revealed benefits from higher muscular strength 
for bone and psychological health and cognitive ability (Smith et al.,2014). 
Muscular fitness (assessed by grip strength and standing long jump tests) has shown to be inversely
associated with future cardiovascular disease risk scores (combined outcome including results for
skinfolds, systolic blood pressure, insulin, glucose, triglycerides, total cholesterol and HDL-C) after a
2-year follow-up (Castro-Pinero et al.,2019). With respect to the future risk for T2DM, Australian and
European data have shown inverse associations between grip strength and adult levels of insulin
resistance and beta cell function, both precursors to the onset of T2DM (Fraser et al.,2018; Grontved et 
al.,2013).
In adulthood, higher grip strength has been associated with a 20-35% lower risk for premature mortality 
due to any cause or cardiovascular disease, independent of blood pressure and BMI as shown in a 
Swedish study of >1 million male adolescents, followed-up for over 24 years (Ortega et al.,2012). 
Similarly, a study in more than half a million participants from the UK Biobank (including 54%
women), aged 40-69 years, showed increased hazard ratios per 5 kg lower grip strength for all-cause 
mortality of 1.20 in women and 1.16 in men, and a cause-specific mortality from cardiovascular disease 
of 1.19 in women and 1.22 in men (Celis-Morales et al.,2018). Grip strength and adiposity have been
shown to independently predict higher mortality risk, with grip strength being capable to partly
attenuate the risk arising from excess adiposity (Kim et al.,2017).  
Data on children investigating grip strength and subclinical cardiovascular phenotypes is sparse: one 
study in children aged 11-12 years with healthy weight demonstrated an inverse association between 
muscular strength and cIMT, independently of cardiorespiratory fitness and central adiposity (Melo et 
al.,2015). Furthermore, data in youth with obesity investigating the impact of grip strength on
cardiometabolic risk factors and vascular health is lacking.
2.6 Cardiovascular risk factors in children and adolescents with obesity
Evidence for an association between increasing weight and cardiovascular risk in early life arose from
pathological investigations by the Bogalusa Heart Study (Berenson et al.,1998) and the Pathobiological
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Determinants of Atherosclerosis in Youth (PDAY) (McMahan et al.,2006). These investigations proved
a weight-dependent increase in the presence of fatty streaks and fibrous plaques in post-mortem analysis
in otherwise healthy children and young adults aged between 2-34 years.
Increasing BMI in childhood and adolescence is associated with more adverse levels of each core 
cardiovascular risk factors including elevated blood pressure (Freedman et al.,2012), dyslipidaemia 
(Margolis et al.,2014), elevated inflammatory biomarkers (Schipper et al.,2012; Skinner et al.,2010)
and altered glucose metabolism (such as insulin resistance or T2DM (Abbasi et al.,2017). Also, the
prevalence of cardiovascular risk factors correlate with the weight category: 37% of normal weight,
49% of overweight and 61% of US adolescents with obesity aged 12 to 19 years had at least one 
cardiovascular risk factor according to the NHANES survey from 1999 to 2008 (May et al.,2012). 
Amongst children and adolescents aged 6-19 years with severe obesity, determined by the ≥ 120% of
95th BMI-centile, the odds ratio (OR) compared to normal-weight counterparts for high blood pressure 
were 5.3; for high total cholesterol 2.4; for low high-density lipoprotein-cholesterol (HDL-C) 7.3; for 
high triglycerides 4.5; for high LDL-C 2.3; and for high fasting glucose 2.7 (Li et al.,2016).
Up to 80% of children with obesity will remain obese in adulthood (Juonala et al.,2011; Ward et 
al.,2017). As a consequence, paediatric obesity is increasingly associated with obesity-related co-
morbidities in adulthood including CVD , T2DM and non-alcoholic fatty liver disease (Daniels et 
al.,2005; Morrison et al.,2007).
2.6.1 Blood pressure
The overall prevalence of hypertension amongst US children and adolescents is ~3-5% and up to 25%
amongst children with obesity (Flynn et al.,2017; Hansen et al.,2007). Studies in adults have shown a 
near linear association between BMI with SBP and DBP (Hall,2003). However, not every individual 
with obesity has a blood pressure in the hypertensive range. Higher proportions of body fat in visceral 
and retroperitoneal parts have been shown to increase the risk for higher BP values (Tchernof et 
al.,2013). Increasing fat mass causes a higher total blood flow to supply the extra adipose tissue causing
an overall higher resting tissue blood flow. This in turn is accompanied by a limited blood flow reserve 
that is normally needed during exercise, partly explained by endothelial dysfunction (Raitakari et 
al.,2004). This functional vascular dilatation and higher blood flow increases cardiac output and
increases peripheral resistance, contributing to the development of hypertension and left ventricular
hypertrophy (Hall,2000). Impaired renal-pressure natriuresis causing increased renal sodium absorption 
is another major mechanism to initiate higher blood pressure levels. As a result of impaired pressure
natriuresis, higher BP measures are needed to maintain normal natriuresis in individuals with excessive 
weight (Hall,1997). Factors related to obesity-induced renal-pressure natriuresis impairment include: i)
physical compression of the kidneys due to retroperitoneal fat tissue (Hall et al.,2014); ii) an activated
renin-angiotensin-aldosterone system and activated mineralocorticoid receptors independent of
aldosterone (Hall et al.,2012); iii) a dysfunctional, activated sympathetic nervous system (Hall et 
al.,2015); and iv) an impaired proatrial natriuretic peptide control. Levels of natriuretic peptides are
inappropriately low in obese hypertensive individuals compared to lean normotensive individuals 
despite higher salt intake (Asferg et al.,2013) and their release in response to a volume load was shown 
to be impaired (Savoia et al.,2009). 
The assessment of blood pressure among children necessitates appropriate methods to avoid false
measures including i) repeated measures within one visit (Alpert et al.,2006), ii) assessment on multiple, 
different visits (McNiece et al.,2007), iii) using appropriate cuff sizes (Pickering et al.,2005), and iv) 
using the auscultatory method (Urbina et al.,2015). Auscultatory BP values, gained by aneroid and
mercury devices are comparable (Duncombe et al.,2017). In contrast, oscillatory devices, despite
increasingly used, have some limitations compared to auscultatory methods. First, they systematically
overestimate SBP and DBP compared to auscultatory devices (Chio et al.,2011). Second, target organ
damage such as elevated left ventricular mass or higher PWV are better predicted by auscultatory 
devices (Urbina et al.,2015). Third, oscillatory devices show a large within-visit variation with 
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inaccurately high readings particularly at the first measurement (Negroni-Balasquide et al.,2016). 
Fourth, rather than directly measuring SBP or DBP, the devices us a proprietary algorithm to calculate 
the SBP and DBP from the mean arterial pressure (Alpert,2010). However, if the device is approved
for children and adolescents and if the aforementioned limitations are accounted for, the oscillatory
method can be used as an alternative for BP assessment in children and adolescents (Duncombe et 
al.,2017). 
Ambulatory blood pressure monitors record blood pressure values every 20-30 minutes through 
daytime and every 45-60 minute at night. They are recommended in adulthood before starting treatment 
for hypertension (Siu et al.,2015). For children, the use of ambulatory blood pressure measurements is 
recommended for the diagnosis of hypertension, to detect for non-dipping of blood pressure measures
overnight, to avoid white coat hypertension or masked hypertension, and should be strongly considered 
in children with obesity and other conditions (Flynn et al.,2017). Non-dipping refers to the inability of
the blood pressure regulating system to reduce the overall mean blood pressure values by 10% over 
night. White coat hypertension is an entity describing isolated office hypertension with normal values
outside the office setting. In a cost-effectiveness analysis of 24-hour ambulatory blood pressure 
measurements, a proportion of 46% of children suspected of hypertension were diagnosed with white
coat hypertension (Swartz et al.,2008). Masked hypertension is referred to the identification of 
hypertension in children based on ambulatory blood pressure measurements with normal blood pressure 
readings in the office setting. Masked hypertension is well described at a rate of 5-25%, particularly for
children with obesity (Lurbe et al.,2005; Maggio et al.,2008)
It is recommended for children with obesity to test for blood pressure at every visit encounter (Lo et 
al.,2014) and every diagnosis of hypertension warrants exclusion of secondary causes for hypertension 
(Lurbe et al.,2016). Once hypertension is diagnosed, an echocardiography is recommended to assess
cardiac structure and function. High blood pressure in childhood correlates with higher blood pressure
in adolescence and with higher risk of hypertension in adulthood (Chen et al.,2008; Juhola et al.,2011). 
With obesity and dyslipidaemia, hypertension was confirmed a key modifiable risk factor in childhood 
for elevated cIMT in adulthood (relative risk 1.9 for cIMT >95th centile) (Koskinen et al.,2018). Rising
blood pressure levels from as low as 115 mmHg systolic and 75 mmHg diastolic are linearly associated 
with increased mortality among adults (Lewington et al.,2002). 
For children, age-, sex- and height-related, normative blood pressure reference charts based on 
auscultatory technique from ~50`000 children and adolescents have been updated in 2017 (Flynn et 
al.,2017). The updated definitions of blood pressure categories and stages are illustrated in table 3. Two
important changes were implemented in the 2017 reference charts compared to the previous ones from
2004 (National High Blood Pressure Education Program Working Group on High Blood Pressure in et 
al.,2004): first, only children and adolescents with normal weight (BMI <85th centile) were included;
and second, for adolescents aged 13 years and older, adult guidelines for classifying elevated stage 1 
and stage 2 hypertension were used (Whelton et al.,2018). The rationale behind these changes were i) 
to avoid introducing bias due to the strong association between overweight/obesity and hypertension,
and ii) the predictive value of adult cut-offs is strongly related to CVD-outcomes whereas the paediatric 
cut-offs are based on their statistical distribution (Daniels,2016). 
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Table 3. Blood pressure categories in children
Children age 1-13 years Children >13 years
Normal BP: <90th centile Normal BP: <120/<80mmHg
Elevated BP: ≥90th centile to <95th centile or,
120/80 mmHg to <95th centile (whichever is lower)
Elevated BP: 120 to 129 / <80mmHg
Stage 1 HTN: ≥95th centile to <95th centile +12 mmHg,
or 130/80 to 139/89 mmHg (whichever is lower)
Stage 1 HTN: 130/80 to 139/89mmHg
Stage 2 HTN: ≥95th centile +12 mmHg,
or ≥140/90 mmHg (whichever is lower)
Stage 2 HTN: ≥140/90mmHg
Abbreviations: BP: blood pressure; HTN: hypertension.
Excluding overweight and obese children caused the 2017 cut-off values for blood pressure categories
to be lower than the equivalent from 2004. One recent study compared the validity of the two
hypertension definitions, investigating i) the difference in prevalence of hypertension in childhood and
ii) the predictive value of being diagnosed with hypertension by either the 2004 or 2017 reference charts 
towards an adult diagnosis of hypertension, metabolic syndrome or left ventricular hypertrophy (Du et 
al.,2019). The prevalence of hypertension was 7% and 11%, respectively, as defined in the 2004 and 
2017 guidelines and the associations with adult outcomes were overall similar. However, the proportion 
of individuals who developed adult left ventricular hypertrophy increased from 12% to 19% using the
newer guidelines from 2017 (Du et al.,2019). 
2.6.2 Dyslipidaemia
Normative levels for lipids – cholesterol and triglycerides – in children and adolescents change with
age and pubertal development (Expert Panel on Integrated Guidelines for Cardiovascular Health Risk
Reduction in Children Adolescents,2011). Lipid concentrations increase significantly over the first year 
of life and then increase more slowly until ages 9-11 years, when they more closely reflect adult levels.
During puberty the total cholesterol and LDL-C levels decrease as much as 10% to 20% or more, most
likely due to elevated sex hormone levels before returning to baseline around the second decade of life 
(Elkins et al.,2019). Accepted levels for children and adolescents <19 years of age are summarized in 
table 4. 
Table 4. Acceptable, borderline and high plasma lipid measures for children and adolescents
Category Acceptable, mg/dl Borderline mg/dl, High mg/dl,
(mmol/l) (mmol/l) (mmol/l)
Total cholesterol <170 (<4.3) 170–199 (4.3-5.1) ≥200 (≥5.1)
LDL-C <110 (<2.8) 110–129 (2.8-3.3) ≥130 (≥3.4)
Non–HDL cholesterol <120 (<3.1) 120–144 (3.1-3.7) ≥145 (≥3.7)
Triglycerides
0–9 years <75 (<0.8) 75–99 (0.8-1-1) ≥100 (≥1.1)
10–19 years <90 (<1.0) 90–129 (1.0-1.5) ≥130 (≥1.4)
HDL-C >45 (>1.2) 40–45 (1.0-1.2) <40 (<1.0)
Adapted from Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction
in Children and Adolescents, National Heart, Lung, and Blood Institute (2011). LDL-C: low-density 
lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol.
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Dyslipidaemia disorders are categorized into primary and secondary forms. Primary forms include
hereditary forms such as familial hypercholesterolaemia and hereditary hypertriglyceridaemia whereas
secondary forms are caused by non-hereditary conditions such as obesity, hypothyroidism, uncontrolled 
diabetes, hepatic and renal dysfunction or the use of medications such as corticosteroids, retinoids or 
oral contraceptive drugs (Elkins et al.,2019). 
In children and adolescents with obesity, the prevalence of dyslipidaemia correlates with the severity
of obesity. In a cross-sectional study with children and adolescents aged 3-19 years who were included 
in the National Health and Nutrition Examination Survey from 1999 to 2012, individuals were
categorized according to the %>95th BMI centile into class I (95th BMI centile - 120% of the 95th BMI-
centile), class II (≥120 - <140%) and class III (≥140%) (Flegal et al.,2009) and the distribution of
cardiometabolic risk markers was evaluated (Skinner et al.,2015). Among 12-19 years old, levels of
total cholesterol, non-HDL cholesterol and triglycerides increased with weight classes and HDL-C 
decreased. However, LDL-C did not show a similar association with weight categories above the 95th 
BMI-centile (Skinner et al.,2015) in this age group. A recent study aimed to evaluate the additive effect 
on discriminating individuals aged 12-18 years with a high (study-specific) cIMT >90th centile, when 
adding dyslipidaemia into a model including BMI, blood pressure, age and sex. The AUC of the model
including lipid measures was slightly higher at 0.701 versus 0.688 for the model without lipid measures 
(Koskinen et al.,2018).
The 2011 Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in 
Children and Adolescents, National Heart, Lung, and Blood Institute guidelines recommend a universal
screening for dyslipidaemia at the age of 9-11 and after puberty at the age of 17-21 years (Expert Panel 
on Integrated Guidelines for Cardiovascular et al.,2011). Selective screening is based on underlying
risk factors, co-morbidities or positive family history (Elkins et al.,2019). This approach allows an early
detection of primary and secondary lipid abnormalities (including familial hypercholesterolaemia, the
prevalence of the heterozygous state was estimated at around 1 in 200 to 500 individuals (Singh et 
al.,2015)), and the identification of those who may respond favourable to lifestyle modification. 
2.6.3 Inflammation
Obesity induces and maintains a chronic low-grade inflammation that triggers the development of many
non-communicable diseases, including metabolic syndrome, type 2 diabetes mellitus, non-alcoholic 
fatty liver disease, CVD and various cancers (Christ et al.,2019). Adipose tissue`s core function is to
store energy that can be released in times of starvation. However, if available in excess, it is also 
involved in inflammatory processes (Hajer et al.,2008). Subsequently, obesity-related mechanisms that 
trigger a chronic inflammation and common inflammatory markers that are associated with obesity are 
discussed. The focus will be on inflammatory markers that are linked with obesity and arteriosclerosis
and a novel measure for chronic low-grade inflammation is introduced.
Several obesity-related mechanisms contribute to this inflammatory response: The intake of a 
Westernized diet (i.e. energy-dense, fatty, salty, sugary diets and ultra-processed foods that are low in
fibres but rich in additives for longer storage and palatability) is driving excessive weight gain
(Mozaffarian,2016) and correlates with elevated serum inflammatory markers such as C-reactive
protein (CRP) and interleukin-6 (Lecube et al.,2019; Lopez-Garcia et al.,2004). Diet-induced
alterations in the gut microbiome composition and gut-leakage are discussed as mediators between this
association (Wan et al.,2019). Finally, an abundance of fatty acid substrates, exceeding the storage
capacity of adipocytes has shown to cause adipocyte stress (Crewe et al.,2017) that induces pro-
inflammatory changes in number and function of adipose tissue-resident macrophages (McLaughlin et 
al.,2017).
In children, inflammatory markers such as CRP (Kapiotis et al.,2006; Patel et al.,2006; Weiss et 
al.,2004), interleukin-6 (Kapiotis et al.,2006) and oxidised LDL Cholesterol, a marker of oxidative
stress (Norris et al.,2011) have been shown to correlate in a linear manner with increasing weight 
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categories from normal weight (<85th BMI centile) to overweight (between 85th and 95th BMI centile),
obesity (>95th BMI centile) and extreme obesity (≥1.2 times the 95th BMI-centile). Conversely, anti-
inflammatory markers such as interleukin-10 (Mattos et al.,2016) and adiponectin (Orlando et al.,2019; 
Stefan et al.,2002) are reduced in children with increasing weight status. There is evidence to suggest
that the obesity-related inflammatory condition is crucial for rapidly progressing arteriosclerosis in 
obese individuals (Rocha et al.,2009), as arteriosclerosis per se is an inflammatory process (Libby et 
al.,2002). Studies in children and adolescents, investigating cross-sectional associations between 
inflammatory markers and non-invasive subclinical atherosclerosis outcomes (such as flow-mediated
dilatation, cIMT, PWV) have shown that inflammatory markers remain significantly associated with
subclinical atherosclerosis outcomes after adjustment for BMI (Di Bonito et al.,2016; Giannini et 
al.,2009; Jarvisalo et al.,2002; Lopez-Garcia et al.,2004).
High-sensitivity CRP (hs-CRP) is the most widely used inflammatory marker in the context of obesity
and CVD. In the Framingham Study, the relative risk (RR) for future stroke for the highest quartile of 
hs-CRP compared with the lowest was 2.0 for men and 2.7 for women (Rost et al.,2001) with similar
results from corresponding studies restricted to men (Ridker et al.,1997) and women (Ridker et 
al.,2000). However, another study did not find an association between hs-CRP and hard cardiovascular
endpoints when adjusted for other cardiovascular risk factors (Folsom et al.,2001). Similar, according 
to the Cardiovascular Risk in Young Finns Study, hs-CRP did not show a benefit to predict future cIMT
measures in adulthood (Juonala et al.,2006b).
2.6.3.1 Glycoprotein acetyls, a marker for risk prediction for adverse health
Glycoprotein acetyls (GlycA), initially identified as N-acetylated carbohydrate side-chains of acute-
phase plasma glycoproteins, were first described in 1987 as a broad nuclear magnetic resonance (NMR)
spectroscopy signal (Bell et al.,1987). The NMR technique utilizes the magnetic behaviour of hydrogen
nuclei. Similar to a compass needle, hydrogen nuclei behave like little magnets and align (energetically 
stable) or oppose (unstable) to an externally applied magnetic field. By applying a combination of
specific radio frequency waves (usually at 60-100 MHz) and an external magnetic field, hydrogen 
nuclei may flip from the stable alignment to the less stable alignment. This particular situation – the
flipping of the hydrogen nuclei – is known as the resonance condition and can be detected. Hydrogen 
makes up >60% of the atoms of a human body. Most of them are bound in molecules with a specific
structure. For a given radio frequency, hydrogen atoms bound to molecules will require a slightly
different magnetic field applied to it to achieve the resonance condition. The necessary strength of the
magnetic field will depend on the environment of the hydrogen atom, i.e. on the structure of the
molecule that incorporates the hydrogen atom. Resulting spectra from NMR spectroscopy will therefore
show peaks of signals from hydrogen atoms in different molecules. The y-axis of such spectra reflects
the number of hydrogen atoms in a similar environment/molecule, whereas the x-axis gives the 
chemical shift that is a standardised value (in parts per million (ppm)) of the required strength of the
magnetic field to achieve the resonance condition.
In 1987, broad peaks at a range of the chemical shift between 2.04 - 2.08ppm were identified and 
assigned to N-acetyl protons of N-acetylated carbohydrate side-chains that were associated with acute-
phase plasma glycoproteins (Bell et al.,1987). And in 2015, this particular NMR signal received its new
name – glycoprotein acetyls (GlycA) (Otvos et al.,2015). Human plasma contains many glycoproteins 
with N-acetylated sidechains including α1-antitrypsin, transferrin, haptoglobin, α1-acid glycoprotein 
(acute-phase glycoproteins), and immunoglobulins and fibrinogen. Most of them are produced and
secreted by the liver, mediated by interleukin-6 (Gabay et al.,1999), and the concentration of GlycA
will rise or fall according to acute and chronic inflammation (Gornik et al.,2008). Recent studies
performing high-throughput NMR metabolomics profiling of large prospective cohorts have introduced 
glycoprotein acetyls (GlycA) as a strong predictive biomarker for long-term risk of morbidity and
mortality from diverse diseases (Connelly et al.,2017). Diseases, for which GlycA was predictive
include CVD (Akinkuolie et al.,2014; Duprez et al.,2016), certain cancers (Fischer et al.,2014), T2DM
(Akinkuolie et al.,2015; Connelly et al.,2016), non-alcoholic fatty liver (Kaikkonen et al.,2017) and 
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severe infections (Ritchie et al.,2015), many of which share a chronic inflammatory component
(Connelly et al.,2017). Also, GlycA have been associated with and is predictive for all-cause mortality
in adults (Akinkuolie et al.,2014; Fischer et al.,2014; Otvos et al.,2015), and is associated with obesity 
in young adults (Wurtz et al.,2014). 
GlycA offers particular advantages to solitary inflammatory markers such as hs-CRP: first, hs-CRP and
various cytokines are of much lower concentrations and therefore, they contribute negligibly to the 
measured GlycA signal. Therefore, GlycA may reflect different aspects of inflammatory conditions that
provide an additional value in risk prediction (Otvos et al.,2015). Second, hs-CRP needs at least two 
serial measurements due to within-individual variability before making clinical decisions (DeGoma et 
al.,2012). A recent study investigating risk prediction capability of GlycA and hs-CRP for incident 
hospitalization and mortality in two large Finnish cohorts showed that GlycA had additional predictive 
value beyond that of hs-CRP (Kettunen et al.,2018). 
Data on GlycA in childhood and adolescence is sparse: one study in 27 obese, prediabetic adolescent
Latinos illustrated improved GlycA values after a lifestyle intervention (Olson et al.,2019); another
study attributed a mediating effect of GlycA in children with overweight or obesity aged 11 years on
microvascular venular calibre (Liu et al.,2020); and a recent study investigated the association between 
GlycA and hs-CRP and measures for inflammatory immune measures revealing that GlycA may be a
better measure of inflammation in children and has potential value as a measure of chronic inflammation 
from very early childhood (Collier et al.,2019).
2.7 Metabolomics, BMI and cardiovascular risk
Metabolomics is a rather novel tool to study disease pathogenesis and to identify novel biomarkers for
future disease risk (Monteiro et al.,2013). Metabolomic studies refer to the identification and
quantification of small molecule metabolic products in biological specimens (e.g. urine, blood, organs)
at a specific point in time. The resulting metabolome is considered a top-down extract that covers
genetic, transcriptional and translational information all of which are influenced by environmental 
factors (Zhang et al.,2013) (see figure 4). 
Figure 4. Omics hierarchy
Genome
Transcriptome
Proteome
Metabolome
Omics hierarchy, illustrating the direction of the flow of information from the genome towards the
metabolome and intersected omics-platforms, where the information is processed.
Two general approaches are used in metabolomic studies, targeted and nontargeted. Targeted
metabolomics investigate a selected group of metabolites, often chemically or metabolically related for 
precise quantification and interpretation for specific research questions. In contrast, non-targeted
approaches aim to discover and quantify as many metabolites as possible (McGarrah et al.,2018).
39
  
         
   
          
           
          
          
      
 
       
       
    
              
  
    
             
     
          
      
          
          
       
   
         
       
               
 
 
      
    
  
      
      
 
             
          
           
                 
    
            
       
 
 
   
     
         
        
           
     
         
          
         
         
Metabolomic studies in adults have revealed distinct metabolic patterns related to increasing BMI, to
cardiometabolic risk factors (Ho et al.,2016; Holmes et al.,2014; Tulipani et al.,2016; Wang et al.,2011; 
Welsh et al.,2018; Zhao et al.,2016) and to CVD events (Holmes et al.,2018). Using Mendelian
randomisation, Wurtz et al. have shown in young adults (aged 26 years) that increasing BMI is an
antecedent for such metabolic patterns (Wurtz et al.,2014). In healthy and obese adults, NMR
metabolomic analyses have also shown sex-dependent variation, in particular for levels of branched 
chain amino acids that are related to future T2DM development (Vignoli et al.,2018; Xie et al.,2014).
Data in children and adolescents are sparse, particularly in those with obesity. Particularly in this age 
group, sex and pubertal development need to be considered as covariates, given their impact on body 
composition (Loomba-Albrecht et al.,2009) and cardiometabolic risk factors (Reinehr et al.,2015). 
These caveats in mind, metabolomics may be a promising tool with higher predictive capacity for adult
cardiometabolic disease compared to BMI (Umer et al.,2017).
2.8 Continuous metabolic syndrome score
Cardiometabolic risk factors tend to cluster, particularly in individuals with obesity. Therefore, a
common concept in adulthood is to summarize this co-occurrence of risk factors, including elevated 
blood pressure, abdominal obesity, elevated triglycerides and glucose, and low level HDL-C, under the
umbrella-term metabolic syndrome (National Cholesterol Education Program Expert Panel on
Detection Evaluation and Treatment of High Blood Cholesterol in Adults,2002). The pathophysiology
is largely explained by a selective insulin resistance with continuous hepatic lipogenesis and continuing 
hepatic gluconeogenesis (Rask-Madsen et al.,2012). Along with insulin resistance, a concomitant 
chronic inflammation and ectopic fat distribution are the main components of metabolic syndrome 
(Magge et al.,2017). However, the substitutes for the definition of metabolic syndrome vary between 
organisations. The most widely used definition is the National Cholesterol Education Program (NCEP)
Adult Treatment Panel III (ATP III), founded 2001 and updated in 2005, including any 3 or more of the
following conditions (Grundy et al.,2005): 
- Fasting glucose >5.6mmol/l or treatment for elevated glucose 
- HDL-Cholesterol <1.0mmol/l
- Triglycerides >1.7mmol/l
- Obesity (waist circumference >102 in man or 88cm in woman)
- Hypertension: BP >130/85mmHg or on treatment for medication)
The International Diabetes Federation (IDF) updated in 2006 warrants three of the aforementioned
conditions with a more stringent waist circumference of 94 cm for man and 80 cm for woman, a higher
threshold for HDL-Cholesterol in woman of 1.3mmol/l and including individuals diagnosed with
T2DM. As a consequence of the more stringent criteria used by the IDF, the percentage of individuals
diagnosed with metabolic syndrome using the NHANES 1999 to 2002 dataset was slightly higher for
the IDF criteria at 39% compared to the ATP III criteria with 34.5%. However, the two definitions 
overlapped for 93% of the subjects evaluated for the presence or absence of metabolic syndrome 
(Adams et al.,2005). 
In children and adolescents, the utility of the metabolic syndrome beyond the significance of its
contributors remains questionable (Goodman et al.,2007; Steinberger et al.,2009). Uncertainties are
around the specific factors and their thresholds to use, as for many factors the risk likely is a continuum.
Also, there are ethnic differences in the rates of obesity and cardiometabolic risk factors (Ogden et 
al.,2014). Last, the diagnosis of metabolic syndrome in childhood is very unstable with up to 50% of 
children diagnosed no longer qualify for the diagnosis when reassessed within 3 weeks (Gustafson et 
al.,2009)) or within 9 years (Stanley et al.,2014), irrespective of weight change over the time observed. 
An approach to solve the problems around thresholds and ethnic differences was to develop continuous
metabolic syndrome scores based on BMI z-score, HDL-cholesterol, triglycerides, fasting glucose, and 
systolic blood pressure (Gurka et al.,2012). Until such continuous metabolic syndrome risk scores have
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a clinical applicability, the current recommendations are to identify and treat single risk factors (Magge
et al.,2017). 
2.9 Subclinical cardiovascular phenotypes 
Subclinical cardiovascular phenotypes reflect the severity of atherosclerosis prior to clinical 
manifestation of CVD, and therefore are used as intermediate outcomes to assess CVD risk in youth. 
Subclinical cardiovascular phenotypes include the measurements of cIMT, carotid-femoral PWV and 
arterial elasticity. These measures can be assessed non-invasively, e.g. via ultrasound, are reproducible,
well-tolerated and safe for children and adolescents (Urbina et al.,2009b). 
CIMT and PWV are the most widely used measures. In childhood, the severity and the number of co-
existing cardiovascular risk factors are associated with elevated cIMT (Juonala et al.,2010) and PWV
(Koivistoinen et al.,2011) in adults. CIMT and PWV assessed in adulthood are associated with and 
predictive for CVD and mortality (Lorenz et al.,2007; Mattace-Raso et al.,2006; Mitchell et al.,2010). 
Specifically, a systematic review showed that for every 0.1mm cIMT, the risk for future myocardial 
infarction (MI) increases by 10% to 15%, and for future stroke by 13% to 18% (Lorenz et al.,2007). 
Adding cIMT to the Framingham Risk Score revealed some small, but significant improvement for the
10-year risk prediction of first-time stroke and MI, particularly in those with intermediate risk (Den
Ruijter et al.,2012). Arterial elasticity describes vascular diameter changes during the systole-diastole 
cycle (Boesen et al.,2015). In adulthood, arterial elasticity is associated with the severity of 
atherosclerosis, carotid plaque presence, incident stroke (Boesen et al.,2015) and all-cause mortality 
(van Sloten et al.,2014).
2.9.1 Carotid intima-media thickness
The method to assess intima-media thickness was first described by Pignoli et al. in 1986, illustrating a 
close correlation of in vitro aortic intima-media thickness when assessed with ultrasound and light
microscopy (Pignoli et al.,1986). Commonly the right, far wall cIMT is assessed with B mode
ultrasound imaging, illustrating the arterial wall layers as shown in figure 5. Using semi-automated 
edge-detecting software allows accurate quantification of the IMT which has further improved
reproducibility (Peters et al.,2012). The use of standardized protocols by trained sonographer has 
revealed reliable IMT measures, independent of whether the proximal part, the bulb or the internal 
carotid arteries were scanned (Riches et al.,2010). For cIMT assessment in children, a simultaneous
ECG gating is recommended due to changes in IMT during the cardiac cycle (Rueb et al.,2017).
Distance between arrows is the intima-media thickness.
Figure 5. Illustration of a B-mode ultrasound image to assess arterial intima-media thickness
White arrow pointing to the lumen-intima border, black arrow pointing to the adventitia-media border.
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Cardiovascular risk factors in childhood predict young adult`s cIMT, however the strength of this
relation depends on age as shown in a large dataset including 4 prospective cohorts with 4380 
participants (the Cardiovascular Risk in Young Finns Study, Childhood Determinants of Adult Health
study, Bogalusa Heart Study and the Muscatine Study). The number of childhood cardiovascular risk
factors (total cholesterol, triglycerides, blood pressure and BMI) in their highest quintile was predictive
for the highest decile in cIMT in young adulthood (20-45 years) for children aged 9, 12, 15 and 18 
years: OR were: for 9 years old 1.37 [95%CI 1.16 to 1.61], p-value=0.0003; for 12 years old 1.48 
[95%CI 1.28 to 1.72], p-value<0.0001; for 15 years old 1.56 [95%CI 1.36 to 1.78], p-value<0.0001;
and for 18 years old 1.57 [95%CI 1.31 to 1.87], p-value<0.0001 (Juonala et al.,2010).
With respect to BMI, studies from the international Childhood Cardiovascular Cohort (i3c) consortium,
systematic reviews and other longitudinal studies have shown that increasing BMI levels during 
childhood are predictive for cIMT in adulthood, and remain predictive after adjustment for other
cardiovascular risk factors (Ajala et al.,2017; Dwyer et al.,2013; Juonala et al.,2006a; Oikonen et 
al.,2013; Oren et al.,2003; Petkeviciene et al.,2015; Raitakari et al.,2003). A recent study from the i3c
consortium involving individuals aged 12-18 years old with 23.4 years of follow-up data, a BMI in the
obese range was the risk factor most strongly associated with cIMT values >90th centile (relative risk 
3.7 [95%CI 2.0-7.0], followed by male sex (relative risk 2.7 [95%CI 2.0-2.6], hypertension (relative
risk 1.9 [95%CI 1.3-2.9] and high LDL-C (relative risk 1.6 [95%CI 1.1-2.1]) (Koskinen et al.,2018).
2.9.2 Pulse-wave velocity
PWV is the most widely used measure of arterial stiffness and best correlated with cardiovascular
disease mortality when assessed between the carotid and femoral artery (Mitchell et al.,2010). PWV for 
the purpose of this study was calculated according to the method shown in figure 6. Faster PWV means
higher arterial stiffness along the investigated arterial vasculature, and hence more progressed
atherosclerosis and cardiovascular disease risk. In children and adolescents, PWV is highly
reproducible and a well-tolerated measure of arterial stiffness, when assessed with applanation 
tonometry (Lowenthal et al.,2014). Other methods to assess PWV include the ArteriographÒ, a method
where oscillations serve as indirect measure for pulsatile pressure changes in the artery (Baulmann et 
al.,2008). Probably the best non-invasive method to study the artery propagation wave is the MRI 
method as no geometric assumptions need to be made (Joly et al.,2009). A more complete review 
including current available methods is provided by Pereira et al. (Pereira et al.,2015). Besides different
devices, PWV may also be assessed in different arterial fields, i.e. brachial PWV versus carotid-femoral 
PWV, revealing different results that are dependent amongst others on arterial wall composition.
Figure 6. Assessment of carotid-femoral pulse-wave velocity
Left: A doppler ultrasound device detects the pulse wave at the carotid bulb, a thigh cuff detects the 
pulse wave at the femoral artery. Right: Pulse-wave velocity is calculated out of ratio between the 
Δlength (distance between carotid bulb and proximal cuff margin at the thigh) and the Δt (time interval 
between the detection of the pulse wave at the two sites).
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PWV in healthy children varies with age, sex and blood pressure and various reference data, the largest
a multicentre study involving 1008 children aged 6-20 years, exist (Reusz et al.,2010). According to a
meta-regression analysis involving 9 studies on the relation between age and PWV in childhood, every
year of ageing increases PWV by 0.12m/s per year (Stoner et al.,2020).
Studies investigating the impact of body composition measures on PWV revealed opposing findings. 
One meta-analysis included 14 studies and revealed a 0.45m/s increase in PWV in children with obesity
compared to children with normal weight (Hudson et al.,2015). Limiting factors in this study were that
different methods to assess PWV were compared (e.g. carotid-femoral versus brachial PWV), and when
studies with high risk of bias were excluded, the association was no longer significant. A more recent 
meta-analysis including studies with overall high quality and >100 individuals found mixed 
associations between body composition measures and PWV (Stoner et al.,2020): of 10 cross-sectional 
studies investigating the association between body composition (such as BMI, DXA, and percentage
body fat) and PWV, four reported a positive association, two a negative and another four found no
association (Stoner et al.,2020).
2.9.3 Carotid elasticity
Elastic properties of arteries can be assessed using various metrics (e.g. absolute distension,
distensibility, Young`s Elastic Modulus), reflecting structural (i.e. the amount of elastic fibres) and 
functional characteristics (i.e. changes in artery diameter according to arterial blood pressure) (Boesen
et al.,2015). Decreased arterial elasticity has been associated with diabetes (Prenner et al.,2015), 
hypertension (Mitchell,2014) and obesity (Tokita et al.,2009), and it correlates with the degree of 
atherosclerosis and risk for incident stroke (Boesen et al.,2015).
A commonly used measure for carotid elasticity in children (Liu et al.,2019) and adults (Juonala et 
al.,2005) is assessed with ultrasound calculating the systolic-diastolic diameter change, normalized to 
the diastolic diameter and pulse pressure. In the Special Turku Coronary Risk Factor Intervention
Project for Children study, the number of ideal cardiovascular health metrics according to the American
Heart Association (Lloyd-Jones et al.,2010) was directly related to carotid elasticity in adolescents
(Pahkala et al.,2013). Also, cardiovascular risk factors defined as values at or above the age- and sex-
specific 80th percentile for LDL-C, blood pressure, skinfold thickness, at or below the 20th percentile 
for HDL-C and smoking were directly related with arterial elasticity in adulthood after adjustment for
risk factors identified in adulthood (Juonala et al.,2005).
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3 Aims of the Study
Figure 7. Study aims
Aim II Aim III 
Testing the Metabolomic
protein leverage profiles related to Obesity-relatedEnergy intake / hypothesis Obesity in children cardiovascular risk 
Energy expenditure & adolescents metabolomic
profiles 
Aim I Aim IV 
Association of Obesity-related Association of changes in 
grip strength with adiposity measures, lipid profile, cardiovascular risk
subclinical cardiovascular blood pressure, chronicfactors 
phenotypes and inflammation with subclinical
cardiometabolic outcomes 
ye
ar
s f
ol
lo
w
-u
p 
5.
5 
cardiovascular phenotypes
Subclinical cardiovascular phenotypes 
- Carotid intima-media thickness 
- Pulse-wave velocity 
- Carotid elasticity
Overview to illustrate the study aims
Studies for this thesis aimed to investigate the association between determinants for an adverse 
TEI/TEE ratio with the severity of obesity, with obesity-related cardiometabolic risk factors and with
subclinical cardiovascular phenotypes. As depicted in figure 7, the specific aims were:
I. to investigate the association of grip strength, a global measure of muscle strength, on 
cardiovascular risk factors and subclinical cardiovascular phenotypes among obese youth;
II. to investigate the relation between the dietary macronutrient composition with TEI and BMI in
children and adolescents with obesity;
III. to investigate the relation between clinically assessed adiposity measures and a metabolomic
platform with metabolites assessed for cardiometabolic risk in sera of children and adolescents 
with obesity stratified for sex and pubertal development;
IV. to investigate the association of change in adiposity measures and cardiovascular risk factors
from early (10.2 years) to late adolescence (15.7 years) on non-invasive subclinical 
cardiovascular phenotype assessment in children and adolescents with obesity.
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4 Subjects and Methods
4.1 Description of the study cohort
Figure 8. Illustration of the COBRA and COBRA-CVR follow-up cohort
Longitudinal follow-up COBRA, n = 438 COBRA-CVR, n = 101 
mean interval 5.5 years 
Demography Demography 
Medical history Medical history 
Anthropometry Anthropometry 
Cardiovascular risk factors Cardiovascular risk factors 
Energy balance (intake & expenditure) Subclinical atherosclerosis outcomes 
Metabolomic data Physical fitness 
4.1.1 COBRA – Childhood Overweight Biorepository of Australia
The Childhood Overweight Biorepository of Australia (COBRA) is a single centre cohort study, located
at the Royal Children`s Hospital (RCH), a tertiary care paediatric hospital in Australia (Sabin et 
al.,2010). Research projects including COBRA participants are conducted in collaboration with the 
onsite research institute, the Murdoch Children`s Research Institute (MCRI), providing the 
epidemiologic and statistical research support and infrastructure.
Since 2009, COBRA participants are recruited from the RCH Weight Management Service, a tertiary
care outpatient clinic to provide support to families and healthcare professionals to assist with weight
management for infants, children and adolescents. Reviewed by the local RCH ethical board, a broad
ethical consent was obtained from COBRA participants, or in the case of minors from their legal
representatives, to collect detailed demographic and anthropometric data, medical and family history
and questionnaire data. The consent also included the collection and storage of blood and urine samples 
at the local MCRI biobanking facility for future, ethically approved, research projects.
The COBRA biorepository was set up as a library of biological and health-related information from a
large number of individuals with overweight or obesity (overweight and obesity determined the 85th 
and 95th percentile cut-offs of US-derived data produced by the Centers for Disease Control and
Prevention (http://www.cdc.gov)). This library aimed to provide answers to research questions related
but not limited to:
I. identify the factors contributing to overweight and obesity in children and adolescents;
II. identify weight-related co-morbidities at presentation; and
III. identify factors that contribute to future, weight-related co-morbidities.
4.1.2 COBRA-CVR – Cardiovascular Risk in COBRA
COBRA-Cardiovascular Risk (COBRA-CVR) is a longitudinal study-arm of COBRA (see figure 8). 
To be eligible to participate in COBRA-CVR, the criteria were:
- former COBRA participant;
- consent to be re-contacted and permission to use collected data and stored biological samples;
- aged 6-18 years;
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- ability to understand and provide consent (or to provide a legally acceptable representative who 
can understand and provide consent);
- not meeting any of the exclusion criteria.
Exclusion criteria for the COBRA-CVR study were:
- children, adolescent or representative with intellectual impairment to give informed consent;
- families whose level of English precluded adequate understanding to give informed consent;
- primary or secondary immunodeficiency;
- adolescents with conditions requiring current or recent (within the previous three months)
immunosuppressive medication, including oral or IV steroids (inhaled or topical steroids were
not exclusion criteria);
- history of acute infection requiring hospitalisation within the last four weeks;
- children with central venous access or indwelling prosthetic devices.
4.2 Collected data for COBRA and COBRA-CVR
Data used for this thesis were obtained from participants at the time-point of enrolment for COBRA
and at the time-point of participating for COBRA-CVR (see figure 9). 
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Figure 9. Overview and comparison of collected data for COBRA and COBRA-CVR
Data collection 
Longitudinal follow-up COBRA 
mean interval 5.5 years 
Demography 
- Age 
- Sex 
- Socio-economic Indexes for Areas (SEIFA scores) 
Medical history 
- Medication 
- Previous medical conditions 
Anthropometry
Adiposity measures 
- Body-mass index 
- % >95th BMI centile 
- Waist circumference 
- Waist-to-height ratio 
- % Total body fat 
- % Truncal fat 
- Fat-free mass 
Pubertal stage 
- Tanner stage 
Cardiovascular risk factors 
- Blood pressure (systolic and diastolic BP) 
- Lipids (LDL-, HDL-, total cholesterol, triglycerides) 
- Fasting glucose, HbA1c 
- Glycoprotein acetyls 
Energy balance 
- Total energy intake & macronutrients ratios 
- Energy expenditure, accelerometry data 
Metabolomic data 
- Serum metabolomic profiles 
COBRA-CVR 
Demography 
- Age 
- Sex 
- Socio-economic Indexes for Areas (SEIFA scores) 
Medical history 
- Medication 
- Previous medical conditions 
Anthropometry
Adiposity measures 
- Body-mass index 
- % >95th BMI centile 
- Waist circumference 
- Waist-to-height ratio 
- % Total body fat 
- % Truncal fat 
- Fat-free mass 
Pubertal stage 
- Tanner stage 
Cardiovascular risk factors 
- Blood pressure (systolic and diastolic BP) 
- Lipids (LDL-, HDL-, total cholesterol, triglycerides) 
- Fasting glucose, HbA1c 
- Glycoprotein acetyls 
- Smoking status 
Subclinical atherosclerosis
outcomes
- Carotid intima-media thickness 
- Carotid-femoral pulse-wave velocity 
- Carotid elasticity 
Physical fitness 
- Grip strength 
4.2.1 Acquisition of demographic, medical history and anthropometric data
Demographic information was collected at the study visits for COBRA and COBRA-CVR, including
date of birth, age, sex and contact details to obtain postcodes for the SEIFA-scores. Socioeconomic 
status was measured using SEIFA-scores of Relative Socioeconomic Advantage and Disadvantage 
according to the participant’s postal code at COBRA-CVR (Liu et al.,2017). The SEIFA score is a
standardized score compiled from census data summarizing information about economic and social
conditions of people and households according to their living area. The score is scaled at a numeric 
mean of 1000 and a standard deviation of 100. A higher score represents an area of more advantage and
less disadvantage.
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Data from medical history were collected at the study visits according to the inclusion/exclusion criteria.
This information was sourced from the participant, their parent/guardian, and their hospital medical
records. 
Anthropometric measures included height (cm) and weight (kilograms). Height was measured without
shoes to the nearest 0.5 cm, using a fixed Harpenden stadiometer (Holtain Ltd., Crymych, Dyfed, UK). 
Weight was assessed in light clothes to the nearest 0.1 kilogram. Adiposity measures included BMI,
BMI z-score, %>95th BMI-centile, % total body fat (%BF), % truncal fat (%TF), fat-free mass (FFM), 
WC and WtH-ratio. 
BMI was calculated according to the formula weight in kilograms divided by height in meters squared
and then converted into age- and sex-specific BMI z-scores using the US CDC growth reference charts
(Kuczmarski et al.,2000). %BF and %TF were assessed by a four-point bioimpedance device, Tanita
BC-418 segmental body composition analyzer (Tanita Corporation, Tokyo, Japan), which was
previously validated for the use in children > 6 years (McCarthy et al.,2006b). The FFM was calculated
according to the formula FFM = weight (kilograms) × (100 − %BF) and then used to calculate BMR
according to the Schofield equation (Schofield,1985b). 
Pubertal development was assessed with an orchidometer and graded according to Tanner stages by a 
specialist paediatric endocrinologist or a consultant general paediatrician. Tanner 1 was considered pre-
pubertal, Tanner 2 to 3 was peri-pubertal, and Tanner 4 to 5 was post-pubertal (Tanner,1986). 
4.2.2 Acquisition of cardiovascular risk data
Blood pressure measurements at COBRA enrolment were performed with a manual
sphygmomanometer (Welch Allyn, Macquarie Park, Australia) by auscultation of the right brachial 
artery when the participant was sitting, quiet and calm. At COBRA-CVR, the right brachial SBP, DBP, 
mean arterial pressure, and pulse pressure and heart rate were measured using a SphygmoCor XCEL
system (AtCor Medical Pty Ltd., Naperville, USA) after a 5-minute rest in supine position. The mean
of three measurements was used. The cuff-size was fitted according to published clinical practise
guidelines (Flynn et al.,2017) and the updated 2017 clinical guidelines were used to define normal or
elevated blood pressure and stage I and II hypertension (Flynn et al.,2017). 
Lipid profiles at the COBRA and COBRA-CVR time-points included total cholesterol, HDL-C, LDL-
C and triglycerides. They were derived from a NMR spectroscopy platform (Nightingale Health,
Helsinki, Finland) (Saner et al.,2019). Results were obtained from serum blood samples that were
collected after a minimum six hour fast. LDL-C, HDL-C and total cholesterol levels derived from
metabolomics profiling are lower than a standard lipid profile. 139 pairs of NMR and standard 
laboratory LDL-C levels were compared, available from analysis performed in COBRA participants 
using the Bland Altmann method (Altman et al.,2017). The mean difference and limits of agreement 
between the Nightingale LDL-C and standard laboratory LDL-C was -1.1mmol/l [95%CI -1.9 to -
0.3mmol/l]. A regression model was used to calculate LDL-C levels that were comparable to standard
laboratory LDL-C levels.
Fasting glucose and HbA1c were analysed on fresh blood using standard methods (fluoride oxalate 
plasma on VITROS 5600, Ortho Clinical Diagnostics, Australia; and EDTA plasma on BIO-RAD D10,
Gladesville, Australia, respectively). Type 2 diabetes mellitus or prediabetes was diagnosed according
to standard criteria of the American Diabetes Association (American Diabetes,2019).
Glycoprotein acetyls (GlycA) is a measure for chronic inflammation and predictive for cardiovascular
disease and mortality (Akinkuolie et al.,2014; Lawler et al.,2016) and was derived from the NMR
spectroscopy platform. 
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4.2.3 Acquisition of energy balance data
Energy intake
TEI and relevant proportions of energy intake from macronutrients (carbohydrates %EC; fats %EF and
proteins %EP) were collected using the Australian Child and Adolescent Eating Survey Food-frequency
questionnaire (ACAES-FFQ) (Watson et al.,2009) between the years 2010 and 2018. As part of the 
Australian Eating Survey suite of food questionnaires, these questionnaires have undergone 
comprehensive evaluation for validity and reproducibility, and they can be self-administered or
completed by parents for young children. Reproducibility and comparative validity for this survey have 
previously been established (Watson et al.,2009). The ACAES-FFQ is a 120 item semiquantitative FFQ
with 15 supplementary questions regarding age, use of vitamin supplements, food behaviours, and 
sedentary behaviours. While completing the survey, a list of the most commonly eaten foods by
Australians are given and the participant indicated the frequency of consumption of these foods. The
ACAES-FFQ was sent to the University of Newcastle for scanning, and nutrient analysis was assessed 
using FoodWorks software (version 8.0.3553; Xyris Software, Xyris, Australia) to elicit TEI, %EP, 
%EC and %EF. Absolute measures of energy from dietary carbohydrate, fat, and protein were
calculated by multiplying grams of intake by 16.7 kJ/g for carbohydrate and protein and 37.7 kJ/g for
fat (National Health and Medical Research Council,2006, updated September 2017).
Energy expenditure
A subgroup of COBRA participants had physical activity measured by Actical accelerometers (Philips
Respironics, Philips, USA) worn on the left hip on an elasticized belt continuously for 7 days, including
water-based activities and sleep. Accelerometer results were considered valid for participants with data
on three or more weekdays and one or more weekend days, with a wearing time of at least 600 minutes
and a maximum non-wear time of 360 minutes in each 24-hour period, as per published guidelines
regarding acceptability (Colley et al.,2010). Actical accelerometery physical activity intensity was
categorized according to published intensity cut-off points (Colley et al.,2011).
4.2.4 Acquisition of grip strength data
Grip strength was measured in kilograms using a digital dynamometer (T.K.K. 5401; Takei Scientific 
Instruments Co., Ltd, Japan), which has the highest criterion validity and reliability in adolescent 
populations (Espana-Romero et al.,2010). As grip span has been shown to affect grip strength
performance, hand span of participants was measured to determine the optimal grip span for the
dynamometer based on age- and sex-specific equations for children and adolescents (Ruiz et al.,2006). 
Grip strength was then measured twice on both hands from participants according to protocols from the 
2011-12 NHANES (CDC,2011). Results were adjusted for body weight due to reported weight-related
influence (Aasa et al.,2003; Milliken et al.,2008) and subsequently categorized into low, moderate and 
high grip strength according to previously published normalized values (see table 5) (Peterson et 
al.,2016).
Table 5. Sex-specific normalized grip strength categories for children and adolescents
Normalized grip strength category (kg/kg) Boys Girls
Low £0.33 £0.28
Moderate >0.33 to £0.45 >0.28 to £0.36
High >0.45 >0.36
Normalized grip strength categories as the ratio of raw grip strength (kg) is divided by body weight
(kg) 
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4.2.5 Acquisition of metabolomic data
Metabolomic analysis from stored serum samples was performed on the Nightingale® NMR
spectroscopy platform as previously described (Kettunen et al.,2012; Soininen et al.,2009). A total of 
73 metabolites, capturing the majority of variation within the dataset, were used in analyses, including 
lipid subclass concentration, composition, size and ratios and concentrations of apolipoproteins, 
cholesterols, fatty acids, glycerides, phospholipids, amino acids, glycolysis related products, albumin,
creatinine and glycoprotein acetyls.
4.2.6 Acquisition of subclinical cardiovascular phenotypes
Carotid intima-media thickness
The right common carotid artery was assessed in the supine participant with their head turned 45° to 
the left, according to on-site standardized protocols (Liu et al.,2019). Simultaneous ECG gating was 
performed to allow the assessment of cIMT at end-diastole (R-wave of ECG) due to changes in cIMT 
during the cardiac cycle in children (Rueb et al.,2017). Ultrasound images were obtained using a 10-
MHz linear array probe (Vivid I; GE Healthcare, Parramatta, NSW, Australia). Real-time B-mode
ultrasound cine loops over five heartbeats were captured in triplicate. The qualitatively best loop was
further processed using Carotid Analyzer (Medical Imaging Applications, Coralville, Iowa, USA), a
commercially available semiautomatic edge-detection software program. Carotid IMT was measured 
~10 mm proximal to the carotid bulb, over a distance of 5 to 10 mm. The far wall cIMT, averaged from
the mean of five frames at end-diastole was used in the analysis.
Carotid-femoral pulse wave velocity
The pulse-wave velocity was determined using the SphygmoCor XCEL (AtCor Medical, Australia)
(Butlin et al.,2013) in the supine participant after a 5-minute rest. The PWV was calculated as the ratio
of the distance of the carotid-femoral arterial segment and the time interval needed for the pulse wave
to travel this distance. The distance was measured with a non-flexible tape measure using the following
anatomical landmarks: from the carotid pulse to the suprasternal notch to the right femoral artery 
(estimated midway the crease between thigh and torso when the knee was bent) to the proximal end of 
the thigh cuff. The time interval was measured from simultaneously recorded waveforms by applanation 
tonometry at the carotid pulse and the cuff at the upper right thigh. The mean of the three measures was
used for analysis (Liu et al.,2019).
Carotid elasticity
Carotid elasticity (%/mmHg) was calculated as previously described in adults (Juonala et al.,2005)
and children (Liu et al.,2019) according to the formula:
!"#$%& − "#$()*"#$() . 100%Δ, 
The maximum (LDmax) and minimum (LDmin) lumen diameter was calculated with the Carotid
Analyser software (Medical Imaging Applications, Coralville, IA, USA). Pulse pressure (Δ,) was 
calculated as the difference between systolic and diastolic blood pressure.
4.2.7 Reproducibility of cIMT results
Subclinical cardiovascular phenotypes outcome data were assessed by a PhD applicant after a training 
period of three months by expert examiners on-site. To test for reliability, a random sample of 30 de-
identified loops with five heartbeats of B-mode images (~25 frames per heartbeat) to assess cIMT were
re-analysed by a second reader. The results were compared using the Bland Altman method (Bland et 
al.,1986a).
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4.3 Statistical analyses
All analyses were performed using the software R® 3.4.3 (R Foundation, Vienna, Austria). Figures
were drawn using the R-package ggplot2 or Microsoft PowerPoint (Microsoft Corporation, WA, USA). 
A significance level was set at p < 0.05.
All data were checked for plausibility prior to analysis. Values incompatible with life were removed
from the dataset. Unlikely but plausible values were retained. 
Variables included in analysis were checked for their symmetry of distribution according to visual
inspection of histograms and by using the skew function of the e1071-R-package (David Meyer, 2018).
4.3.1 Sample size estimation
There are no equivalent data available for grip strength (aim I), macronutrients analysis (aim II) or 
metabolomic profiles (aim III) in children and adolescents with obesity. The impact of evidence 
provided by the design for aim IV was considered highest. Therefore, a sample size estimation for aim
IV was performed to detect an effect size meeting the criteria of α= 0.05 and β=0.2 (allowing for 80%
power) for PWV. Published data on PWV between obese versus normal weight adolescents showed 
mean and SD differences of 3.7 m/s ± 0.34 versus 4.02 m/s ± 0.44 (Nunez et al.,2010). Unadjusted
correlation coefficients from a large population-based study for BMI and PWV are reported at 0.21 
(Baier et al.,2018). Using the R-package pwr, the minimum necessary samples size was calculated
assuming a correlation coefficient r = 0.3, indicating a medium effect size, resulting in a minimum
number of 84 individuals. To assure an adequate sample size the ethics application included a minimum
of 84 individuals with a maximum of 120 individuals
4.3.2 Descriptive statistics
Participant characteristics, study exposures, outcomes and covariates were described in mean and 
standard deviation (SD) for continuous and number (%) for categorical variables including the range
from min to max.
4.3.3 Inferential statistics
Directed acyclic graphs (DAG) were used to define the nature of the variables from an analysis 
perspective. A DAG is an illustration of a research hypothesis that includes the variables of interest
ordered according to their causal relations to each other. This method facilitates the definition of
exposures, confounders, mediators, colliders and outcomes for the inferential analysis (Greenland et 
al.,1999). See figure 10 for an illustration adapted from (Williams et al.,2018b).
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Figure 10. Illustration of the definition of variables according to their relation to exposures and
outcomes
a) Energy-densenutrition Obesity 
b) Energy-dense
nutrition 
Energy intake Obesity 
Parental education 
Energy-dense Energy intake Obesity 
c) 
nutrition 
d) Parental education 
a) Energy-dense nutrition (exposure) causes obesity (outcome). b) Energy-dense nutrition acts on 
obesity through the mediator of increased energy intake. c) Parental education causes increased intake
of energy-dense nutrition and obesity and is therefore a confounder. d) Body image is a collider in the
path from the consumption of energy-dense nutrition to obesity.
Adjustments for mediators (i.e. variables that are on the causal pathway between exposures and
outcomes) was occasionally performed to assess direct effects of the exposure variable on the outcome 
and to evaluate mediation of an additional variable (Baron et al.,1986). Colliders - descendant of both 
the exposure and outcome – were not included to avoid the finding of associations between variables
where there are none (collider bias).
Regression analyses were the main method used for assessing the direction and strength of associations
between variables in most studies (see aim-specific statistical analysis). Adjustment was performed for 
true confounders, such as age and sex, to describe the total effect between exposure and outcomes. 
Energy-dense
nutrition 
Energy intake Obesity 
Body image 
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4.3.4 Aim-specific statistical analysis
Aim I: to investigate the association of grip strength, a global measure of muscle
strength, on cardiovascular risk factors and subclinical cardiovascular 
phenotypes among obese youth
Data preparation
Participants were divided into categories of normalized grip strength according to previously defined 
thresholds described in the methods (table 5).
Confounding by age, sex, and pubertal stage was tested before considering adjustment for these
variables. Similar, within the relationship of grip strength and the subclinical cardiovascular
phenotypes, BMI z-score may act as a mediator (Fraser et al.,2018) or confounder (Fraser et al.,2016), 
hence results for BMI z-score adjusted analysis were provided. 
Main analysis
The associations between normalized grip strength categories (independent variable) and 
cardiometabolic, preclinical markers (dependent variables) were estimated using linear regression.
Aim II: to investigate the relationship between macronutrient composition and total energy 
intake and BMI (specifically the protein leverage hypothesis) in children and 
adolescents with obesity.
Modelling the relation between macronutrients and total energy intake using power functions
The relation between the proportion of energy from protein sources and the total energy intake follows
a power function. To determine the strength of the leverage from macronutrients on total energy, power 
functions were fitted. The default formula for a power law solution adapted for PL is characterized by 
the following equation: 
2345(637 8997 ():%;3 (() =6%$>) = , & A! 
where P is the targeted intake of protein in grams, p is the proportion of protein from a given diet, and
L is the strength of leverage. P and p are derived from the analysis, and the exponent L reveals the
strength of leverage. Assuming full protein leverage that is, L = −1, small changes in the proportion of
energy from protein (p) will cause substantial changes in total energy intake. Assuming no protein
leverage that is, L = 0, changes in p will not cause any changes in total energy intake (Raubenheimer et 
al.,2019).
Compositional data analysis to explain total energy intake from macronutrient composition
Multiple regression with compositional predictors (e.g., percentages of energy from relevant
macronutrients) warrant a different approach to simple linear regression as covariance among the
percentages of different components may cause inferential errors. For example, an increase in %EP 
must necessarily lead to a decrease in %EF and/or %EC.
Mixture models, also known as Scheffés` polynomials, are an analytical framework that is based on 
multiple regression and robust to the analysis of outcomes with compositional predictors (Lawson et 
al.,2016). To test the sensitivity of our results to the choice of analysis, the total energy intake and BMI 
z-score data was analysed as a function of dietary macronutrient content (%EC, %EF, and %EP) in a 
mixture model framework, which allows to test for effects of all three macronutrients simultaneously.
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Five different models were fitted with increasing complexity for each outcome. Model 1 was a null
model, which assumes no effect of dietary composition on the outcomes. Models 2 through 5 were
mixture models, corresponding to equations 1 through 4 in Lawson and Willden (Lawson et al.,2016)
to test for linear additive through increasingly complex nonlinear interactive effects of macronutrients 
on total energy intake and BMI z-score. Noteworthy that model 2, which tests for linear effects, is 
identical to the partition substation model commonly used in nutritional epidemiology (Song et al.,2018; 
Willett et al.,1997). To select among models, an information theoretic approach based on Akaike
information criterion (AIC) was used (Akaike,1992). Of the five models fitted, the model with the
smallest AIC was selected. In the event that two models were within two AIC points of one another,
the simplest model was selected. Where the null model is favoured, no effect of macronutrient
composition on the outcome is inferred, with subsequent models suggesting more complex effects of
diet composition on the outcome of interest.
Mixture models were implemented using the “MixModel” function in the R package mixexp (The R
Foundation for Statistical Computing, Vienna, Austria). For interpretation, the predictions from the 
AIC-favoured model were plotted as surfaces on a right-angle mixture triangle (Raubenheimer,2011). 
Aim III: to investigate the relation between clinically assessed adiposity measures and a
metabolomic platform with cardiometabolic interests in sera of children and
adolescents with obesity.
Data preparation
Adiposity measures (BMI, total %BF, %TF, WC and WtH-ratio but not BMI z-scores) and metabolites 
were scaled to SD-units to facilitate the comparison of estimates across metabolite measures.
Multivariate analysis of metabolomic data
Principal component analysis (PCA), a common approach in multivariate data analysis, was used to 
investigate the dataset`s variability and to uncover clusters within the dataset (Worley et al.,2013). The
value of PCA is to reduce the dataset`s variability into principal components that explain most (PC1),
second most (PC2), and so forth, of the variability. For illustration, the principal components one and
two were plotted including their relation to age and sex. The percentage contribution to the variability
of the dataset is given in a table for the most important five principal components.
PCA was used to gain an informative understanding of the dataset structure. PCA aims to identify class 
differences from a multivariate dataset. A class may refer to any relevant characteristic such as sex, use
of a specific medication or different genetic traits. The precondition to detect such bias within the 
dataset is that the within-class variation must be sufficiently less than the between-class variation.
Main analysis and adjustments for multiple comparisons
Multiple linear regression was applied for a 1 standard deviation change in each adiposity measure 
(predictor) and the metabolite measure (outcome), adjusted for age and sex as confounders. In addition, 
linear regression modelling was applied to sex and puberty-specific datasets to illustrate trends for 
metabolites in these subgroups. A Benjamini-Hochberg (Hochberg et al.,1990) false discovery rate of 
0.1 was used to adjust for multiple testing.
Aim IV: to investigate the association of adiposity measures and cardiovascular risk factors over
time on a comprehensive, non-invasive set of subclinical cardiovascular phenotypes in
children and adolescents with obesity.
Selection of covariates: sex, age, socioeconomic status, pubertal status and smoking status
The analysis accounted for factors that were potential confounders of the association between adiposity
measures or cardiovascular risk factors and subclinical atherosclerosis. Selection was based on evidence
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in the literature and included socioeconomic status, age, sex, and pubertal status. The confounding for
subclinical atherosclerosis outcomes by age, sex and socioeconomic status is well described (Liu et 
al.,2017). In contrast, for pubertal status the evidence is less clear. Pubertal status may be on the causal
pathway between adiposity measures and outcomes and hence act as a mediator. Results including
pubertal status as a covariate were therefore provided in a supplementary table. Similar, smoking status
(within the last 30 days) (Liu et al.,2017) was assessed at the COBRA-CVR visit but not included in
the analysis because it may act as a mediator and the sample size was too small for robust analysis.
Models including BMI z-score or %BMI>95th centile were not adjusted for age and sex as they are 
based on BMI centiles that already standardized for age and sex.
Estimation of effect measures
Multiple linear regression was used to assess the association between adiposity measures and 
cardiovascular risk factors (at visit 2) on subclinical atherosclerosis outcomes (at visit 2). Models were
adjusted for available confounders including: the relevant adiposity measure or cardiovascular risk
factor at COBRA visit, age (COBRA and COBRA-CVR visits), sex and SEIFA scores. 
Because the exposure and outcome measures are assessed at the same time (at the COBRA-CVR visit) 
it is necessary to establish the direction of the association. This was achieved by conditioning the effect
estimate on the exposure at the COBRA visit (a preceding time-point). Also, from a mechanistic point 
of view, adiposity and cardiovascular risk factors are both preceding, causative factors for
atherosclerosis that change slowly. As described above, the interest was in the total effect of the 
exposures, therefore the models were not adjusted for likely mediators (systolic blood pressure or LDL-
C), as suggested by Westreich and Greenland (Westreich et al.,2013). The estimates of the associations
of each adiposity measure or cardiovascular risk factor at the COBRA-CVR visit with subclinical 
cardiovascular phenotypes was visualised by tables and forest plots.
To address the effect of increasing versus decreasing the %>95th BMI-centile over time on subclinical
atherosclerosis outcomes, the %BMI >95th centile was dichotomized depending on whether
participants increased or decreased their percentage level of BMI>95th during the visit-interval. The
resulting binary variable was used as the exposure, with the subclinical atherosclerosis measures at the 
COBRA-CVR visit as outcomes, adjusted for age at both visits and SEIFA scores. The analysis was
stratified for sex.
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5 Results
Four aims were studied in different subpopulations of the COBRA cohort. To allow comparison of
relevant characteristics, the results of the aim-specific subpopulations are illustrated in combination
with the results from the original cohort the subpopulation was derived from. Aim IV was based on
longitudinal data from COBRA-CVR participants with data collected at COBRA enrolment and at
COBRA-CVR participation; Participant characteristics are shown for both time-points. Subclinical
cardiovascular phenotypes were analysed for aim I and aim IV and results shown in section 5.1.6.
5.1 Participant characteristics 
5.1.1 Participant characteristics for COBRA-CVR and aim I
From the original COBRA biorepository (n= 438), a total of 101 participated in the COBRA-CVR
follow-up. From COBRA, a total of 30 individuals were excluded due to a BMI < 95th CDC centile or 
age below 6 years, resulting in 408 individuals suitable for recruitment. Of those, 115 declined
participation for COBRA-CVR, 96 had lapsed contact details, 74 were excluded after three failed
attempts and 22 had relocated inter-state. Finally, a total of 101 participants were recruited and had data 
collected for COBRA-CVR. Of those, a total of 43 were eligible for addressing aim I. Participants with 
no grip strength data and a BMI <95th BMI centile were excluded (see table 6).
Table 6. Characteristics for participants of COBRA-CVR and eligible participants for aim I
COBRA-CVR Grip strength
Characteristic n Mean (SD) Range n Mean (SD) Range
Sex, males (%) 101 52 (51.5) 43 21 (49)
Age (y) 101 15.7 (3.7) 6.1-24.3 43 14.8 (3) 8.7-19.9
Weight (kg) 101 101.7 (30.5) 40.8-187.7 43 107.9 (27.2) 57.3-179.4
Height (m) 101 1.67 (0.13) 1.26-1.95 43 1.67 (0.12) 1.38-1.95
BMI (kg/m2) 101 35.7 (7.9) 18.2-60.9 43 38.1 (6.9) 27.0-60.9
BMI z-score 101 2.27 (0.61) -0.53-3.39 43 2.53 (0.29) 2.03-3.12
%>95th BMI-centile 101 131.5 (26.4) 75.6-202 43 141.1 (21.1) 113.5-200.4
n <100% 9 0
n ≥100% - <120% 26 6
n ≥120% - <140% 33 18
n ≥140% 33 19
Waist circumference (cm) 79 105.0 (16.4) 66-153 41 108.9 (13.2) 82-139
Waist-to-height ratio 79 0.62 (0.08) 0.43-0.83 41 0.62 (0.07) 0.54-0.83
Truncal fat % 99 36.4 (9.5) 15-58.8 42 39.6 (7.9) 22.6-58.8
Total body fat % 99 40.6 (9.9) 18.6-67.8 42 44.4 (7.2) 30.4-60.8
Tanner stage (%) 43
n pre-pubertal 10 (10) 5 (12)
n peri-pubertal 16 (16) 6 (14)
n post-pubertal 75 (74) 32 (74)
Results are given in mean and standard deviation (SD), absolute number of participants (n) and ratios 
(%). The range provides maximum and minimum levels of the relevant characteristics. Standard
international units are used such as years (y), kilograms (kg) and meters (m)
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5.1.2 Cardiovascular risk factors for COBRA-CVR and eligible participants for aim I
Table 7 illustrates cardiovascular risk factors in the subgroup of COBRA-CVR participants who were
eligible to participate for aim I. Also illustrated are the cardiovascular risk factors for the COBRA-CVR 
cohort from where participants were recruited for comparison.
Table 7. Cardiovascular risk factors for COBRA-CVR and participants eligible for aim I
COBRA-CVR Grip strength
Cardiovascular risk
factor
n Mean (SD) Range n Mean (SD) Range
Systolic BP (mmHg) 100 126 (13) 96-162 43 127.7 (13.1) 104-156
Diastolic BP (mmHg) 100 69 (8) 50-89 43 69.4 (8) 52-81
Normal BP 28 18
Elevated BP 33 4
Stage I Hypertension 19 16
Stage II Hypertension 20 5
LDL-C (mmol/l) 98 1.76 (0.58) 0.9-4.6 43 1.4 (0.52) 0.7-3.7
Triglycerides (mmol/l) 98 1.15 (0.40) 0.6-2.5 43 1.3 (0.44) 0.7-2.5
GlycA (mmol/l) 98 1.11 (0.11) 0.88-1.40 43 1.16 (0.09) 0.93-1.34
HbA1c (%) 94 5.2 (0.4) 4.1-6.5 43 5.3 (0.4) 4.1-6.3
Fasting glucose (mmol/l) 94 4.6 (0.5) 3.7-7.1 43 4.7 (0.5) 3.7-6.7
Diabetes 8 0
Pre-Diabetes
Smoking status
8 6
Never smoked 92 43
Current smoker 9 1
Cardiovascular risk factors for participants eligible for aim I and for all COBRA-CVR. Numbers are
given in mean and standard deviation (SD), absolute number of participants (n) and ratios (%). The 
range provides maximum and minimum levels of the relevant characteristics. Standard international
units are used such as millimetres of mercury (mmHg), millimole per litre (mmol/l). BP: blood pressure;
LDL-C: Low-density lipoprotein cholesterol; GlycA: glycoprotein acetyls; HbA1c: Haemoglobin A1c.
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5.1.3 Participant characteristics – for COBRA and aims II and III
Table 8 displays demographic and anthropometric characteristics for the COBRA cohort and the 
relevant characteristics for the eligible participants for aims II and III. For aim II, 203 individuals had 
food frequency questionnaires completed. Of those, a total of 137 fit the age criteria (i.e. >6 years), 
were classified as obese, had plausible energy intake according to a Goldberg cut-off of >1.2 and were 
considered for further analysis. For aim III, 269 individuals had blood samples collected and stored for
metabolomic analysis. Of those, 50 individuals were excluded due to age (<6 years) and/or a BMI z-
score below 2.0. An additional five individuals were excluded due to analytical errors. Finally, 214 
participants with serum derived metabolomic data were included in the analysis.
Table 8. Participant characteristics for COBRA and eligible participants for aims II and III
Visit 1, COBRA Protein leverage
hypothesis
Metabolomics
Characteristic n Mean (SD) n Mean (SD) n Mean (SD)
Sex, males (%) 438 206 (47) 137 68 (50) 214 101 (47)
Age (y) 438 11.1 (3.6) 137 11.3 (2.7) 214 11.9 (3.1)
Weight (kg) 438 78.4 (31.7) 137 77.6 (26.3) 214 85.9 (30.2)
Height (m) 438 1.51 (0.19) 137 1.52 (0.15) 214 1.55 (0.16)
BMI (kg/m2) 438 32.6 (7.36) 137 32.5 (6.0) 214 34.5 (7.1)
BMI z-score 438 2.53 (0.49) 137 2.47 (0.27) 214 2.49 (0.24)
Waist circumference
(m)
355 1.01 (0.20) 169 1.06 (0.19)
Waist-to-height ratio 355 0.67 (0.09) 169 0.69 (0.08)
Truncal fat % 313 36.8 (9.1) 175 38.2 (8.7)
Total body fat % 329 42.8 (8.4) 182 44.3 (7.8)
Tanner stage (%) 371 137 214
n pre-pubertal 165 (45) 66 (48) 83 (39)
n peri-pubertal 93 (25) 40 (29) 58 (27)
n post-pubertal 113 (30) 21(23) 75 (74)
Demographic and anthropometric data for COBRA participants and eligible participants for aims II
and III. Numbers are given in mean and standard deviation (SD), absolute number of participants (n)
and ratios (%). The range provides maximum and minimum levels of the relevant characteristics.
Standard international units are used such as years (y), kilograms (kg) and meters (m). BMI: body mass
index.
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5.1.4 Participant characteristics for the COBRA-CVR longitudinal subsample
From the original COBRA biorepository (n= 438), a total of 101 participated for COBRA-CVR. Table
9 shows characteristics of the 101 COBRA-CVR participants at baseline and at follow-up, mean interval 
5.5 years.
Table 9. Baseline and follow-up characteristics of COBRA-CVR participants
Baseline (COBRA) Follow-up (COBRA CVR)
Characteristic n Mean (SD) Range n Mean (SD) Range
Sex, males (%) 101 52 (51.5) 101 52 (51.5)
Age (y) 101 10.2 (3.5) 3.0 -16.9 101 15.7 (3.7) 6.1-24.3
Weight (kg) 101 71.8 (29.3) 19.1-157.7 101 101.7 (30.5) 40.8-187.7
Height (m) 101 1.49 (0.20) 1.00-1.90 101 1.67 (0.13) 1.26-1.95
BMI (kg/m2) 101 30.9 (6.2) 18.4-51.8 101 35.7 (7.9) 18.2-60.9
BMI z-score 101 2.52 (0.36) 1.70-3.90 101 2.27 (0.61) -0.53-3.39
%>95th BMI-centile 101 135.3 (19.2) 100.5-204.4 101 131.5 (26.4) 75.6-202
n <100% 0 9
n ≥100% - <120% 24 26
n ≥120% - <140% 43 33
n ≥140% 34 33
Change in %>95th
BMI centile
101 -3.8 (19.9) -60.5 - 46.6
Waist circumference (cm) 85 96.1 (17.8) 54.0-138.0 79 105.0 (16.4) 66-153
Waist-to-height ratio 85 0.65 (0.07) 0.50-0.80 79 0.62 (0.08) 0.43-0.83
Truncal fat % 72 35.05 (7.77) 16.4-60.3 99 36.4 (9.5) 15-58.8
Total body fat % 75 41.43 (6.92) 24.7-58.0 99 40.6 (9.9) 18.6-67.8
Tanner stage (%) 96
n pre-pubertal 50 (52) 10 (10)
n peri-pubertal 22 (23) 16 (16)
n post-pubertal 24 (25) 75 (74)
SEIFA Score 101 1004.21 802-1134
(64.76)
Demographic and anthropometric data for COBRA-CVR participants at the COBRA and COBRA-CVR 
visits and for the individuals eligible for aim I. The mean interval between visits was 5.5 (2.1) years.
Numbers are given in mean and standard deviation (SD), absolute number of participants (n) and ratios
(%). The range provides maximum and minimum levels of the relevant characteristics. Standard
international units are used such as years (y), kilograms (kg) and meters (m)
59
  
     
       
    
 
           
      
        
       
         
         
   
 
         
 
          
                
       
      
     
  
 
 
 
  
     
 
  
 
        
       
       
         
           
           
           
           
       
        
       
        
       
          
           
       
            
           
5.1.5 Cardiovascular risk factors for the COBRA-CVR longitudinal subsample
Cardiovascular risk factors included blood pressure, LDL-C, triglycerides, GlycA, HbA1c, fasting
glucose and smoking status. Available data on these characteristics including the relevant values at the 
initial COBRA enrolment are shown in table 10. 
The prevalence of normal blood pressure decreased from 62% (59 out of 95) to 28% (28 out of 100) at
the follow-up visit. In contrast, the percentage of participants with elevated blood pressure and stage II
hypertension increased during the 5.5 years interval (from 7% to 33% and from 9% to 20%,
respectively). Lipid profiles assessed by NMR metabolomic profiles revealed lower LDL-C and lower
triglyceride levels at the follow-up visit. GlycA remained the same at both visits. At the initial COBRA
visit, two participants (2%) were diagnosed with diabetes, whereas 8 (8%) were diagnosed with diabetes 
at follow-up.
Table 10. Baseline and follow-up cardiovascular risk factors of COBRA-CVR participants
Baseline (COBRA) Follow-up (COBRA CVR)
Cardiovascular risk
factor
n Mean (SD) Range n Mean (SD) Range
Systolic BP (mmHg) 95 109 (17) 80-160 100 126 (13) 96-162
Diastolic BP (mmHg) 95 66 (11) 45-95 100 69 (8) 50-89
Normal BP 59 28
Elevated BP 7 33
Stage I Hypertension 20 19
Stage II Hypertension 9 20
LDL-C (mmol/l) 67 2.54 (0.55) 1.0-4.0 98 1.76 (0.58) 0.9-4.6
Triglycerides (mmol/l) 67 1.37 (0.68) 0.4-4.6 98 1.15 (0.40) 0.6-2.5
GlycA (mmol/l) 67 1.11 (0.13) 0.9-1.6 98 1.11 (0.11) 0.88-1.40
HbA1c (%) 94 5.2 (0.4) 4.1-6.5
Fasting glucose (mmol/l) 86 4.6 (0.5) 3.5-6.1 94 4.6 (0.5) 3.7-7.1
Diabetes 2 (2) 8 (9)
Pre-Diabetes
Smoking status
12 (14) 8 (9)
Never smoked 92
Current smoker 9
Cardiovascular risk factors in participants at the initial COBRA and follow-up COBRA-CVR visit.
Numbers are given in mean and standard deviation (SD), absolute number of participants (n) and ratios
(%). The range provides maximum and minimum levels of the relevant characteristics. Standard
international units are used such as millimetres of mercury (mmHg), millimole per litre (mmol/l). BP: 
blood pressure; LDL-C: Low density lipoprotein cholesterol; GlycA: glycoprotein acetyls; HbA1c: 
Haemoglobin A1c.
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5.1.6 Subclinical cardiovascular phenotypes for COBRA-CVR participants
Data on subclinical cardiovascular phenotypes (cIMT, PWV, elasticity), collected in COBRA-CVR 
participants are shown in table 11. 
Table 11. Subclinical cardiovascular phenotypes for COBRA-CVR participants
Subclinical Atherosclerosis Outcomes n Mean (SD) Range
Carotid IMT (Bm) 100 457 (62) 344-608
Carotid-femoral PWV (m/s) 98 5.32 (0.87) 3.57-7.9
Elasticity (%/10mmHg) 100 4.24 (1.25) 1.84-8. 40
Subclinical cardiovascular phenotypes assessed at COBRA-CVR visit. n = number of participants
with available data. Data are given in mean, SD (standard deviation), and range from minimum to 
maximum. IMT: Intima-media thickness; PWV: pulse-wave velocity. Units used were micrometer
(Bm), meter/second (m/s) and percentage change per 10 millimetres mercury (%/10mmHg).
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5.2 Aim I: association between grip strength and cardiometabolic risk 
Aim I was to investigate the association of grip strength, a global measure of muscle strength, 
on cardiovascular risk factors and subclinical cardiovascular phenotypes among obese youth;
Participant characteristics and data on cardiovascular risk factors for aim I are displayed in tables 6 and
7 with relevant data from the original COBRA-CVR cohort for comparison. Table 12 illustrates data
on grip strength in all participants with normalized grip strength categories (low, moderate and high).
The mean maximum grip strength was 32.2 kg. Only 4 participants (9.3 %) had a high normalized grip
strength and therefore, the categories of moderate and high normalized grip strength were collapsed
into one category (moderate/high) for further analysis. 
Table 12. Grip strength in COBRA-CVR participants
Grip strength assessed at COBRA-CVR visit. n = number of participants with available data. Data
Variable n Mean (SD) Range (min-max) %
Grip strength, kg
Normalized grip strength
Normalized grip strength categories
Low
43
43
21
32.2 (8.3)
0.30 (0.06)
16.2-53.5
0.20-0.42
48.8
Moderate 18 41.9
High 4 9.3
are given in mean, SD (standard deviation), and range from minimum to maximum.
In univariable analysis, age, sex, and pubertal stage were not associated with normalized grip strength 
(p-values 0.40, 0.29, and 0.62, respectively). Therefore, these covariates were not included in the
regression models. 
Mean levels of cardiometabolic risk factors according to normalized grip strength categories (high,
moderate and low) are shown in table 13. In general, participants with low normalized grip strength had
poorer cardiometabolic risk measures than those with moderate/high normalized grip strength. The
mean difference between normalized grip strength groups (moderate/high vs. low) was +0.05 mm for 
cIMT, +13 mmHg for systolic blood pressure, +0.26 mmol/l for LDL-C, and +0.36 for metabolic
syndrome (MetS) score. 
After adjustment for BMI z-score, the difference between groups remained largely unchanged for cIMT 
(+0.06 mm, +2 %, p-value = 0.003, n = 43), whereas the difference was reduced for systolic blood 
pressure (+9 mmHg, -30 %, p-value = 0.015, n = 43) and LDL-C (+0.23 mmol/l, -10 %, p-value = 0.10,
n = 41). BMI z-score is a factor in the MetS score, and therefore did not require additional adjustment. 
Because systolic blood pressure and LDL-C might be intermediates between grip strength and cIMT, a 
model was fit including these covariates. The difference in cIMT between normalized grip strength
groups remained (+0.06 mm, p-value = 0.003, n = 41).
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Table 13. Adjusted means of cardiometabolic risk variables according to normalized grip strength
category
Normalized grip strength
category
Moderate/High Low
Cardiometabolic risk n* Mean ± SE Mean ± SE Mean difference p
variable [95%CI]
Total cholesterol, mmol/l 41 2.91 ± 0.10 3.19 ± 0.12 0.27 (-0.04, 0.59) 0.08
LDL-C, mmol/l 41 1.21 ± 0.08 1.46 ± 0.10 0.26 (0.00, 0.51) 0.048
Triglycerides, mmol/l 41 1.14 ± 0.07 1.24 ± 0.08 0.11 (-0.12, 0.33) 0.34
HbA1c (%) 41 5.30 ± 0.09 5.36 ± 0.15 0.06 (-0.19, 0.31) 0.63
Fasting glucose (mmol/l) 41 4.69 ± 0.11 4.53 ± 0.10 -0.15 (-0.44, 0.14) 0.29
Systolic BP (mmHg) 43 120 ± 2 133 ± 3 13 (6, 20) 0.001
Diastolic BP (mmHg) 43 68 ± 2 72 ± 2 3 (-2, 8) 0.20
Continuous metabolic 41 1.16 ± 0.09 1.52 ± 0.09 0.36 (0.11, 0.62) 0.007
syndrome score
Glycoprotein acetyls 41 1.13 ± 0.10 1.17 ± 0.08 0.04 (-0.10, 0.01) 0.12
(mmol/l)
Carotid IMT (µm) 43 0.46 ± 0.01 0.52 ± 0.01 0.05 (0.02, 0.09) 0.002
Pulse wave velocity (m/s) 43 5.21 ± 0.17 5.42 ± 0.20 0.21 (-0.32, 0.74) 0.43
Carotid elasticity (%/mmHg) 40 0.34 ± 0.02 0.34 ± 0.02 -0.01 (-0.07, 0.05) 0.81
*Number of participants in the normalized grip strength categories were 21 (low) and 22
(moderate/high) when n=43. Participants in the normalized grip strength categories were 21 (low) and
20 (moderate/high) when n=41. Participants in the normalized grip strength categories were 19 (low)
and 21 (moderate/high) when n=40. Participants in the normalized grip strength categories were 19 
(low) and 19 (moderate/high) when n=38. The reduced sample sizes for some analyses are due to
participants missing data on the cardiometabolic risk variable. Abbreviations: CI, confidence interval;
LDL-C: low-density lipoprotein cholesterol; HbA1c: glycated hemoglobin A1c; N: number of
participants; SE: standard error.
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5.3 Aim II: testing the protein leverage hypothesis
Aim II was to test the relation between the macronutrient composition with TEI and BMI in children
and adolescents with obesity. Particularly, the protein leverage hypothesis was tested, indicating that a 
lower proportion of energy derived from proteins drives excessive total energy intake and may
contribute to excessive weight gain.
The main participant characteristics for aim II are displayed in table 8 with relevant data from the
original COBRA cohort for comparison.
5.3.1 Total energy intake
Table 14 shows data on total energy intake and the proportional energy intake of macronutrients in
eligible participants, derived from the Australian Child and Adolescent Eating Survey - Food Frequency 
Questionnaire (ACAES-FFQ).
The overall energy intake was at 10`330 kJ with the proportions of energy from proteins calculated at
18.4%, from carbohydrates at 50.6% and fats at 31.6%.
Table 14. Total energy intake and macronutrient composition
Variable Mean (SD) Range (min–max)
Total energy intake (TEI in kJ) 10`330 (2728) 5467-17`886
Total daily protein intake (g)
Energy intake from proteins (kJ)
% TEI protein
110 (30)
1831 (497)
18.4 (3.1)
56-213
933-3565
11.0-30.0
Total daily carbohydrate intake (g)
Energy intake from carbohydrates (kJ)
% TEI carbohydrate
307 (95)
5119 (1293)
50.6 (6.1)
154-611
2563-10`202
32.0-68.0
Total daily fat intake (g)
Energy intake from fats (kJ)
% TEI fat
84 (27)
3173 (1013)
31.6 (4.9)
37-195
1408-7354
21.0-51.0
Total energy intake as calculated from Australian Child and Adolescent Eating Survey - Food
Frequency Questionnaire (ACAES-FFQ), given as total energy intake (TEI) and macronutrients
(protein, carbohydrate and fat) in gram, kilojoules and percentages from TEI.
5.3.2 Energy expenditure, assessed by accelerometry
A subgroup of participants for aim II had accelerometry data collected. Results are illustrated in table 
15. The Australian guidelines recommend 60 minutes of moderate to vigorous activity per day for
children and adolescents aged 5-17 years. Of the 57 individuals with valid accelerometry data, 48 (84%)
did not meet these recommendations and for the purpose of our study were considered to be physically 
inactive individuals (Australian Commonwealth Department of Health,2019)
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Table 15. Accelerometry-data on energy expenditure 
Variable n (%) Mean (SD) Range
Accelerometry 57
Ave. counts/d 249`734 (97`904) 96`841 – 493`728
MVPA (min/d) 43.4 (24.1) 3.5 - 110.8
<60min MVPA/d 47 (84%)
Accelerometry; Ave. counts/d: number of signals reflecting deceleration and acceleration forces
counted by the accelerometer, averaged per day. MVPA: moderate to vigorous physical activity given 
in minutes, derived from Ave. counts/d according to published intensity cut-off points (Colley et 
al.,2011).
5.3.3 Bivariate modelling of each macronutrient and total energy intake 
Figure 11a illustrates associations between proportion of energy derived from each macronutrient (x-
axis) and the TEI (y-axis) in all individuals and in the physically inactive subgroup. In all individuals
(Figure 11a), the distribution of percentage intake from macronutrients and TEI significantly followed
a power function for %EP, but not for %EC or %EF. For protein, the strength of leverage for protein 
was -0.48 (p < 0.001), whereas the exponent (L) for carbohydrates and fats were 0.22 (p=0.23) and 0.06
(p=0.67), respectively (see figure 11a and table 16).
Figure 11b illustrates the associations between percentages of energy intake from each macronutrient
(x-axis) and the total energy intake (y-axis) in the physically inactive subgroup. The %EP and %EC
followed a power function with respect to TEI. Relevant exponents (L) for protein were -0.57 (p < 
0.05), for carbohydrates 0.82 (p < 0.05) and for fats 0.82 (p 0.30) (see figure 11b and table 16).
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Figure 11. Bivariate modelling between macronutrient proportions and total energy intake
a) All individuals 
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Power functions between relevant percentages of energy from macronutrients and total energy intake. 
Scatterplots revealing associations between proportions of each macronutrient and total energy intake 
that followed the law of a power function (see Methods). (A) All individuals (n = 137). Small changes 
in proportion of energy only from protein sources resulted in substantial changes in total energy intake. 
(B) Physically inactive subgroup (n = 48). Proportions of proteins and carbohydrates followed a power 
function: for proteins, the association was negative and for carbohydrates positive (see table 16).
Table 16. Results from power functions fitted between macronutrients and TEI
All individuals, n=137
Macronutrient Strength of leverage (L) p value
Protein -0.48 <0.001
Carbohydrate
Fat
0.22
0.06
0.23
0.67
Physically inactive subgroup, n=47
Macronutrient Strength of leverage (L) p value
Protein -0.57 <0.05
Carbohydrate
Fat
0.82
-0.31
<0.05
0.30
Model coefficients for fitted power functions for the whole cohort and for the physically inactive
subgroup. L indicating strength of leverage for each macronutrient (-1 signifies complete leverage, 0 
means no leverage). In the whole cohort, leverage on total energy intake was only significant from the
proportion of protein. In the physically inactive group, leverage on total energy intake was significant
from proportions of protein and carbohydrate
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5.3.4 Compositional data analysis between macronutrients with TEI and BMI 
To assess whether there was a relationship between the macronutrient composition of diet, TEI and 
BMI z-score, mixture model analysis was performed. For TEI, model 2 had the most favourable AIC 
(see table 17 for AIC results and table 18 for the AIC-chosen model coefficients), which suggests a 
linear effect of dietary macronutrients on TEI.  TEI was highest in those diets with the lowest proportion 
energy from proteins (see 12a for visual interpretation). In this population of youths with obesity, 
dietary macronutrient composition was not a significant driver of BMI z-score, as the null model was 
favoured (see table 17 for AIC results).  
 
Compositional data analysis in the physically inactive group revealed model 2 favoured by AIC, 
suggesting linear effects of dietary macronutrients on TEI (see figure 12b for visual interpretation, table 
19 for AIC results and table 20 for the AIC-chosen model coefficients). For BMI z-score in physically 
inactive youths, compositional model 4 was favoured, suggesting complex, non-linear effects of 
macronutrients composition on BMI z-score: physically inactive individuals with a diet high in %EP 
with moderate %EC had lower BMI z-scores, whereas individuals with a diet moderate in %EP and 
low %EC had higher BMI z-scores (see table 19 for AIC and table 21 for the AIC-chosen model 
coefficients). 
 
Figure 12.  Rectangular mixed triangle to illustrate compositional data analysis from macronutrients  
   composition on total energy intake and BMI z-scores  
 
a) All individuals 
Energy Intake (kJ) BMI Z Score  
 
 
 
 
 
 
 
 
 
0 20 40 60 80 0 20 40 60 80
Protein (%) Protein (%)
 
Right-angle mixture triangles (RMTs) illustrating (a) energy intake (kJ) and (b) BMI z-score as a 
function of percentage total energy from protein (x-axis), carbohydrates (y-axis) and fats (implicit-axis) 
in series a) for all individuals (n=137) and series b) for physically inactive subgroup (n=48). Values 
shown are as predicted by AIC-favoured mixture models. Areas of red and blue space correspond to 
high and low outcomes, respectively. 
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Table 17. AIC scores for five mixture-models in all individuals
Model Energy intake (kJ) BMI z-score
1 2559.47 37.83
2 2549.87 36.84
3 2553.16 37.11
4 2554.39 43.52
5 2554.87 38.4
AIC scores to test for effects of percentage energy from protein, carbohydrates and fats on energy intake 
and BMI z-scores. Models with minimal AIC scores are favoured. In the event that two models where
within two AIC points of one another, the simplest model was selected. Model 1 refers to the Null model,
indicating no effect from macronutrient ratios.
Table 18. Coefficients for effects of macronutrients on TEI as estimated by model 2 for the
physically inactive subgroup
Model
2
Coefficient
P
C
F
Estimate
-16796
18594
12343
LCL
-40568
11253
-2316
UCL
6976
25935
27002
AIC favoured model 2. Coefficient`s estimates for model 2 and their lower and upper (LCL and UCL)
95% confidence limits are given
Table 19. AIC scores for five mixture-models in the physically inactive subgroup
Model Energy intake (kJ) BMI z-score
1 904.52 12.37
2 901.28 16.12
3 904.09 15.8
4 911 8.76
5 905.74 15.95
AIC scores to test for effects of percentage energy from protein, carbohydrates and fats on energy
intake and BMI z-scores in the physically inactive subgroup. Models with minimal AIC scores are
favoured. In the event that two models where within two AIC points of one another, the simplest
model was selected.
68
  
               
 
 
      
      
     
    
           
      
 
               
 
 
      
      
    
    
      
     
     
     
    
    
    
           
    
Table 20. Coefficients for effects of macronutrients on TEI as estimated by model 2 for the
physically inactive subgroup
Model
2
Coefficient
P
C
F
Estimate
-16796
18594
12343
LCL
-40568
11253
-2316
UCL
6976
25935
27002
AIC favoured model 2. Coefficient`s estimates for model 2 and their lower and upper (LCL and 
UCL) 95% confidence limits are given.
Table 21. Coefficients for effects of macronutrients on BMI z-score as estimated by model 4 for 
the physically inactive subgroup
Model Coefficient Estimate LCL UCL
4 P -898.00 -1891.10 95.10
C 0.02 -20.72 20.75
F -367.65 -743.02 7.72
cubic(P, C) 1312.43 404.88 2219.99
cubic(P, F) -1006.34 -2759.78 747.11
cubic(C, F) -211.55 -667.19 244.10
P:C 2046.05 329.75 3762.34
P:F 2169.65 282.17 4057.13
C:F 690.17 6.74 1373.59
P:C:F -3539.23 -5948.22 -1130.25
AIC favoured model 4. Coefficient`s estimates for model 4 and their lower and upper (LCL and UCL)
95% confidence limits are given.
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5.4 Aim III: adiposity measures and CVD-related metabolomic profiles
Aim III was to investigate the relation between clinically assessed adiposity measures and a 
metabolomic platform with cardiometabolic interests in sera of children and adolescents with obesity.
Results were further stratified for sex and pubertal development (Tanner stages for pre-, peri-, and post-
pubertal stages).
The main participant characteristics for aim III are displayed in table 8 with relevant data from the
original COBRA cohort for comparison.
5.4.1 Multivariate analysis of metabolomic data, principal component analysis
Principal component analysis (PCA) was performed to detect distinguishable clusters of individuals 
according to confounders (age and sex) or the variety of metabolite results. PCA did not reveal separable
clusters by age or sex within the dataset (see figure 13). Principal components 1 to 5 collectively
assessed 73% coverage of the data variability.
Figure 13. Principal components plot
PCA plot for principal component 1 (PC1) and principal component 2 (PC2), graded for age (a) and
sex (b). Section c lists percentage contribution of the top 5 principal components.
5.4.2 Associations between adiposity measures and metabolites
Raw BMI was positively associated with phenylalanine and tyrosine, and negatively associated with 
acetate, adjusted for false discovery rate (see figure 14). Associations were similar between pairs of
BMI and BMI z-score, of %TF and %BF, and of WC and WtH-ratio (see forest plots in figures 14, 15
and 16 for one of each pair). 
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Figure 14. Forest plot with associations between raw BMI and metabolites 
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SD−difference in metabolite concentration (95% CI) per 1 SD = 7kg/m2 increase in body mass index 
Changes in mean and 95% confidence interval per 1-SD increase in BMI. Estimates and 95% CI in 
bold illustrate significance after adjustment for false discovery rate (FDR, according to Benjamini-
Hochberg).
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Figure 15.  Forest plot with associations between %BF and metabolites 
 
 
Changes in mean and 95%CI per 1-SD increase in total body fat %. Estimates and 95%CI in bold 
illustrate significance after adjustment for false discovery rate (FDR, according to Benjamini-
Hochberg). 
  
●
●
●
●
●
Lipoprotein subclass
Lipoprotein particle size
Apolipoproteins
Cholesterol
Fatty acids
Fatty acid ratios
Amino acids
Glycerides and phospholipids
Glycolysis related
Ketone bodies
Liver function
Renal function
Inflammation
−0.4 −0.2 0.0 0.2
Total lipids in small HDL (mmol/L)
Total lipids in medium HDL (mmol/L)
Total lipids in large HDL (mmol/L)
Total lipids in very large HDL (mmol/L)
Total lipids in small LDL (mmol/L)
Total lipids in medium LDL (mmol/L)
Total lipids in large LDL (mmol/L)
Total lipids in IDL (mmol/L)
Total lipids in very small VLDL (mmol/L)
Total lipids in small VLDL (mmol/L)
Total lipids in medium VLDL (mmol/L)
Log Total lipids in large VLDL (mmol/L)
Log Total lipids in very large VLDL (mmol/L)
Log Total lipids in chylomicrons and extr. large VLDL (mmol/L)
Mean diameter for HDL particles (nm)
Mean diameter for LDL particles (nm)
Mean diameter for VLDL particles (nm)
Ratio of apolipoprotein B to apolipoprotein AI
Apolipoprotein B (g/L)
Apolipoprotein AI (g/L)
Free cholesterol (mmol/L)
Esterified cholesterol (mmol/L)
Total cholesterol in HDL3 (mmol/L)
Total cholesterol in HDL2 (mmol/L)
Total cholesterol in HDL (mmol/L)
Total cholesterol in LDL (mmol/L)
Remnant cholesterol (nonHDL, nonLDL cholesterol) (mmol/L)
Total cholesterol in VLDL (mmol/L)
Serum total cholesterol (mmol/L)
Saturated fatty acids (mmol/L)
Monounsaturated fatty acids  16:1, 18:1 (mmol/L)
Polyunsaturated fatty acids (mmol/L)
Omega6 fatty acids (mmol/L)
Omega3 fatty acids (mmol/L)
18:2, linoleic acid (mmol/L)
22:6, docosahexaenoic acid (mmol/L)
Estimated degree of unsaturation
Total fatty acids (mmol/L)
Ratio of saturated fatty acids to total fatty acids (%)
Ratio of monounsaturated fatty acids to total fatty acids (%)
Ratio of polyunsaturated fatty acids to total fatty acids (%)
Ratio of omega6 fatty acids to total fatty acids (%)
Ratio of omega3 fatty acids to total fatty acids (%)
Ratio of 18:2 linoleic acid to total fatty acids (%)
Ratio of 22:6 docosahexaenoic acid to total fatty acids (%)
Tyrosine (mmol/L)
Phenylalanine (mmol/L)
Valine (mmol/L)
Leucine (mmol/L)
Isoleucine (mmol/L)
Histidine (mmol/L)
Glycine (mmol/L)
Glutamine (mmol/L)
Alanine (mmol/L)
Total cholines (mmol/L)
Sphingomyelins (mmol/L)
Phosphatidylcholine and other cholines (mmol/L)
Ratio of triglycerides to phosphoglycerides
Total phosphoglycerides (mmol/L)
Triglycerides in HDL (mmol/L)
Triglycerides in LDL (mmol/L)
Triglycerides in VLDL (mmol/L)
Serum total triglycerides (mmol/L)
Log Lactate (mmol/L)
Glucose (mmol/L)
Citrate (mmol/L)
Pyruvate (mmol/L)
Log 3hydroxybutyrate (mmol/L)
Log Acetoacetate (mmol/L)
Log Acetate (mmol/L)
Albumin (mmol/l)
Creatinine (umol/L)
Glycoprotein acetyls, mainly a1acid glycoprotein (mmol/L)
SD−difference in metabolite concentration (95% CI) per 1 SD = 8% increase in Total body fat
M
et
ab
ol
ite
Metabolic associations with Total body fat percentage
•• 
~ • ... 
• I • I • • I •• •• 
~ ~ • ,. 
~ • • • 
I 
• •• ••• 
I • 
t • • •• 
I 
•• • I • I • • I e .: 
•• 
l •• • I e •• 
I 
' • • • .. ; • • 
I 
• • ... 
•• , . 
•• • •• 
~ '• •• e I 
~ • 
-I e I 
-I 
 73 
Figure 16.  Forest plot with associations between waist circumference and metabolites 
 
 
Changes in mean and 95%CI per 1-SD increase in waist circumference. Estimates and 95%CI in bold 
illustrate significance after adjustment for false discovery rate (FDR, according to Benjamini-
Hochberg). 
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5.4.3 All associations between various adiposity measures and metabolites 
 
Across different adiposity measures associations were broadly similar in terms of the direction, with some variability in the strength of the associations with 
individual metabolites (see table 22). 
 
Table 22.  Associations between various adiposity measures and metabolites 
 
  BMI BMI z -score BF% TF%  WC WtH 
Metabolites & direction of association 
 
       
Total lipids in very large HDL (mmol/l) neg ns. p < 0.05 ns. ns. ns. ns. 
Total lipids in medium HDL (mmol/l) pos ns. ns. p < 0.01 p < 0.01 ns. ns. 
Total lipids in small HDL (mmol/l) pos p < 0.05 ns. p < 0.05 p < 0.05 ns. ns. 
Estimated degree of unsaturation neg p < 0.05 p < 0.01 p < 0.05 ns. ns. ns. 
22:6, docosahexaenoic acid(mmol/l) neg ns. ns. ns. p < 0.05 ns. ns. 
Ratio of docosahexaenoic acid to total fatty acids (%) neg p < 0.05 P < 0.05 p < 0.01 p < 0.01 ns. ns. 
Ratio of omega3 fatty acids to total fatty acids (%) neg ns. p < 0.05 ns. ns. ns. ns. 
Glutamine (mmol/l) neg ns. ns. p < 0.05 p < 0.05 ns. ns. 
Histidine (mmol/l) neg ns. p < 0.05 p < 0.01 p < 0.01 ns. p < 0.05 
Phenylalanine (mmol/l) pos p < 0.001 p < 0.01 ns. p < 0.05 p < 0.01 ns. 
Tyrosine (mmol/l) pos p < 0.001 p < 0.05 p < 0.05 ns. p < 0.001 p < 0.05 
Log acetate (mmol/l) neg p < 0.001 p < 0.001 p < 0.01 p < 0.05 p < 0.001 p < 0.05 
Log acetoacetate (mmol/l) neg ns. ns. p < 0.05 ns. ns. ns. 
Albumin (mmol/l) neg ns. ns. ns. ns. p < 0.05 p < 0.05 
Creatinine (µmol/l) neg ns. ns. p < 0.001 p < 0.01 p < 0.05 p < 0.05 
Glycoprotein acetyls (mmol/l) pos p < 0.05 ns. p < 0.05 p < 0.05 ns. ns. 
Results from multiple regression modelling with each adiposity measure as explanatory variable and the metabolite as outcome, adjusted for age and sex. In 
bold are the ones adjusted for false discovery rate (FDR). Abbreviations: BMI: body mass index; BF%: total body fat percentage; TF%: truncal fat 
percentage; WC: waist circumference; WtH: waist to height ratio; HDL: High density lipoprotein; ns: non-significant; pos: positive association; neg: 
negative association 
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5.4.4 Sex- and puberty-related associations between BMI z-score and metabolites 
Figure 17 illustrates the association of BMI z-score with metabolites stratified by sex and pubertal 
development. In post-pubertal females, the only metabolite associated with BMI z-score after multiple 
comparison was tyrosine (positively associated).  
 
In contrast, several associations were found between BMI z-score and metabolites in post-pubertal 
males, including: the concentration of total lipids, cholesterols and triglycerides in VLDL lipoproteins, 
the ratio of apolipoprotein B/A1 and the mean diameter for VLDL and LDL particles. Associations 
were also seen with concentrations of total fatty acids, linoleic acid, omega-6 fatty acids, and 
polyunsaturated, monounsaturated and saturated fatty acids (all positively associated) and the estimated 
degree of unsaturation (negatively associated). Further associations were found with triglycerides in 
HDL, total phosphoglycerides, isoleucine and leucine, glycoprotein acetyls (all positively associated) 
and log acetoacetate (negatively associated).  
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Figure 17.  Associations between BMI z-score and metabolites, stratified for sex and pubertal stage 
 
 
Changes in mean and 95%CI per 1-SD increase in BMI z-score categorized by sex and pubertal stage. 
Pre-pubertal (red) = Tanner stage. 1. Peri-pubertal (blue) = Tanner stage 2-3. Post-pubertal (yellow) 
= Tanner stage 4-5). Females in the left panel, males in the right panel. In post-pubertal subgroup 
(yellow), * indicates association after multiple regression modelling, including adjustment for false 
discovery rate (FDR, according to Benjamini-Hochberg).  
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5.5 Aim IV: associations of changes in adiposity measures and 
cardiovascular risk factors on subclinical cardiovascular phenotypes  
Aim IV was to investigate the association of changes in adiposity measures or cardiovascular risk 
factors over time on a comprehensive, non-invasive subclinical cardiovascular phenotype assessment 
in children and adolescents with obesity. Participant characteristics in the longitudinal study are 
displayed in tables 9 & 10. Results for the subclinical cardiovascular phenotypes are shown in table 
11. 
 
Associations between age or sex and the subclinical cardiovascular phenotypes are reported with a 
scatterplot for illustration (figure 19). Table 23 reports the association of changes in various adiposity 
measures on subclinical cardiovascular phenotypes, and table 24 illustrates the association from a 
reference model including baseline age, sex and SEIFA scores, then each of the cardiovascular risk 
factors is included one at a time in the model. A graphical abstract, summarizing the main findings from 
this study is illustrated in figure 18. 
 
Figure 18.  Graphical abstract for aim IV 
 
 
A graphical abstract, summarizing the main findings from study IV. With special thanks to Siroon 
Bekkering, co-author for her creativity.  
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5.5.1 Subclinical cardiovascular phenotypes by age and sex 
In a linear regression model with each of the subclinical cardiovascular phenotypes as the independent 
variable and age, sex and SEIFA scores as dependent variables, cIMT measures were larger for males 
than females (mean difference for males 34	"m [95%CI 10-58 "m, p-value 0.006]), but did not change 
significantly for the observed age-interval [95%CI -2 to +2 "m, p-value 0.516] (see figure 19).  
 
There were no sex differences for PWV (mean difference for males 0.163m/s [95%CI -0.122 to 0.448, 
p-value 0.259] and elasticity (mean difference for males -0.239 [95%CI -0.659 to 0.181%/10mmHg]). 
However, both measures changed with age: PWV increased by a mean of 0.136m/s [95%CI 0.098-
0.174, p-value <0.001] per one year of ageing and elasticity decreased by a mean of -0.187%/10mmHg 
[95%CI -0.243 to – 0.130, p-value <0.001] per one year of ageing) (see figure 19). 
 
Figure 19.  Subclinical cardiovascular phenotypes stratified for sex and age  
 
 
Scatterplots illustrating the change of each subclinical cardiovascular phenotypes per age, classified 
for sex. Units used for carotid intima-media thickness are micrometers, for pulse-wave velocity are 
meters per second and for elasticity are % per 10 millimetres of mercury. Results for males are shown 
in black, for females grey, lines illustrate the regression line. 
5.5.2 Associations of changes in adiposity measures on subclinical cardiovascular 
phenotypes 
The estimated associations of changes in adiposity measures over time with the subclinical 
cardiovascular phenotypes at follow-up are shown in table 23, adjusted for SEIFA scores, sex, age at 
the follow-up visit and the relevant adiposity measure, and age at the initial visit (mean interval 5.5 
years). 
 
Increasing levels for BMI, BMI z-score, the %>95th BMI-centile, WtH ratio and WC were associated 
with higher pulse wave velocity. All adiposity measures were inversely associated with carotid artery 
elasticity. There was no evidence for an association between adiposity measures and cIMT. Overall, 
results were similar for BMI and BMI z-score, WC and waist to height ratio and %BF and truncal fat 
percentage. 
 
  
400
500
600
10 15 20 25
Age (years)
C
ar
ot
id
 in
tim
a−
m
ed
ia
 th
ic
kn
es
s 
(m
ic
ro
m
et
re
)
sex
F
M
Carotid intima−media thickness by Age and Sex 
4
5
6
7
8
10 15 20 25
Age (years)
Pu
ls
e 
w
av
e 
ve
lo
ci
ty
 (m
/s
)
sex
F
M
Carotid−femoral pulse−wave velocity by Age and Sex 
2
4
6
8
10 15 20 25
Age (years)
El
as
tic
ity
 (%
/m
m
H
g)
sex
F
M
Difference in carotid elasticity per by Age and Sex 
.. .. .. 
.. . . 
·: . 
. . . . . . . . 
: ~-•' . . . . . 
. . .. . ·, . ·,_·. _: · .. 
/ "• . , .. -,.~ . . . . •, 
 79 
Table 23. Changes in adiposity measures and associations with subclinical cardiovascular phenotypes 
 
 Pulse Wave Velocity (m/s) 
Predictors Estimates  CI P N 
BMI 0.045 0.021 – 0.068 <0.001 98 
BMI z-score 0.716 0.447 – 0.985 <0.001 96 
%>95th Centile 0.011 0.004 – 0.017 0.002 98 
Waist to height ratio 4.439 1.640 – 7.238 0.002 70 
Waist circumference 0.028 0.014 – 0.042 <0.001 70 
% Truncal fat 0.016 -0.010 – 0.041 0.231 70 
% Body fat 0.004 -0.022 – 0.030 0.761 73 
Elasticity (%/10mmHg) 
Predictors Estimates CI p N 
BMI  -0.063 -0.100 – -0.026 <0.001 100 
BMI z-score -0.975 -1.351– -0.600 <0.001 98 
%>95th Centile  -0.020 -0.032 – -0.007 0.002 100 
Waist to height ratio -4.399 -8.686– -0.112 0.044 70 
Waist circumference  -0.035 -0.056 – -0.015 0.001 70 
% Truncal fat -0.052 -0.087– -0.018 0.004 71 
% Body fat  -0.050 -0.085 – -0.016 0.004 74 
Regression coefficients per 1-unit change in predictor (1kg/m2 for BMI, 1 z-score for BMI z-scores, 1% for %>95th 
BMI centile, 1cm for Waist circumference, 1 unit for waist to height ratio and 1% for truncal fat and body fat) 
over time. Linear regression models are adjusted for age and predictor at baseline, age at follow up, sex and 
SEIFA score. Models including BMI z-score and %>95th centile as predictor were only adjusted for %>95th centile 
at baseline and SEIFA scores. BMI: Body-mass index measured as weight in kg / height in m2. %>95th centile: 
percentage above the 95th centile for BMI based on CDC growth charts. BMI z-score based on CDC growth charts  
Mean carotid intima-media thickness (#$) 
Predictors Estimates CI p N 
BMI  0.985 -1.204 – 3.174 0.374 100 
BMI z-score 12.093 -9.876 – 34.063  0.277 98 
%>95th Centile  0.314 -0.311 – 0.940 0.321 100 
Waist to height ratio 29.578 -230-968 – 290.123 0.821 70 
Waist circumference  0.216 -1.092 – 1.523 0.734 70 
% Truncal fat -0.482 -2.772 – 1.807 0.675 71 
% Body fat  0.090 -2.210 – 2.389 0.938 74 
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5.5.3 Associations between changes in cardiovascular risk factors on subclinical 
cardiovascular phenotypes 
Table 24 reports the associations for sex, age and SEIFA-scores as the reference model. The coefficients 
for age and sex, each are given. The coefficient for SEIFA scores was not significant in any model and 
is therefore not shown. Adding to the reference model, subsequent models add changes in each 
cardiovascular risk factor over time on the subclinical cardiovascular phenotypes. Every year of ageing 
was associated with an increase in PWV by 0.136 m/s [95%CI 0.098-0.174], a decrease in carotid 
elasticity by 0.187%/10mmHg [95%CI -0.243 to – 0.130], but there was no evidence for an association 
with cIMT. In contrast, male sex was associated with a higher cIMT by 34	"m [95%CI 10-58], 
compared with females. 
 
An 5 kg/m2 increase in BMI and a 10 mmHg increase in systolic blood pressure was associated with a 
higher PWV (0.223m/s [95%CI 0.105-0.340] for BMI; 0.260m/s [95%CI 0.150-0.370] for SBP), 
adjusted for sex, SEIFA scores and age at both visits. For elasticity, a 5 kg/m2 increase in BMI was 
associated with a lower carotid elasticity by 0.315 %/10mmHg [95%CI -0.130 to -0.500] and a 
50mmol/l increase in GlycA was associated with a lower carotid elasticity by -0.162 %/10mmHg 
[95%CI -0.006 to -0.318]. There was no evidence to suggest LDL-C and fasting glucose associated 
with subclinical cardiovascular phenotypes (table 24). 
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Table 24.  Association between changes in cardiovascular risk factors and subclinical  
   cardiovascular phenotypes  
 
Mean carotid intima-media thickness (#$) 
Predictors %-coefficient CI p N 
Age*, Sex, SEIFA scores 1.05 -2.15 – 4.26 0.516 100 
Age, Sex*, SEIFA scores 34  10 – 58 0.006 100 
+ 5 kg/m2 BMI 5 -6 – 15 0.374 100 
+ 10 mmHg systolic BP 0.7 -5 – 6 0.798 94 
+ 50 "mol/l GlycA 3 -5 – 12 0.449 64 
+ 0.1 mmol LDL-C 1 -3 – 6 0.573 64 
+ 0.1 mmol glucose 1 -2 – 4 0.370 81 
Linear regression derived coefficients for total effects from cardiovascular risk factors on pulse wave velocity (in 
m/s), elasticity (in %/10mmHg) and cIMT (in !"). Initial model adjusted for age, sex and SEIFA scores. * 
indicates the coefficient illustrated. The coefficient for SEIFA scores was not significant in any model. Subsequent 
Pulse Wave Velocity (m/s) 
Predictors %-coefficient CI p N 
Age*, Sex, SEIFA scores 0.136 0.098 – 0.174 <0.001 98 
Age, Sex*, SEIFA scores 0.163 -0.122 – 0.448 0.259 98 
+ 5 kg/m2 BMI 0.223 0.105 – 0.340 <0.001 98 
+ 10mmHg systolic BP 0. 260 0.150 – 0.370 <0.001 92 
+ 50 "mol/l GlycA 0.022 -0.093 – 0.137 0.709 62 
+ 0.1 mmol LDL-C 0.008 -0.052 – 0.069 0.786 62 
+ 0.1 mmol glucose 0.022 -0.013 – 0.057 0.209 79 
Elasticity (%/10mmHg) 
Predictors %-coefficient CI p N 
Age*, Sex, SEIFA scores -0.187 -0.243 – -0.130 <0.001 100 
Age, Sex*, SEIFA scores -0.239 -0.659 – 0.181 0.261 100 
+ 5 kg/m2 BMI -0.315 -0.500 – -0.130 0.001 100 
+ 50 "mol/l GlycA -0.162 -0.006 – -0. 318 0.042 64 
+ 0.1 mmol LDL-C 0.004 -0.081 – 0.090 0.919 64 
+ 0.1 mmol glucose -0.007 -0.056 – 0.042 0.773 81 
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models include each specific cardiovascular risk factor separately. Coefficients are given for a per unit increase 
as indicated: For BMI: body-mass index in 5 kg/m2; for systolic BP: systolic blood pressure in 10 mmHg; for 
GlycA: glycoprotein acetyls in 50 !mol/l; for LDL-C: low-density lipoprotein cholesterol in 0.1 mmol/l; for 
Glucose: fasting glucose in 0.1 mmol/l. 
5.5.4 Associations between changes in the severity of obesity over time with subclinical 
cardiovascular phenotypes  
Figure 20 shows associations between changes in the percentage level above the 95th BMI-centile over 
time with subclinical cardiovascular phenotypes. The exposure variable was dichotomized into i) 
individuals who maintained or decreased their %>95th BMI centile and ii) individuals who increased 
their %>95th BMI centile over time. Using this approach, 62 participants maintained or decreased, 
whereas 37 participants increased their severity of adiposity over time.  
 
Decreasing the %>95th BMI-centile from visit 1 (COBRA enrolment) to visit 2 (COBRA-CVR visit) 
was associated with a lower PWV in males (-0.750m/s [95%CI -1.137 to -0.363, p-value <0.001]), but 
there was no evidence for an association in females (0.014m/s [95%CI -0.408 to 0.435, p-value 0.95]). 
In corresponding regression models for carotid elasticity, decreasing the %>95th BMI-centile was 
associated with higher carotid elasticity in females (0.945%/10mmHg [95%CI 0.365 to 1.525, p-value 
< 0.005]), but there was no strong evidence for an association in males (0.429%/10mmHg [95%CI -
0.214 to 1.073, p-value = 0.186]). There was no association between increasing or decreasing %>95th 
BMI centile with cIMT in either sex (see figure 20). 
 
Figure 20.  Association between changes in the %>95th BMI-centile from visit 1 to visit 2 and 
subclinical cardiovascular phenotypes, stratified by sex 
 
 
Boxplots for participants with increasing (left) versus decreasing (right) %>95th BMI-centile between 
visit 1 and 2, stratified for sex (females white, males grey). P-values are shown for the estimate of the 
association of the change in the %>95th BMI-centile between visit 1 and visit 2 (dichotomized as 
increasing or decreasing), adjusted for SEIFA scores at visit 2 and age at both visits. 
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6 Discussion 
 
This study provides evidence that macronutrient composition is related to higher total energy intake in 
children and adolescents with obesity. Also, higher levels of obesity measures and lower levels of BMI-
normalized grip strength were shown to associate with obesity-related adverse cardiometabolic 
outcomes and adverse subclinical cardiovascular phenotypes. An overview of the main findings is 
illustrated in figure 21. The main finding from aim I was that lower normalized grip strength identifies 
youth with adverse cardiometabolic risk factors and increased cIMT. The study related to aim II showed 
that protein leverage increases total energy intake in youth with obesity and contributes to increasing 
BMI levels in a physically inactive subgroup. The study for aim III showed that increasing adiposity 
measures, particularly in post-pubertal males, associate with adverse metabolomic profiles that are 
linked with CVD manifestation in adulthood. The main findings from aim IV were that changes in 
adiposity measures over a mean interval of 5.5 years between baseline (mean age 11.2 years) and 
follow-up (mean age 15.7 years) were associated with adverse arterial stiffness measures at follow-up. 
Additionally, changes in SBP was associated with increased PWV and changes in GlycA were inversely 
related to carotid elasticity. Male sex was the only cardiovascular risk factor associated with higher 
cIMT measures.  
 
Figure 21.  Overview of the main study results 
 
 
Overview illustrating the main results of aims I to IV. Red arrows indicate the direction of associations 
from exposures towards outcomes. Abbreviations: BMI: body mass index; %BMI: percentage level 
above the 95th BMI centile; WC: waist circumference; WtH ratio: waist to height ratio; %Fat: % total 
body and truncal fat; BP: blood pressure; CVD: cardiovascular disease; CVR: cardiovascular disease; 
BP: blood pressure; MetS: Continuous metabolic syndrome score; LDL-C: Low-density lipoprotein 
cholesterol; GlycA; glycoprotein acetyls; cIMT; carotid intima-media thickness; PWV: pulse wave 
velocity. 
 
  
CVD-related 
metabolomic profiles
Adiposity Measures
BMI-normalized 
Grip strength
- Mainly in post-pubertal males
Protein 
Leverage
total energy intake 
Aim II 
BMI z-score 
in physically inactive
Aim III
Aim I 
Subclinical atherosclerosis phenotypes
Cardiovascular 
risk factors
LDL-C
MetS score
cIMT PWVCarotid Elasticity
Systolic BP
GlycA
Males
BMI, %BMI, WC, 
WtH ratio, %Fat
Aim IV
Changes in adiposity 
measures and 
cardiovascular risk 
factors over 5.5 years 
interval
Longitudinal data on exposure
Cross-sectional data on exposure
 84 
6.1 Participants 
The participants for the studies included in this thesis were from the Childhood Overweight 
BioRepository of Australia (COBRA), a prospective cohort study established in 2009 that included 438 
children and adolescents with overweight and obesity (Sabin et al.,2010). Three studies (aims I, II and 
III) used a cross-sectionally study design, whereas aim IV included 101 participants from COBRA who 
were re-measured an average of 5.5 years later as part of the longitudinal study arm (COBRA-CVR).  
 
For COBRA, all patients referred to the Weight Management Service, the largest tertiary-hospital based 
Weight Management Service across Australia (Spilchak et al.,2008) were approached to participate. 
COBRA was the first prospective cohort with children and adolescents with obesity to establish a 
biorepository including a comprehensive assessment of environmental and anthropometric measures, 
clinical data and blood samples that were “biobanked” for future batch analysis. Environmental 
measures were mainly assessed through self-completed, preferably validated and standardised 
questionnaires. Anthropometric measures (including weight, height, WC) were assessed by specialized 
nursing stuff using the same equipment to limit measurement error (Carsley et al.,2019). 
 
The number of individuals included for the specific aims were mostly dependent on the availability of 
data and the eligibility criteria. The next section will briefly discuss factors that are to be considered to 
evaluate the representativeness of study populations and to evaluate the generalisability of study results, 
followed by sections to assess the comparability of the aim-specific subpopulations.  
6.1.1 Representativeness and generalisability of the study participants 
Depending on the research question, the representativeness of the cohort investigated is paramount to 
extrapolate the findings to individuals that have not been part of the study. In contrast, the 
generalisability of the study results is more a matter of statistical inference which in turn is a matter of 
available data to account for potential confounding (Richiardi et al.,2013).  
 
Some factors related to the representativeness of the COBRA participants could not have been 
influenced by the study coordinators. First, the resources for weight management services for children 
and adolescents with obesity are limited despite the high prevalence of overweight and obesity in youth. 
Second, the rates of health-carers to refer a child with overweight or obesity to a weight management 
service vary considerably depending upon factors such as their sex, their specialty occupation, the 
socioeconomic status of the patients they care for and whether the referrer had an affiliation with the 
hospital or not (Imoisili et al.,2018). Third, once referred, the attendance rates of children and 
adolescents with obesity at weight management services are notoriously low due to factors such as the 
distance of the individual`s home from the treatment site, lower gross family income and youth self-
report of depressive symptoms (Jensen et al.,2012).  
 
Moreover, the eligibility criteria for the studies presented here were consistent, having a BMI at 
COBRA enrolment that classifies the individual as being obese and having an age of 6 years or over, 
with no other criteria that could introduce selection bias. Also, the COBRA biorepository collected 
comprehensive data that allowed adjustment for the main confounding factors. Having such a 
comprehensive dataset that included potential confounders is particularly important to evaluate the 
generalisability of the results. If the specific confounders to a relevant research question in a particular 
population are known, inference can be drawn and results may be generalisable for a sample size that 
is large enough to provide adequate power (Richiardi et al.,2013). 
 
The next two sections discuss the participant`s comparability between the subpopulations investigated 
for the specific aims and the COBRA cohort from where the participants were selected. 
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6.1.2 Comparability between aim-specific characteristics with the COBRA cohort 
Participant characteristics for aims II and III are listed in table 8. For aim II, investigating the protein 
leverage hypothesis, the main characteristics for age, sex and BMI did not show significant differences 
in their distribution between the participants for aim II and the COBRA cohort. Participants for aim III 
were slightly older (11.9 years versus 11.1 years, p-value 0.006) and had a slightly higher BMI value 
(34.5 kg/m2 versus 32.6 kg/m2, p-value 0.001) compared to the COBRA cohort without difference in 
the sex distribution. However, approximately 1 kg/m2 can be explained by the difference in age, and 
the remaining difference (<1 kg/m2) is considerably small to have major impact on the generalisability 
for the results amongst children and adolescents with obesity.  
6.1.3 Comparability between participants for aim IV with the COBRA cohort 
COBRA-CVR was designed as a longitudinal follow-up of the initial COBRA cohort that aimed to 
determine how changes in adiposity measures associated with subclinical cardiovascular phenotypes. 
A sample size estimation for aim IV found that a minimum sample size of 84 participants was needed 
to provide adequate statistical power to detect the expected differences in PWV. 
 
As a principle, for conclusions to be valid for the original COBRA cohort, the loss to follow-up 
percentage shall be as low as possible to reduce selection bias (Howe et al.,2016). From computational 
modelling, a loss to follow-up for up to 60% did not result in bias (Kristman et al.,2004). In this study, 
from a total of 438 COBRA participants, 30 participants were excluded due to a BMI <95th BMI-centile 
or age below 6 years, resulting in 408 individuals suitable for recruitment. Of those, 96 (24 %) had 
outdated contact details (phone number disconnected or changed owner), 74 (18%) were excluded after 
three failed contact attempts, 115 (28%) declined to participate, 22 (5%) had relocated interstate and 
101 (25%) agreed and consented to participate. Outdated contact details (24%), failed attempts (28%) 
and relocation (5%) are unlikely related to the exposures and outcomes of aim IV.  
 
The main characteristics and cardiovascular risk factors in COBRA and the COBRA-CVR cohort are 
listed in tables 9 and 10. Based on the observational interval of 5.5 years from early to late adolescence, 
adiposity measures such as weight, BMI and WC increased over time. Also, 75% of the individuals 
participating in COBRA-CVR had completed puberty compared to 24% who had reached this level of 
maturity at baseline. However, the percentages of total body fat and truncal fat, and the severity of 
obesity (assessed by the percentage > 95th BMI-centile) remained comparable for individuals at 131.5% 
(SD 26.4) at baseline versus 135.3% (SD19.2) at follow-up. Similar to BMI and pubertal stage, SBP 
significantly increased from a mean SBP of 109 mmHg at baseline to a mean SBP of 126 mmHg at 
follow-up, a difference that is consistent with age-related changes (Flynn et al.,2017). Also, changes in 
LDL-C levels from a mean level of 2.54 mmol/l at baseline to a mean level of 1.76 at follow-up, most 
likely reflect puberty-related decreases (Elkins et al.,2019).  
 
To conclude, neither the eligibility criteria nor the exposure characteristics between COBRA and 
COBRA-CVR seem to have introduced substantial bias beyond age-related effects. Therefore, the 
participants for each aim can be considered representative and – within the limits of the eligibility 
criteria – the results are generalisable for children and adolescents with obesity.  
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6.2 Methods 
The assessment of exposure and outcome variables including demographic and anthropometric 
measures, nutritional data and grip strength, cardiovascular risk factors and subclinical cardiovascular 
phenotypes followed internationally standardised protocols, were derived from questionnaires that have 
undergone assessments for reproducibility and validity and - for data derived from the COBRA-CVR 
cohort - were performed by one examiner. A few aim-specific methods are discussed in the following 
sections. 
6.2.1 Validity and reliability of grip strength measures 
Grip strength data were assessed by a single examiner using a dynamometer with the highest criterion 
validity and reliability in adolescent populations (Espana-Romero et al.,2010). The assessment followed 
a highly standardized protocol that accounted for grip span (CDC,2011). Raw measures were adjusted 
for body weight due to reported weight-related influence (Aasa et al.,2003; Milliken et al.,2008) and 
subsequently categorized into low, moderate and high grip strength according to previously published 
normalized values (Peterson et al.,2016). 
6.2.2 Validity and reliability of energy intake and energy expenditure data  
Total energy intake was calculated using the Australian Child and Adolescent Eating Survey Food-
frequency questionnaire (ACAES-FFQ) (Watson et al.,2009) which has undergone comprehensive 
evaluation for validity and reproducibility. Reproducibility and comparative validity for this FFQ have 
previously been established (Watson et al.,2009). In contrast to 24-hour recall or food records, FFQ are 
less time-consuming and do not require trained interviewers, meaning they are efficient and practical 
for use in epidemiologic studies (Watson et al.,2009). To address the problem of under-reporting of 
total energy intake those reporting a total energy intake below a Goldberg cut-off of 1.2 were excluded 
(see section 2.5.4.1). Although this reduced the number of participants for analysis, it increased the 
validity of the data. 
 
Accelerometry data to assess physical activity was available from 57 individuals for aim II. The 
accelerometer was worn at the hip due to reported higher accuracy compared to devices worn at the 
ankle (Lynch et al.,2019). A period of one week was chosen and acceptability of data was evaluated 
based on published guidelines (Colley et al.,2010). Accelerometery-derived physical activity intensity 
was categorized according to published intensity cut-off points (Colley et al.,2011). 
6.2.3 Validity and reliability of metabolome data  
Reproducibility analysis for metabolomic results based on an NMR spectroscopy derived metabolomic 
platform used for this study revealed excellent results for both fasting and postprandial metabolite 
concentrations. The mean intra-class coefficients to assess variability were 0.99 (Li-Gao et al.,2019). 
In addition, blood samples were consistently collected in a fasting state, immediately processed and 
stored at the local biobanking facility within 2 hours of sample collection, to minimize pre-analytical 
errors.  
 
Due to lower measure for NMR-derived LDL-C, HDL-C and total cholesterol levels compared to a 
standard lipid profile analyzed by the Royal Children`s Hospital pathology, 139 pairs of NMR and 
standard laboratory LDL-C levels were compared, available from analysis performed in COBRA 
participants using the Bland-Altmann method (Bland et al.,1986b). The mean difference and limits of 
agreement between the Nightingale LDL-C and standard laboratory LDL-C was -1.1mmol/l [95%CI -
1.9 to -0.3mmol/l] with no changes to this difference throughout the range. Whereas this difference 
does not cause an error when included in statistical models, a regression model was used to calculated 
LDL-C levels for comparability to standard laboratory LDL-C levels. 
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6.2.4 Validity, reliability and accuracy of subclinical cardiovascular phenotypes  
Risk factors for, and predictive abilities from, subclinical cardiovascular phenotypes are outlined in 
section 2.8. Available data on the validity, reliability and accuracy of the vascular phenotypes used in 
this study are summarized subsequently. The assessment of non-invasive subclinical cardiovascular 
phenotypes is safe and well-tolerated in children (Urbina et al.,2009a). The expertise at the study site 
to collect and analyze data on cIMT and carotid elasticity via ultrasound as well as PWVis considerable 
with more than 3500 infants, children and adults assessed. Standardized protocols have been developed 
and are in accordance with internationally published guidelines. This expertise is particularly important 
as it allowed reproducible measurements using standardized methods, dedicated software, and 
consideration in the statistical models for important covariates.  
6.2.4.1 Carotid intima-media thickness 
The assessment of cIMT is highly used and validated in adulthood and childhood (Burke et al.,1995; 
Zhao et al.,2019) with available reference data published (Doyon et al.,2013). If the same methodology 
is applied, excellent reproducibility has been reported in youth (Selamet Tierney et al.,2015). Reliability 
for mean cIMT measures was assessed for inter- and intra-rater reliability, with resulting intraclass 
correlations of 0.64 [95%CI 0.54-0.74] and 0.71 [95%CI 0.63-0.78]. Similar,inter-rater reliability, 
assessed by intraclass correlation obtained for a random sample of 30 de-identified cine loops for this 
study was 0.91 [95%CI 0.82-0.96]. Also, for this study, the Bland-Altman method was used (Bland et 
al.,1986b). The mean difference between two raters using was 14 "m and the 95% limits of agreement 
were -50 to 30 "m.  
6.2.4.2 Carotid elasticity  
Results for carotid elasticity are based on the same ultrasound assessment used for cIMT and are 
validated for children and adults (Gardner et al.,2010) with reference data reported (Doyon et al.,2013). 
Similar to cIMT, the use of software for edge-detection has increased the reproducibility of results 
(Selzer et al.,2001). 
6.2.4.3 Pulse wave velocity 
Pulse wave velocity (PWV) is a highly reproducible, non-invasive measure of arterial stiffness 
(Wilkinson et al.,1998). It is a well-tolerated measure in children and adolescents as the maximum 
brachial cuff only reaches systolic pressure to produce the central aortic pressure waveform.  
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6.3 Results 
Results will be discussed in order of the main study aims: 
 
Aim I) Associations between grip strength and cardiometabolic risk  
 
This is the first study to relate hand grip strength in children and adolescents with obesity to 
cardiometabolic risk factors and subclinical cardiovascular phenotypes. Low normalized grip strength 
was shown to identify obese youth who have increased cardiometabolic risk. Youth with low 
normalized grip strength had higher systolic blood pressure (+13 mmHg), LDL-C (+0.26 mmol/l), MetS 
score, and cIMT (+50 µm), compared with those with moderate or high grip strength. These findings 
are important, because systolic blood pressure and LDL-C in youth are shown to independently predict 
coronary artery calcification in adulthood (Hartiala et al.,2012). In addition, youth with low normalized 
grip strength had higher MetS score, which has previously been associated with increased risk for future 
type 2 diabetes (Magnussen et al.,2010).  
 
Previously, Melo et al. (Melo et al.,2015) demonstrated that grip strength was associated with cIMT in 
healthy weight children aged 11-12 years. This finding was extended by showing an inverse association 
of normalized grip strength and cIMT in a cohort of youth aged 8-19 years with severe obesity. The 
difference in cIMT between low and moderate/high normalized grip strength groups in the present study 
was +50 µm. This difference persisted after adjustment for BMI z-score, systolic blood pressure, and 
LDL-C, suggesting that differences in these factors are not on the pathway linking normalized grip 
strength to cIMT. Previously, in the Cardiovascular Risk in Young Finns Study, cIMT was shown to 
increase 5.7±0.4 µm/y in young adults (Juonala et al.,2008). Using the vascular age concept (Stein et 
al.,2004), the difference observed here means that participants with low normalized grip strength were 
almost 9 years older in terms of vascular age than those with moderate/high normalized grip strength. 
 
In adults, poor grip strength and its decrease over time has been related to, and is predictive for, many 
health conditions, for an increased cause-specific mortality for CVD, respiratory diseases, various 
cancers, and all-cause mortality (Celis-Morales et al.,2018; Prasitsiriphon et al.,2018). Grip strength 
has also been shown to improve the prediction utility of a standard office-based risk score (Celis-
Morales et al.,2018). Associations between hand grip strength with all-cause and CVD-specific 
mortality were even stronger than that of SBP or total physical activity, and the strength of associations 
with incidence of CVD was comparable to that for systolic blood pressure and stronger than that for 
physical activity (Roberts et al.,2011).  
 
The physiologic mechanism behind these associations are not completely understood. Grip strength is 
a good marker for overall muscular strength (Bohannon et al.,2012), for nutritional status (Norman et 
al.,2011), for healthy patterns of eating including the intake of antioxidants, fish-oil and grams of 
protein (Robinson et al.,2008) and for physical activity and lower sedentary time (Hamer et al.,2013; 
Rantanen et al.,1997). Therefore, the advantage of grip strength may be based on unifying various 
information in one simple measure that is easy, cheap and reproducible in clinical practice compared to 
other measures of physical fitness (Roberts et al.,2011).  
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Aim II) To test the protein leverage hypothesis in children and adolescents with obesity 
This cross-sectional study analysed macronutrient food composition data derived from FFQs in 137 
children and adolescents with obesity, aged 6-18 years. The findings were that with decreasing 
percentages of total energy intake from protein sources, total daily energy intake increased, consistent 
with the mechanism of protein leverage.  
 
In a physically inactive subgroup, lower percentage energy from protein sources remained the only 
macronutrient to increase total energy intake. Also, in the physically inactive subgroup, a diet high in 
protein and moderate in carbohydrate contents was associated with lower BMI z-score, whereas a diet 
moderate in protein and low in carbohydrates was associated with higher BMI z-scores. This is the first 
study to provide evidence for protein leverage in youth with obesity.  
 
Evidence for the mechanism of protein leverage was found with an observed strength of leverage L = -
0.48, indicating partial protein leverage that is comparable to available studies from adults 
(Raubenheimer et al.,2019). Also, results showed a positive association between TEI and BMI z-scores. 
However, macronutrient analysis was associated with BMI z-scores only in a physically inactive 
subgroup, but not in the whole cohort. Several factors may explain this. First, no information on dietary 
non-macronutrient composition was available, particularly on dietary fibre, which has shown to 
attenuate PL-effects on TEI and obesity in mice (Raubenheimer et al.,2019). Second, normative BMI 
centiles are steadily, in a near-linear manner, trending upwards from about 6 years of life throughout 
childhood and so too does the difference between the 50th and the 95th centile increase (the latter 
representing the threshold to determine obesity in childhood) (Kuczmarski et al.,2000). Hence, for 
protein leverage in this age group to be associated with increasing BMI z-scores, the effect size must 
exceed the one from adulthood, where overweight and obesity are determined by static thresholds (i.e. 
BMI 25kg/m2 and 30kg/m2). Third, protein targets vary through life and particularly throughout the 
childhood age-range, influenced by, amongst other factors, age, early nutritional experience and 
physical activity (Raubenheimer et al.,2019). Limited data collected for physical activity only allowed 
the mechanism of protein leverage and the protein leverage hypothesis to be tested in a physically 
inactive subgroup, where an effect of protein leverage on total energy intake and of dietary 
macronutrients (protein and carbohydrate) on BMI z-scores was found. Hence, the results suggest that 
the mechanism of protein leverage is necessary, but not sufficient for protein leverage to cause obesity 
(Raubenheimer et al.,2019). 
 
Available data on total protein intake and the relation to later adiposity measures suggest that a higher 
protein intake in infancy is associated with higher adiposity at age 5 (Scaglioni et al.,2000) and 6 years 
(Gunnarsdottir et al.,2003). A European multicentre, double-blind, randomised clinical trial (The 
Childhood Obesity Project – CHOP-study) randomly assigned healthy infants to receive a high versus 
lower protein-content formula, differing in an average intake of 6-8 gr protein per day during the first 
year of life. At age 6 years, the high-protein formula fed children had higher BMI (0.51; [95%CI 0.13 
- 0.90]) with an OR of 2.43 [95% CI 1.12-5.27] for obesity compared to the low-protein formula fed 
children (Weber et al.,2014b). Two mechanisms, one in agreement with the protein leverage hypothesis 
(Raubenheimer et al.,2015b) may explain this. If the protein intake target during infancy was set higher 
than normal due to habitually higher protein intakes, protein leverage may drive an increased total 
energy intake later in life to achieve this higher protein set point, therefore contributing to obesity 
(Raubenheimer et al.,2019). The other mechanism, termed ‘the early protein hypothesis’, assumes that 
higher protein intake in infancy triggers elevated levels of insulin-like growth factor 1 (IGF-1) and 
insulin (Socha et al.,2011) and therefore stimulates early weight gain. Studies in later childhood and 
early adolescence that investigate the effects of higher intake of protein on later body mass index and 
cardiometabolic risk factors (including hypertension, dyslipidaemia and insulin resistance) found 
limited and inconclusive results for adverse effects (Gow et al.,2014; Voortman et al.,2015). However, 
none of the aforementioned studies have used the method of compositional data analysis to investigate 
the effect of proportional intake of macronutrients on outcomes of interest in contrast to studies in 
adults.  
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In adulthood, population-based studies investigating macronutrient composition trends over the last 
four decades in the US (Hall,2019) have shown a decrease in the percentage intake of energy from 
protein sources accompanied by an increase in the overall intake of total energy, correlating with 
increasing trends in BMI. A recent NHANES analysis from data between 2009-2010 identified the most 
likely causative food product for this trend as being ultra-processed foods (UPF). UPF is a group of 
food products including soft drinks, industrialized desserts, reconstituted meat products, and “ready to 
consume” products, representing almost 60% of all energy intake in the US diet but containing just 
around 9.5% energy from protein sources (Martinez Steele et al.,2018). On a population level, the 
mechanism of the PLH may well contribute to an overall obesity epidemic as recently published 
according to a study investigating data from the US food supply since 1973 (Hall,2019).  
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Aim III) to investigate the relation between clinically assessed adiposity measures and a  
   metabolomic platform with cardiometabolic interests in sera of children and adolescents  
   with obesity, related to sex and pubertal development 
 
This retrospective cohort study analysed the relation between adiposity measures and a NMR-
spectroscopy derived metabolomic profile with cardiometabolic interest in 214 children and adolescents 
with obesity, aged 6-18 years. Findings were that an increase in a range of adiposity measures (BMI, 
BMI z-score, whole body and truncal fat percentage, WC and WtH) was associated with changes in the 
concentration of several metabolites and lipid subclass size. The strongest evidence for associations 
was observed in post-pubertal males.  
 
A higher BMI z-score was positively associated with elevated concentrations for phenylalanine and 
negatively associated to log acetate after correction for FDR. Changes in lipid content in very large 
HDL lipoproteins, the estimated degree of unsaturation, the ratio of 22:6 docosahexaenoic acid and 
omega-3 fatty acids to total fatty acids were all negatively associated with BMI z-score in linear 
regression modelling, but these associations did not remain significant after adjustment for FDR.  
 
In post-pubertal males, associations between increasing BMI z-score with elevated levels of 
triglyceride- and cholesterol-carrying VLDL and LDL particles, lower levels of larger HDL particles, 
increased levels of fatty acids, higher levels of BCAA (i.e. leucine, isoleucine and valine) and aromatic 
amino acids (AAA, e.g. phenylalanine, tyrosine, histidine) and elevated levels for a marker of chronic 
inflammation - glycoprotein acetyls - were found. 
 
Several of those metabolites are critically involved in the process of atherosclerosis: i) elevated levels 
of VLDL lipoproteins, their cholesterol- and triglyceride-content and the ratio of apolipoprotein B/AI 
are key initial steps of atherosclerosis, from endothelial penetration and subendothelial retention of 
modified lipoprotein particles to the initiation of an inflammatory cascade (Back et al.,2019); ii) 
decreased ratios of docosahexaenoic acid/total fatty acids and omega-6 fatty acids/total fatty acids have 
recently been related to a decreased inhibition of the NLRP3 inflammasome, a core inflammatory 
pathway involved in atherosclerosis (Lopategi et al.,2019); iii) decreasing levels of larger and increasing 
levels of small HDL particles. Recent studies have shown that NMR spectroscopy based differentiation 
of HDL particles revealed superior cardiovascular risk assessment as compared to the classical HDL-C 
concentration (Santos-Gallego,2015). And iv), GlycA is a measure for chronic inflammation. Chronic 
inflammation is a major mechanism underlying obesity-related comorbidities including increased risk 
for cardiovascular (MI and intracranial haemorrhage) and all-cause mortality (Akinkuolie et al.,2014; 
Lawler et al.,2016; Wurtz et al.,2015), and for incident CVD (MI, ischaemic stroke, coronary 
revascularization, and CVD death) in initially healthy women followed up for 17.2 years (Akinkuolie 
et al.,2014). Also, weight loss over 12 months after bariatric surgery (Roux-en-Y gastric bypass or 
sleeve gastrectomy) was associated with a significant reduction in GlycA (Manmadhan et al.,2019). In 
this study, GlycA showed a positive trend with increasing BMI, total and truncal body fat percentages, 
although not after FDR correction. Association between higher BMI, BMI z-score or waist to height 
ratio with GlycA were primarily found amongst post-pubertal males.  
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Metabolomic patterns and CVD risk 
Changes in metabolomic profiles are suggested to lay on the causal pathway, located between a risk 
factor for CVD and the manifestation of CVD, thereby offering an opportunity for early risk 
stratification. Evidence for this is based on two studies. The first, a longitudinal study over 6 years in 
adults, used Mendelian randomisation to show casual effects from increasing adiposity on multiple 
metabolites including elevated levels of triglyceride- and cholesterol-carrying VLDL and LDL 
particles, lower levels of larger HDL particles, increased levels of fatty acids, higher levels of BCAA 
and AAA and elevated levels for a marker of chronic inflammation - glycoprotein acetyls (Wurtz et 
al.,2014). The second study used data from the China Kadoorie Biobank, a cohort of more than half a 
million Chinese adults aged 30-79 years (Holmes et al.,2018). The authors related a similar 
metabolomic platform to CVD outcomes including MI and IS. Positive associations with MI and IS 
were found for a 1-SD increase in VLDL and LDL lipoprotein particles, mean VLDL diameter, 
cholesterol in VLDL particles, the ratio of apolipoprotein B / apolipoprotein A1, total fatty acids, 
omega-3 and omega-6 fatty acids, mono and polyunsaturated fatty acids, saturated fatty acids and 
GlycA. Similar, triglycerides levels in all lipoprotein subclasses containing apolipoprotein B were 
positively associated with MI and triglycerides in VLDL lipoproteins, isoleucine and leucine were 
positively associated with IS. Negative OR with MI and IS were found for a 1-SD increase in HDL 
particle size, and solely for MI from cholesterol in HDL2 (larger HDL particles) (Holmes et al.,2018). 
Many associations found in the China Kadoorie Biobank study were observed with increasing BMI z-
score in post-pubertal males in this study. 
 
Metabolomic patterns and T2DM risk 
A study using an untargeted metabolomic approach in a paediatric cohort (Viva La Familia Study, 
n=803, 56% with obesity, mean age 11y), reported positive associations between increasing weight and 
circulating branched chain amino acids and insulin resistance (Butte et al.,2015). In adults, higher 
BCAA and AAA (including phenylalanine and tyrosine) have been positively associated with insulin 
resistance and metabolic syndrome (Wiklund et al.,2014; Wurtz et al.,2012). In the whole cohort, 
associations between BMI and BMI z-score with phenylalanine, BMI and waist circumference with 
tyrosine and a negative association between total body fat percentages and histidine were found. In 
females, negative associations for histidine and positive associations for tyrosine and phenylalanine that 
attenuated towards the null following FDR correction were found. In post-pubertal males, associations 
between increasing BMI z-score and leucine and isoleucine were significant, after adjustment for FDR.  
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Aim IV) to investigate the effect of adiposity measures and cardiovascular risk factors over time  
on a comprehensive, non-invasive subclinical cardiovascular phenotype assessment in 
children and adolescents with obesity 
 
 
This prospective study of 101 children and adolescents with severe obesity followed over 5.5 years, 
found that age and changes in most adiposity measures were associated with arterial stiffness. Of the 
cardiovascular risk factors, changes in GlycA were inversely associated with carotid elasticity; second, 
increased systolic blood pressure was positively associated with faster PWV; and third, male sex was 
the only factor associated with higher cIMT. A maintenance or decrease in the severity of obesity over 
5.5 years during adolescence was associated with improved measures of carotid elasticity in females, 
and reduced PWV results in males. 
 
Arterial stiffness measures for early detection of functional and structural abnormalities  
These prospective results support previous associations between age, male sex, cardiovascular risk 
factors and increased PWV (Urbina et al.,2010). In contrast, the largest study investigating over 6500 
children aged 10-11 years, showed a lower brachial PWV in children with overweight or obesity 
compared to leaner individuals (Charakida et al.,2012). However, that study investigated younger 
children and the BMI range was limited to 15.7-18.8 kg/m2, whereas in the current study participants 
were older (aged 6-25 years) with a higher BMI range 18.2 to 60.9 kg/m2. Also, brachial PWV may not 
be comparable to carotid femoral PWV as the structural component (elastin) varies with the arterial 
segment. Moreover, when a subgroup of adolescents (n=28) was followed up at ages 14 and 19 years, 
brachial PWV increased in individuals with overweight and obesity compared to lean controls, despite 
similar baseline values for PWV (Dangardt et al.,2013), suggesting that a minimum required age and 
duration of exposure to an elevated BMI may be needed to detect increased arterial stiffness measures 
in children with obesity.  
 
The finding for an inverse effect of increasing weight and reduced carotid elasticity are consistent with 
a study in children with obesity with lower carotid elasticity compared to those with healthy weight 
(Tounian et al.,2001). In addition, obesity in childhood is predictive for decreased elasticity in 
adulthood 21-years later (Juonala et al.,2005). The findings of lower carotid elasticity with increasing 
adiposity measures amongst youth with severe obesity are consistent with, and extend, these results. 
The present study is the first to measure GlycA – a composite measure indicative for chronic 
inflammation (Connelly et al.,2017) – in relation to subclinical cardiovascular phenotypes in youth with 
severe obesity. In adulthood, GlycA has been associated with future CVD and mortality (Akinkuolie et 
al.,2014; Kettunen et al.,2018) and is suggested to be a better predictor for the identification and 
stratification of individuals at risk for future CVD than acute phase proteins, such as high sensitivity C-
reactive protein (Connelly et al.,2017). However, there are few studies comparing GlycA and 
established inflammatory markers in childhood.  
 
Arterial structure - carotid intima-media thickness in adolescence 
Studies in the International Childhood Cardiovascular Cohort Consortium have shown improvements 
in cardiovascular risk factor profiles and cIMT for children and adolescents who were overweight or 
obese (mean age 11.4 years) who were non-obese adults (mean age 31years) (Juonala et al.,2011). In 
the current study of children and adolescents with severe obesity, male sex was the only factor 
associated with increased cIMT. No association with cIMT was found for those who decreased or 
increased their %>95th BMI-centile over a mean follow-up time of 5.5 years, when assessed at a mean 
age of 15.7 years. This may be because the appearance of fatty streaks in the carotid artery (in pathology 
studies) occurs after the second decade of life (Kawauchi,1965). Also, the exposure and the severity of 
concomitant cardiovascular risk factors may not have been of sufficient duration to manifest as 
differences in cIMT in this young cohort (Ayer et al.,2015; Park et al.,2015). Moreover, the time-period 
investigated in this cohort includes pubertal transition, when the average increase in sitting height (an 
approximate for the increase in the thoracic arteries length) is ~10 cm (Fredriks et al.,2005). This 
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increase in the longitudinal axis of an elastic artery may limit the detection of changes in cIMT, however 
this remains hypothetical. In line with the latter argument, including pubertal stage in the analysis had 
no effect in this study. 
 
Associations for increasing versus decreasing and maintaining the severity of obesity over time 
In this population of severely obese children and adolescents, an improvement in the %>95th BMI-
centile over a relatively short period was associated with better PWV in males and carotid elasticity in 
females, even if normal weight was not achieved. As data from a systematic review in adults suggest 
that an increase in PWV of 1 m/s results in a 14-15%  increased risk of cardiovascular events, 
cardiovascular mortality and all-cause mortality (Vlachopoulos et al.,2010), the results observed in the 
present study suggest that the 0.75 m/s lower PWV at follow-up for those who reduced or maintained 
their %>95th BMI centile is likely to have a meaningful impact on subsequent CVD risk. 
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6.4 Strengths and limitations 
Strengths of this study are the clear focus on children and adolescents with obesity. This is a vulnerable 
population with still growing trends in prevalence in preschool children and countries with lower 
socioeconomic status. A particular strength was the collection of extensive exposure data including 
several measures of anthropometry, key cardiovascular risk factors, quantitative data on physical 
activity and detailed information on nutrition for the COBRA cohort and follow-up anthropometry, 
demography, and cardiovascular risk factor measures as well as hand grip strength and subclinical 
cardiovascular phenotypes added for the COBRA-CVR cohort. This enabled the investigation of 
associations from various exposures, and allowed for the adjustment of various confounders, which is 
an important determinant for the generalizability of study findings. Also, the longitudinal study design 
for aim IV provides a higher level of evidence as exposure data were assessed over time and hence, 
allow to assess effects from changes of exposures over time on the subclinical cardiovascular 
phenotypes.  
 
Limitations of this study include the cross-sectional assessments of exposures and outcomes, which 
does only provide associational level of evidence. However, the tools and measures used for aims I, II 
and III were novel in their application in youth with obesity and adjusted for available confounders. 
Hence, the resulting findings provide the background to generate new hypotheses that warrant testing 
in larger cohorts over a longer period. Also, this study had no data available on a control group with a 
weight category in the normal range, which limits the extrapolation of our findings to individuals with 
normal-weight BMI values. However, the aims were focussed on a population of youth with obesity, 
which is at higher risk for adverse cardiometabolic outcomes. Another limitation, albeit inevitable in 
clinical cohort studies, was the low number of participants with a complete dataset for all variables of 
interest. Similar, the availability of blood samples in research with children was a limiting factor. Aim-
specific eligibility criteria have sanctioned the number of participants further. However, they also 
increased the validity of the findings. This study was also not designed to provide the physiologic 
background to explain the findings, e.g. what is the physiology behind the association between hand 
grip strength and adverse cardiometabolic outcomes, or why are males more susceptible for early, 
adverse vascular changes. Finally, this study used subclinical cardiovascular phenotypes that represent 
intermediate outcomes on the pathway of arteriosclerosis towards manifest clinical CVD. Nevertheless, 
they are validated, reproducible, well-tolerated and valuable for CVD risk prediction. The manifestation 
of CVD is a process lasting decades, warranting the use of well-validated intermediate outcomes when 
seeking methods for early risk-stratification.  
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6.5 Implications for clinicians and policy makers 
The main outcome of this study is that children and adolescents with obesity represent a vulnerable 
group, with manifestation of adverse cardiometabolic risk factors and adverse vascular changes already 
during adolescence. Effective treatment options in youth are limited, and the persistence of obesity and 
obesity-related cardiometabolic risk factors into adulthood highlights the importance of primary and 
secondary prevention.  
 
Obesity in childhood is a multifactorial health condition that warrants a multidisciplinary approach to 
prevent primarily the development of obesity and secondarily prohibit obesity-related comorbidities. 
Policy makers, state and local organizations, school, childcare, healthcare professionals, families and 
individuals must work together to create an environment that supports primary and secondary 
prevention of this pandemic. The majority of overweight and obesity in childhood is caused by an 
obesogenic environment that is modifiable. Research on identifying determinants for an obesogenic 
environment and markers or methods that allow risk stratification for the child with obesity provide the 
tools for primary and secondary prevention. And often, the nature of such determinants will inform the 
relevant responsible discipline or individuals to adopt measures to make a change.  
 
Findings from this study provide evidence that increasing physical fitness and consuming a diet 
balanced in macronutrients may provide an opportunity to reduce the severity of adiposity and to 
identify youth with obesity who are at higher risk for severe cardiometabolic consequences. Whereas 
the individual`s family and the treating physician is usually thought the first-line responsible to 
encourage physical activity and a healthy, well-balanced nutrition, such individual approaches are 
unlikely to be effective for the whole population. Therefore, higher levels of responsibility are clearly 
needed to address these problems. These include: i) governmental structures that prioritize childhood 
obesity as a major public health problem and provide adequate funding to combat and prevent obesity 
in childhood; and ii) governmental laws, regulations and taxes that influence the food environment, e.g. 
with restrictions to the marketing of ultra-processed foods, and children-targeted advertising of 
unhealthy, calorie-dense foods. Similar, governmental policies and regulations that facilitate and 
promote physical activity from early childhood on, e.g. in childcare, schools and workplaces later in 
adulthood. 
 
Several findings from this study have implications for paediatric primary health carers, specialty 
physicians, dietitians and physiotherapist providing care for weight management services. Simple tools 
such as a dynamometer to assess and monitor grip strength as well as counselling on methods to improve 
physical fitness are likely to have an impact on the cardiometabolic risk profile in children and 
adolescents with obesity. Similar, rather than focussing on single food items, the study investigating 
the protein leverage hypothesis provided evidence for prioritizing a balanced diet with a relevant 
proportion of proteins to reduce total energy intake which will likely reduce the severity of obesity. 
Both these methods are cheap, do not necessitate higher levels of expertise and could be easily 
implemented in practise.  
 
Findings from the metabolomic analysis in this study for risk-stratification are promising. For adults, 
metabolomics showed valuable results to identify those at higher risk for many diseases and mortality 
at an early timepoint, where preventative measures are likely to have highest benefits. However, well-
designed longitudinal studies are needed to assess the true impact of metabolomics. Despite the 
promising results, metabolomic analysis is intense in their requirement for funds to provide the 
necessary expertise to collect, analyse and interpret the results.  
 
Implications for the clinician from findings related to aim IV are that irrespective of the adiposity 
measure assessed, an increase in any of them over a 5.5 years period during adolescence is associated 
with adverse arterial stiffness outcomes. Also, the findings highlighted the potential importance of 
assessing BP and markers for chronic inflammation, as changes over time in both of these 
cardiovascular risk factors were associated with adverse changes in arterial stiffness measures. 
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Last, our results showed that reducing or even maintaining the severity of obesity (assessed as the 
percentage level above the 95th centile, i.e. the definition for obesity) over time was associated with 
beneficial subclinical cardiovascular phenotypes. Translating this into clinical practice, it is important 
to consider that the 95th centile for an 11-year corresponds to a BMI of ~ 24 kg/m2, whereas for a 16-
year old, this corresponds to a BMI of ~ 29 kg/m2. As per our study results, the 11-year old with severe 
obesity who can maintain or increase his BMI by no more than ~5 kg/m2 between 11 to 16 years is 
likely to have better arterial stiffness measures.  
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6.6 Future research perspectives 
The findings from the grip strength study provide evidence on a level of association. Available evidence 
from studies in adults showed that grip strength is strongly associated and highly predictive for a variety 
of diseases and mortality. Longitudinal studies starting from early childhood are needed to evaluate the 
predictive ability and the capacity for risk stratification from hand grip strength in youth. Also, studies 
investigating a series of potentially contributing factors to overall physical fitness are warranted to help 
explain the mechanistic background of this measure of global fitness. Grip strength is easy to collect 
with low risk for inter and intra-observer errors and is inexpensive.  
 
Findings from the protein leverage hypothesis warrant confirmation in an extended BMI range 
including children and adolescents with normal BMI categories. Also, studies investigating the protein 
leverage mechanism with cardiometabolic risk factors and CVD would be interesting to extend the 
existing literature to disease risk factors and disease outcomes rather than just to an anthropometric 
measure. Findings from such studies may provide the background for policy makers to guide the food 
industry in their production and marketing of foods with unfavourable macronutrient composition. 
However, such studies warrant an assessment of large quantities of data to allow adjustment for 
confounders. 
 
Findings from the metabolomics study warrant confirmation in a wider age and BMI spectrum in 
children and adolescents with long-term follow up data on specific disease outcomes. Such studies are 
needed to confirm the existing value of metabolomics in risk stratification and risk prediction. Also, 
once a connection between early adverse metabolomic profiles with specific diseases is established, 
this may guide health carers towards early, preventive treatments for such diseases.  
 
Findings from the subclinical cardiovascular phenotypes study warrant replication in youth with a BMI 
range also extending into the normal weight category. This would allow to identify proportional 
contributing effects from ageing versus BMI. Further, such studies would need to be designed 
longitudinally in large populations to detect small effect sizes. Further research is also warranted 
regarding the subclinical cardiovascular risk factors. Whereas it seems plausible from a wide range of 
observations in nature that form fits function, further large-scale research on vascular phenotypes is 
necessary to detect if functional changes are preceding the structural changes in large arteries. This 
would inform on the age-appropriateness of measures for risk stratification and risk prediction. Such 
studies could also provide evidence as to whether there are sex differences from early adolescence, as 
observed in this study.  
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7 Summary and Conclusions 
 
Aim I. The findings related to grip strength suggest that grip strength may be a useful, cheap and 
efficient method to identify those children and adolescents with obesity with a high risk for a 
wide range of diseases, particularly for future CVD. 
 
Aim II. The findings related to the macronutrient analysis provide evidence for the mechanism of 
protein leverage in youth with obesity. They extend the existing literature on effects from 
proportions of macronutrients on health outcomes in adults to a vulnerable population of youth 
with obesity. Assessing the proportion of energy from proteins may be a useful tool to help 
decrease total energy intake, and as a consequence, to support weight management in youth 
with obesity. 
 
Aim III. The findings related to the investigation of a metabolomic platform with focus on 
cardiovascular disease provide evidence for an association between various measures for 
obesity in youth with adverse metabolomic profiles that themselves are associated with 
increased risk for adverse cardiometabolic outcomes. Particularly, post-pubertal males with 
increasing adiposity were identified as being at risk for adverse profiles. These findings support 
the importance of preventing excessive weight gain prior to puberty to avoid metabolomic 
changes that are likely an intermediate on the pathway to adult health consequences, including 
CVD.  
 
Aim IV. The findings related to the association of changes in adiposity measures and cardiovascular risk 
factors over time on a comprehensive set of subclinical cardiovascular phenotypes in children 
and adolescents with severe obesity were that those individuals who improve or maintain their 
severity-level of obesity from early to late adolescence had reduced arterial stiffness, even 
though a normal weight status was not achieved. Changes in adiposity were identified as the 
main modifiable contributor to arterial stiffness, together with changes in an inflammatory 
marker and blood pressure. Male youth with severe obesity had poorer functional and structural 
markers and should be targeted for early CVD prevention. 
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